Sentence,class,file
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c1/57/rbfis-17-06-0517.PMC4207151.pdf
"Available from: http://apps.who.int/ trialsearch/default.aspx ..Correspondence Cristina Maria Nunes Cabral   Rua Cesário Galeno, 445   CEP 03071-000, São Paulo, SP, Brasil   e-mail: cristina.cabral@unicid.edu.br 529  Braz J Phys Ther.",Non-OADS,/arxiv_data1/oa_pdf/c1/57/rbfis-17-06-0517.PMC4207151.pdf
"Published by the British Institute of Radiology under the terms of the Creative Commons Attribution-NonCommercial 4.0 Unported License http://creativecommons.org/licenses/by-nc/4.0/ , which permits unrestricted non- commercial reuse, provided the origi nal author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/81/8b/bjr.20140454.PMC4207152.pdf
The Special Issue can be accessed online at http://onlinelibrary.wiley.com/doi/10.1002/ejlt.,Non-OADS,/arxiv_data1/oa_pdf/00/d9/ejlt0116-1088.PMC4207189.pdf
"http://www.accessdata.fda.gov/scripts/cder/iig/index.Cfm [42] Abelcet, RxList Inc. http://www.rxlist.com/abelcet ‐drug.htm [43] AmBisome1(amphotericin B) liposome for injection, Astellas Pharma US, Inc. www.ambisome.com [44] Daunoxome (Daunorubicin Citrate) –Summary DrugLib.",Non-OADS,/arxiv_data1/oa_pdf/00/d9/ejlt0116-1088.PMC4207189.pdf
"[49] Myocet 50 mg Pulver, Dispersion und Lösungsmittel für ein Konzentrat zur Herstellung einer Infusionsdispersion TEVAPharma B.V. http://www.pharmazie.com/graphic/A/50/0 ‐ 90350.pdf 2013.",Non-OADS,/arxiv_data1/oa_pdf/00/d9/ejlt0116-1088.PMC4207189.pdf
http://www.visudyne.com/ [51] Regulon Group.,Non-OADS,/arxiv_data1/oa_pdf/00/d9/ejlt0116-1088.PMC4207189.pdf
"[53] Exparel, RxList, Inc. http://www.rxlist.com/exparel ‐drug.",Non-OADS,/arxiv_data1/oa_pdf/00/d9/ejlt0116-1088.PMC4207189.pdf
"htm [54] DepoDur, RxList, Inc. http://www.rxlist.com/depodur ‐drug.",Non-OADS,/arxiv_data1/oa_pdf/00/d9/ejlt0116-1088.PMC4207189.pdf
"htm [55] DepoCyt, RxList, Inc. http://www.rxlist.com/depocyt ‐drug.",Non-OADS,/arxiv_data1/oa_pdf/00/d9/ejlt0116-1088.PMC4207189.pdf
http://www.drugs.com/pro/intralipid.,Non-OADS,/arxiv_data1/oa_pdf/00/d9/ejlt0116-1088.PMC4207189.pdf
"html [60] Intralipid 10%, RxList, Inc. http://www.rxlist.com/intralipid ‐ 10‐drug/indications ‐dosage.htm [61] Diazemuls Emulsion for Injection 5 mg/ml (Diazepam), Actavis Nordic A/S , Actavis Group PTC 2013.",Non-OADS,/arxiv_data1/oa_pdf/00/d9/ejlt0116-1088.PMC4207189.pdf
"Cortical and subcortical brain regions were selected by parcellating the cerebrum and the brain stem into distinct, anatomically separated brain regions on the basis of theT1-weighted image, using the well-validated Freesurfer suite (V4.5, http://surfer.nmr.mgh.harvard.edu/).",OADS,/arxiv_data1/oa_pdf/ac/5e/HBM-35-4386.PMC4207190.pdf
"Sixty-third World Health Assembly WHA63/2010/REC/1, Resolutions and decisions 2010.Available at: http://apps.who.int/gb/ebwha/ pdf_ﬁles/WHA63-REC1/WHA63_REC1-en.",Non-OADS,/arxiv_data1/oa_pdf/99/2d/pan0024-0774.PMC4207194.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMay 2014 |  87  | e51369 | Page 1 of 10Video Article Flame Experiments at the Advanced Light Source: New Insights into Soot Formation Processes Nils Hansen1, Scott A. Skeen1, Hope A. Michelsen1, Kevin R. Wilson2, Katharina Kohse-Höinghaus3 1Combustion Research Facility, Sandia National Laboratories 2Chemical Sciences Division, Advanced Light Source, Lawrence Berkeley National Laboratory 3Physikalische Chemie I, Universität Bielefeld Correspondence to: Nils Hansen at nhansen@sandia.gov URL: http://www.jove.com/video/51369 DOI: doi:10.3791/51369 Keywords: Physics, Issue 87, Combustion, Flame, Energy Conversion, Mass Spectrometry, Photoionization, Synchrotron, Hydrocarbon, Soot, Aerosol, Isomer Date Published: 5/26/2014 Citation: Hansen, N., Skeen, S.A., Michelsen, H.A., Wilson, K.R., Kohse-Höinghaus, K. Flame Experiments at the Advanced Light Source: New Insights into Soot Formation Processes.",Non-OADS,/arxiv_data1/oa_pdf/98/8c/jove-87-51369.PMC4207224.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51369/ Introduction Establishing a consistent and predictive mechanism for molecular growth and soot formation processes is one of the greatest challenges in combustion chemistry research8,9.",Non-OADS,/arxiv_data1/oa_pdf/98/8c/jove-87-51369.PMC4207224.pdf
"5th edn, 2009. http://www.surgery.usc.edu/acutecare/downloads/redbook.pdf (accessed on 26 August 2013).",Non-OADS,/arxiv_data1/oa_pdf/0f/23/rju032.PMC4207256.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(9) 1–3 DOI: 10.1177/2054270414536552",Non-OADS,/arxiv_data1/oa_pdf/fc/82/10.1177_2054270414536552.PMC4207274.pdf
The challenge is to focus on solutionswhich make it easier than at present for junior col-leagues to have both a career and a family and bydoing so help to reduce the attrition rate from paedi- atric specialty training.Declarations Competing interests: None declared Funding: None declared Ethical approval: Ethical approval was not required as this is a service evaluation study (http://www.hra.nhs.uk/research- community/before-you-apply/determine-whether-your-study-is- research).,Non-OADS,/arxiv_data1/oa_pdf/fc/82/10.1177_2054270414536552.PMC4207274.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(9) 1–2 DOI: 10.1177/2054270414543397",Non-OADS,/arxiv_data1/oa_pdf/25/86/10.1177_2054270414543397.PMC4207275.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(9) 1–3 DOI: 10.1177/2054270414538954",Non-OADS,/arxiv_data1/oa_pdf/70/09/10.1177_2054270414538954.PMC4207276.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/e4/c1/10.1177_2047981614530287.PMC4207277.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page(http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/db/2c/10.1177_2047981614545910.PMC4207280.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(9) 1–6 DOI: 10.1177/2054270414543396",Non-OADS,/arxiv_data1/oa_pdf/75/03/10.1177_2054270414543396.PMC4207282.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/cd/f8/10.1177_2047981614549497.PMC4207283.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/3c/06/10.1177_2047981614549269.PMC4207284.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page(http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/de/19/10.1177_2047981614546794.PMC4207288.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(9) 1–2 DOI: 10.1177/2054270414536551",Non-OADS,/arxiv_data1/oa_pdf/d2/b1/10.1177_2054270414536551.PMC4207293.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/ad/87/10.1177_2054270414540139.PMC4207294.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(9) 1–5 DOI: 10.1177/2054270414533327",Non-OADS,/arxiv_data1/oa_pdf/78/a6/10.1177_2054270414533327.PMC4207295.pdf
"Symbyax prescribing information (2013; http://pi.lilly.com/us/ symbyax-pi.pdf.Thase ME, Corya SA, Osuntokun O, Case M, Henley DB, Sanger TM et al (2007).",OADS,/arxiv_data1/oa_pdf/1d/80/npp2014101a.PMC4207330.pdf
Zyprexa prescribing information (2013; http://pi.lilly.com/us/ zyprexa-pi.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1d/80/npp2014101a.PMC4207330.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Amphetamine action in aCaMKII-KO mice T Steinkellner et al 2693 Neuropsychopharmacology",Non-OADS,/arxiv_data1/oa_pdf/5a/89/npp2014124a.PMC4207348.pdf
Available at: http://www.romecriteria.org/pdfs/ AdultFunctGIQ.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ec/b4/ciu629.PMC4207419.pdf
"Vaccination History Inﬂuenza vaccination history was obtained from a real-time, In- ternet-based immunization registry used by all vaccination pro- viders serving the population (available at: http://www.recin.",OADS,/arxiv_data1/oa_pdf/ce/99/ciu680.PMC4207422.pdf
Availability and implementation: ThunderSTORM and the online documentation are both freely accessible at https://code.google.com/p/thunder-storm/ Contact: guy.hagen@lf1.cuni.cz Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/d5/3f/btu202.PMC4207427.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/3f/btu202.PMC4207427.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/03/btu257.PMC4207428.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3c/3b/cmar-6-423.PMC4207437.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pCancer Management and Research 2014:6 423–430Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  423Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S5521 9Preventative therapies for healthy women   at high risk of breast cancer ivana Sestak Centre for Cancer Prevention,   wolfson institute of Preventive  Medicine, Queen Mary University  of London, Charterhouse Square,   London, UK Correspondence: ivana Sestak   Centre for Cancer Prevention, wolfson  institute of Preventive Medicine,   Queen Mary University of London,  Charterhouse Square, London eC1M  6BQ, UK   email i.sestak@qmul.ac.u kAbstract:  Tamoxifen has been shown to reduce the risk of developing estrogen receptor  (ER)-positive breast cancer by at least  50%, in both pre- and postmenopausal women.",Non-OADS,/arxiv_data1/oa_pdf/3c/3b/cmar-6-423.PMC4207437.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/3c/3b/cmar-6-423.PMC4207437.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/3b/cmar-6-423.PMC4207437.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f6/3b/ceor-6-445.PMC4207438.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2014:6 445–450ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  445ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S6892 0Economic burden of asthma in abu Dhabi:   a retrospective study ashraf alzaabi1 Mohammed alseiari2 Bassam Mahboub3 1Respiratory Medicine Division, Zayed  Military hospital, abu Dhabi, United  arab Emirates; 2general secretariat  of Executive Council, abu Dhabi,  United arab Emirates; 3University  of sharjah, Rashid hospital, sharjah,  United arab Emirates Correspondence: ashraf alzaabi   Respiratory Medicine Division,   Zayed Military hospital,   abu Dhabi, United arab Emirates   Tel +971 506 474 488   Email ashraf.alzaabi@utoronto.c aAbstract:  This study evaluates the direct costs of treating asthma in Abu Dhabi in the United  Arab Emirates.",Non-OADS,/arxiv_data1/oa_pdf/f6/3b/ceor-6-445.PMC4207438.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/f6/3b/ceor-6-445.PMC4207438.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/3b/ceor-6-445.PMC4207438.pdf
Available from: http://www.erswhitebook.org/chapters/the-economic- burden-of-lung-disease /.,Non-OADS,/arxiv_data1/oa_pdf/f6/3b/ceor-6-445.PMC4207438.pdf
Available from: http://www.abudhabichamber.ae/PublicationsEnglish/ Doc-29-7-2013-133651.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f6/3b/ceor-6-445.PMC4207438.pdf
"Available from:  http://www.cdc.gov/nchs/icd/icd9.ht m. Accessed May 16th, 2014.",OADS,/arxiv_data1/oa_pdf/f6/3b/ceor-6-445.PMC4207438.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e2/1c/ccide-6-081.PMC4207439.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dentistry 2014:6 81–87Clinical, Cosmetic and Investigational Dentistry Dove press submit your manuscript | www.dovepress.co m Dove press  81REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCIDE.S5346 1Factors influencing repair of dental restorations   with resin composite Igor R Blum1 Christopher D Lynch2 Nairn HF Wilson3 1Maurice Wohl Dental Academy, King’s  College London Dental Institute,   London, UK;  2School of Dentistry,   College of Biomedical and Life  Sciences, Cardiff University, Cardiff,   Wales;  3King’s College London Dental  Institute, London, UK Correspondence: Igor R Blum   Maurice Wohl Dental Academy,   KCL/KCH West Norwood Health &  Wellbeing Centre 25 Devane Way,   West Norwood, London SE27 0DF, UK   Email igor.blum@nhs.ne tAbstract:  The presentation of patients with dental restorations that exhibit minor defects is  one of the commonest clinical situations in the practice of general dentistry.",Non-OADS,/arxiv_data1/oa_pdf/e2/1c/ccide-6-081.PMC4207439.pdf
"Clinical, Cosmetic and Investigational Dentistry Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dentistry-journa lClinical, Cosmetic and Investigational Dentistry is an international,  peer-reviewed, open access, online journal focusing on the latest clini - cal and experimental research in dentistry with specific emphasis on  cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/e2/1c/ccide-6-081.PMC4207439.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/e2/1c/ccide-6-081.PMC4207439.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/83/c2/ccid-7-267.PMC4207440.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2014:7 267–274Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  267OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S6842 4skin-whitening and skin-condition-improving  effects of topical oxidized glutathione: a double- blind and placebo-controlled clinical trial   in healthy women Fumiko Watanabe1 erika hashizume1 gertrude P Chan2 ayako Kamimura1 1healthcare Products Development  Center, KYOW a haKKO BIO  CO., lTD., Tsukuba, Ibaraki, Japan;   2Clinical Trial Management and T esting  associates, Inc., Filinvest Corporate  City, alabang, Muntinlupa City,   Philippines Correspondence: ayako Kamimura   healthcare Products Development   Center, KYOWa haKKO BIO CO.,  lTD., 2 Miyukigaoka, Tsukuba,   Ibaraki 305–0841, Japan   Tel +81 29 856 4354   Fax +81 29 856 4288   email ayako.kamimura@kyowa-kirin.co.j pPurpose:  Glutathione is a tripeptide consisting of cysteine, glycine, and glutamate and  functions as a major antioxidant.",Non-OADS,/arxiv_data1/oa_pdf/83/c2/ccid-7-267.PMC4207440.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/83/c2/ccid-7-267.PMC4207440.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/83/c2/ccid-7-267.PMC4207440.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3d/37/ceor-6-451.PMC4207441.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinicoEconomics and Outcomes Research 2014:6 451–461ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  451ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S6590 0Clinical response and hospital costs associated  with the empirical use of vancomycin and linezolid  for hospital-acquired pneumonia in a Chinese  tertiary care hospital: a retrospective cohort study Yuanlin song1,* Yicheng Yang2,* Wendong Chen3,4 Wei liu2 Kai Wang2 Xuehai li5 Ke Wang2 Manny Papadimitropoulos3,6 William Montgomery7 1Department of Pulmonary Medicine,   Zhongshan hospital, Fudan University,   2lilly suzhou Pharmaceutical Co, ltd,   shanghai Branch, shanghai, People’s  Republic of China;  3Division of social  and administrative Pharmacy, leslie  Dan Faculty of Pharmacy, University  of T oronto,  4normin health, T oronto,   On, Canada;  5Vitalstrategic Research  institute, shanghai, People’s Republic  of China;  6global health Outcomes  Research, Eli lilly, indianapolis, in,   Usa;  7Eli lilly australia Pty ltd, West  Ryde, nsW, australia *These authors contributed equally to  this work Correspondence: William Montgomery   Eli lilly australia Pty ltd,  112 Wharf Rd,  West Ryde, nsW  2064, australia   Tel +61 2 9325 4335  Fax +61 2 9325 4334  Email montgomery_bill@lilly.co mAims:  To evaluate clinical outcomes and allocation of hospital costs associated with empirical  use of vancomycin or linezolid for hospital-acquired pneumonia (HAP) in the People’ s Republic  of China.",Non-OADS,/arxiv_data1/oa_pdf/3d/37/ceor-6-451.PMC4207441.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/3d/37/ceor-6-451.PMC4207441.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/37/ceor-6-451.PMC4207441.pdf
Avail - able from: http://www.tjcn.org/plus/view.php?aid=26117.,Non-OADS,/arxiv_data1/oa_pdf/3d/37/ceor-6-451.PMC4207441.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)LCMV CD8þT-cell responses require IRF4 and BATF M Grusdat et al 1060 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/4f/04/cdd201419a.PMC4207473.pdf
Spectral analysis was carried out using Chronuxtoolbox procedures (http://chronux.org/).,OADS,/arxiv_data1/oa_pdf/5f/dc/acn30001-0015.PMC4207500.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5a/09/dhps-6-151.PMC4207541.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug, Healthcare and Patient Safety 2014:6 151–153Drug, Healthcare and Patient Safety Dove press submit your manuscript | www.dovepress.co m Dove press  151PerSPectiveSopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/DHPS.S7175 7Patient perceptions on the subject   of medical research Gary ventolini1 Breanna Goodwin1 courtney Woody2 1School of Medicine,  2texas tech  University Health Sciences center,   Odessa, tX, USA correspondence: Gary ventolini   School of Medicine, texas tech   University Health Sciences center,  Permian Basin,  800 West  4th Street,  Odessa, tX  79705, USA   email g ary.ventolini@ttuhsc.ed uAbstract:  While performing medical research we often spend little time addressing patient’ s  views on how research participants perceive the trial will affect their own condition.",Non-OADS,/arxiv_data1/oa_pdf/5a/09/dhps-6-151.PMC4207541.pdf
"Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-healthcare-and-patient-safety-journa lDrug, Healthcare and Patient Safety is an international, peer-reviewed  open-access journal exploring patient safety issues in the healthcare  continuum from diagnostic and screening interventions through to treat - ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/5a/09/dhps-6-151.PMC4207541.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/09/dhps-6-151.PMC4207541.pdf
Available from: http://www.wma.net/ en/30publications/10policies/b3 /.,Non-OADS,/arxiv_data1/oa_pdf/5a/09/dhps-6-151.PMC4207541.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3e/82/dddt-8-1955.PMC4207542.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2014:8 1955–1964Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1955Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6024 7intestinal absorption, organ distribution, and  urinary excretion of the rare sugar D-psicose ikuko Tsukamoto1,* akram hossain2,3,* Fuminori Yamaguchi2 Yuko hirata2 Y ouyi Dong2 Kazuyo Kamitori2 li sui2 Machiko nonaka2 Masaki Ueno4 Kazuyuki nishimoto5 hirofumi suda5 Kenji Morimoto6 Tsuyoshi shimonishi7,† Madoka saito8 Tao song9 ryoji Konishi1 Masaaki T okuda2 1Department of Pharmaco-Bio-informatics,  Faculty of Medicine, Kagawa University,  Miki, Kagawa, Japan;  2Department of cell  Physiology, Faculty of Medicine, Kagawa  University, Kagawa, Japan;  3Matsutani chemical  industry co, ltd, itami, Japan; 4Department of  inflammation Pathology, Faculty of Medicine,  Kagawa University, Kagawa, Japan;  5Division of  radioisotope research, life science research  center, Kagawa University, Kagawa, Japan;  6rare  sugar research center, Kagawa University,  Kagawa, Japan;  7iZUMOring llc, Miki, Kita,  Kagawa, Japan;  8Department of Pharmacy,  Okayama University hospital, Okayama, Japan;   9The First affiliated hospital, china Medical  University, shenyang, People’s republic of china *These authors contributed equally to   this work †Tsuyoshi shimonishi has passed awayBackground:  The purpose of this study was to evaluate intestinal absorption, organ distribution,  and urinary elimination of the rare sugar D-psicose, a  3-carbon stereoisomer of D-fructose  that is currently being investigated and which has been found to be strongly effective against  hyperglycemia and hyperlipidemia.",Non-OADS,/arxiv_data1/oa_pdf/3e/82/dddt-8-1955.PMC4207542.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/3e/82/dddt-8-1955.PMC4207542.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/82/dddt-8-1955.PMC4207542.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/76/c8/dddt-8-1979.PMC4207544.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 1979–1983Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1979SHORT REPORTopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/DDDT .S7212 9Efficacy of short novel antimicrobial and   anti-inflammatory peptides in a mouse model  of methicillin-resistant Staphylococcus aureus   (MRSA) skin infection Mohamed F Mohamed Mohamed N Seleem Department of Comparative  Pathobiology, College of Veterinary  Medicine, Purdue University, West  Lafayette, IN, USAAbstract:  The therapeutic efficacy of two novel short antimicrobial and anti-inflammatory  peptides (RR and RRIKA) was evaluated in a mouse model of staphylococcal skin infection.",Non-OADS,/arxiv_data1/oa_pdf/76/c8/dddt-8-1979.PMC4207544.pdf
"Furthermore, both RR and RRIKA enhanced the antistaphylococcal Correspondence: Mohamed N Seleem Department of Comparative  Pathobiology, College of Veterinary  Medicine, Purdue University,  625 Harrison Street, Lynn 1298,  West Lafayette, IN 47907-2027, USA Tel +1 765 494 0763 Fax +1 765 496 2627 Email mseleem@purdue.ed u Journal name: Drug Design, Development and Therapy Article Designation: SHORT REPORT Y ear: 2014 Volume: 8 Running head verso: Mohamed and Seleem Running head recto: Efficacy of peptides in a mouse model of MRSA skin infection DOI: http://dx.doi.org/10.2147/DDDT.S72129",Non-OADS,/arxiv_data1/oa_pdf/76/c8/dddt-8-1979.PMC4207544.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/76/c8/dddt-8-1979.PMC4207544.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/76/c8/dddt-8-1979.PMC4207544.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1d/24/copd-9-1207.PMC4207545.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2014:9 1207–1224International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1207RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S5122 6Oxidative stress and free radicals in COPD –  implications and relevance for treatment wolfgang Domej1 Karl Oettl2 wilfried Renner3 1Division of Pulmonology, Department  of Internal Medicine, 2Institute of  Physiological Chemistry, 3Clinical  Institute of Medical and Chemical  Diagnostics, Medical University of  Graz, Graz, Austria Correspondence: wolfgang Domej   Division of Pulmonology, Department   of Internal Medicine, Medical University  of Graz, Auenbruggerplatz 20,   A-8036 Graz, Austria   Tel +43 316 385 80250   Fax +43 316 385 13930   email wolfgang.domej@medunigraz.a tAbstract:  Oxidative stress occurs when free radicals and other reactive species overwhelm  the availability of antioxidants.",Non-OADS,/arxiv_data1/oa_pdf/1d/24/copd-9-1207.PMC4207545.pdf
"Available from: http://www.nature.com/nature/index.htm l. Abbreviations:  CAT, catalases; GPx, peroxidases; NADPH, ; RNS, reactive nitrogen species; SOD, superoxide dismutases.",Non-OADS,/arxiv_data1/oa_pdf/1d/24/copd-9-1207.PMC4207545.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/1d/24/copd-9-1207.PMC4207545.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1d/24/copd-9-1207.PMC4207545.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e7/2a/dhps-6-131.PMC4207549.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug, Healthcare and Patient Safety 2014:6 131–138Drug, Healthcare and Patient Safety Dove press submit your manuscript | www.dovepress.co m Dove press  131Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DHPS.S6920 1T opical steroid addiction in atopic dermatitis Mototsugu Fukaya1 Kenji Sato2 Mitsuko Sato3 Hajime Kimata4 Shigeki Fujisawa5 Haruhiko Dozono6 Jun Y oshizawa7 Satoko Minaguchi8 1Tsurumai Kouen Clinic, Nagoya,   2Department of Dermatology, Hannan  Chuo Hospital, Osaka,  3Sato Pediatric  Clinic,  Osaka, 4Kimata Hajime Clinic,   Osaka, 5Fujisawa Dermatology Clinic,   T okyo, 6Dozono Medical House,   Kagoshima, 7Yoshizawa Dermatology  Clinic, Y okohama, 8Department of  Dermatology, Kounosu Kyousei  Hospital, Saitama, Japan Correspondence: Mototsugu Fukaya   Tsurumai Kouen Clinic,  5-20-6, Chiyoda,  Naka-ku, Nagoya-City, Aichi Prefecture,   460-0012 Japan   email moto@earth.ocn.ne.j pAbstract:  The American Academy of Dermatology published a new guideline regarding topical  therapy in atopic dermatitis in May  2014.",Non-OADS,/arxiv_data1/oa_pdf/e7/2a/dhps-6-131.PMC4207549.pdf
Or use: http://dvpr.es/XNuad g,Non-OADS,/arxiv_data1/oa_pdf/e7/2a/dhps-6-131.PMC4207549.pdf
"Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-healthcare-and-patient-safety-journa lDrug, Healthcare and Patient Safety is an international, peer-reviewed  open-access journal exploring patient safety issues in the healthcare  continuum from diagnostic and screening interventions through to treat - ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/e7/2a/dhps-6-131.PMC4207549.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/2a/dhps-6-131.PMC4207549.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 1893–1910Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1893Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6925 8Multipotent cholinesterase/monoamine oxidase  inhibitors for the treatment of alzheimer’s  disease: design, synthesis, biochemical evaluation,  aDMeT, molecular modeling, and Qsar analysis  of novel donepezil-pyridyl hybrids Oscar M Bautista- aguilera1,*  gerard esteban2,*  Mourad chioua1  Katarina nikolic3  Danica agbaba3  ignacio Moraleda4  isabel iriepa4  elena soriano5  abdelouahid samadi1  Mercedes Unzeta2 José Marco-contelles1 1laboratory of Medicinal chemistry  (institute of general Organic  chemistry [ iQOg], national  research council [csic]), Madrid,   spain; 2Department of Biochemistry  and Molecular Biology, institute  of neurosciences, autonomous  Barcelona University, Barcelona,   spain; 3institute of Pharmaceutical  chemistry, Faculty of Pharmacy,   University of Belgrade, Belgrade,   serbia; 4Department of Organic  chemistry, Faculty of Pharmacy,   University of alcalá, ctra Barcelona,   alcalá de henares, spain; 5synthesis,   and structure of Organic compounds  (sePcO) (iQOg, csic), Madrid, spain *These authors have equally  contributed to this workAbstract:  The design, synthesis, and biochemical evaluation of donepezil-pyridyl hybrids  (DPHs) as multipotent cholinesterase (ChE) and monoamine oxidase (MAO) inhibitors  for the potential treatment of Alzheimer’s disease (AD) is reported.",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"AD is characterized  by a selective loss of cholinergic neurons as a consequence of decreasing levels of correspondence:  José Marco-contelles laboratorio de Química Médica  (iQOg, csic), c/Juan de la cierva 3,  28006-Madrid, spain Fax +34 91 546 4853 email iqoc21@iqog.csic.e s Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Bautista-Aguilera et al Running head recto: Multipotent inhibitors for the treatment of Alzheimer’s disease DOI: http://dx.doi.org/10.2147/DDDT.S69258",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
chemistry The synthesis of the target DPH molecules was carried  out as shown in schemes 1 and 2 (Supplementary  material http://www.iqog.csic.es/iqog/sites/default/files/public/ User/Jos%C3%A9%20Luis%20Marco%20Contelles/ Supplementary %20material.pdf ).,OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"In the synthesis  of compound 20, minor amounts of N,N′-di(C2,6)alkylated  product were isolated and characterized (Supplementary  material http://www.iqog.csic.es/iqog/sites/default/files/ public/User/Jos%C3%A9%20Luis%20Marco%20Contelles/ Supplementary %20material.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"3D-Qsar study of novel DPhs  The 3D-QSAR study has been carried out on these  hybrids with main goal to define structural requirements  for high inhibitory activity on the enzymes involved,  following the usual methods (Supplementary material  http://www.iqog.csic.es/iqog/sites/default/files/public/ User/Jos%C3%A9%20Luis%20Marco%20Contelles/ Supplementary %20material.pdf ).",OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"The IC50 inhibition values of MAO A/B and AChE/ BuChE by donepezil-pyridine hybrids (Chart S1, Supplemen - tary material http://www.iqog.csic.es/iqog/sites/default/files/ public/User/Jos%C3%A9%20Luis%20Marco%20Contelles/ Supplementary %20material.pdf ), and 37 donepezil-indole (Charts S2 and S3, Supplementary material http://www.iqog.",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"Hydrogen bond acceptor (HBA) properties of O-bridge  create crucial favorable interactions (v892: N1-TIP) (Figure  S1, Supplementary material http://www.iqog.csic.es/iqog/ sites/default/files/public/User/Jos%C3%A9%20Luis%20 Marco%20Contelles/Supplementary%20material.pdf ) for  MAO A inhibiting activity with steric properties of the  propargylamine moiety (Donz-D4/Donz-D9, Figure S2A/B,  Supplementary material http://www.iqog.csic.es/iqog/ sites/default/files/public/User/Jos%C3%A9%20Luis%20 Marco%20Contelles/Supplementary%20material.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"The  unsaturated bond of the propargylamine moiety also forms  a favorable interaction (v287: TIP-TIP, v344: TIP-TIP)  with the nearest terminal hydrogen  (Donz-D4/Donz-D9,   Figure S2A/B, Supplementary material http://www.iqog.",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"Substitution of the terminal hydrogen of propargylamine  moiety (Donz-D4/Donz-D9, Figure S2 A/B, Supplementary  material http://www.iqog.csic.es/iqog/sites/default/files/ public/User/Jos%C3%A9%20Luis%20Marco%20Con - telles/Supplementary%20material.pdf ) with bulky groups  could enhance MAO A inhibiting activity of the examined  compounds by facilitating the favorable interactions (v892:  N1-TIP, v287: TIP-TIP, v344: TIP-TIP).",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"Also, HBA O-bridge forms very specific unfavor - able interactions (v854: N1-TIP and v868: N1-TIP) with  N-Me group of the indole moiety (Donz-D9, Figure S2B,  Supplementary material http://www.iqog.csic.es/iqog/ sites/default/files/public/User/Jos%C3%A9%20Luis%20 Marco%20Contelles/Supplementary%20material.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"Furthermore, the N-Me group of the indole moiety forms  unfavorable interactions (v301: TIP-TIP, v325: TIP-TIP,  and v332: TIP-TIP) with meta/para positions of the benzyl  moiety (Donz-D4/Donz-D9, Figure S2 A/B, Supplementary  material http://www.iqog.csic.es/iqog/sites/default/files/NTDepr DPH12NTDepr020406080100120 Pre-di lution Post-dilutionhMAO B activity remaining (mFU/min, % NT ) DPH12 Figure 5 assessment of  reversibility of hMaO B activity inhibited by DPh14  (50 µM) and R-deprenyl (500 nM).",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"Finally, the HBD properties of the N-atom in the piper - idinyl or piperazinyl moiety create very specific unfavorable  interactions (v783: O-TIP) with meta positions of the benzyl  moiety (Donz-D4/Donz-D9, Figure S2 A/B, Supplemen - tary material http://www.iqog.csic.es/iqog/sites/default/ files/public/User/Jos%C3%A9%20Luis%20Marco% 20 Contelles /Supplementary%20material.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"Predictive potential of the developed 3D-QSAR (MAO  A)  model was tested by use of leave-one-out cross validation  of the training set (Q2: 0.87, R2 Observed vs Predicted: 0.977, and  root mean square error of estimation [RMSEE]: 0.229) and  verification set (R2 Observed vs Predicted: 0.804 and root mean square  error of prediction [RMSEP]: 0.578) (Table S1, Supplemen - tary material http://www.iqog.csic.es/iqog/sites/default/files/ public/User/Jos%C3%A9%20Luis%20Marco%20Contelles/ Supplementary %20material.pdf ).",OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"Hydrogen bond donor (HBD) properties of amino  groups of propargylamine and indole moieties create very  specific favorable interactions (v765: O-TIP, v775: O-TIP)  (Figure S3, Supplementary material http://www.iqog.csic.",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"pdf) for MAO B inhibiting activity with unsaturated back  chain (Donz-D3/Donz-D5, Figure S4 A/B, Supplemen - tary material http://www.iqog.csic.es/iqog/sites/default/ files/public/User/Jos%C3%A9%20Luis%20Marco% 20 Contelles /Supplementary%20material.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"The  propargylamine group creates favorable interaction (v295:  TIP-TIP, v314: TIP-TIP) with N-CH3 group of the indole  moiety, and also forms favorable interaction with meta/para  positions of the benzyl moiety (Donz-D3/Donz-D5, Figure  S4A/B, Supplementary material http://www.iqog.csic.",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"Also, the hydrophobic part of the propargylamine moiety  forms unfavorable interactions (v477: N1-DRY, v527: N1-DRY)  with HBA ortho-C-atom of the benzyl moiety (Donz-D3, Fig - ure S4A, Supplementary material http://www.iqog.csic.es/ iqog/sites/default/files/public/User/Jos%C3%A9%20Luis%20 Marco%20Contelles/ Supplementary %20material.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"Predictive potential of the developed 3D-QSAR (MAO  B)  model was tested by use of leave-one-out cross validation of  the training set (Q2: 0.82, R2 Observed vs Predicted: 0.956, and RMSEE:  0.314) and verification set (R2 Observed vs Predicted: 0.924 and RMSEP:  0.410) (Table S2, Supplementary material http://www.iqog.",OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"HBD properties of N-atom in the piperidine ring and  secondary N-atom in the propargylamine group create very  specific unfavorable interactions (v133: O-O) (Figure S5,  Supplementary material http://www.iqog.csic.es/iqog/ sites/default/files/public/User/Jos%C3%A9%20Luis%20 Marco%20Contelles/Supplementary%20material.pdf )  for AChE inhibition (DPH8,  Figure S6A, Supplementary  material http://www.iqog.csic.es/iqog/sites/default/files/ public/User/Jos%C3%A9%20Luis%20Marco%20Contelles/ Supplementary%20material.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"HBD feature of N-atom in piperidinyl moiety creates  very specific unfavorable interaction (v678: O-N1) with  the cyano group (DPH4, Figure S6B, Supplementary mate - rial http://www.iqog.csic.es/iqog/sites/default/files/pub - lic/User/Jos%C3%A9%20Luis%20Marco%20Contelles/ Supplementary %20material.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"Drug Design, Development and Therapy 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1902Bautista-aguilera et al Supplementary material http://www.iqog.csic.es/iqog/sites/ default/files/public/User/Jos%C3%A9%20Luis%20Marco%20 Contelles/Supplementary%20material.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"HBA feature of N-atom in the pyridine ring creates  favorable interactions with meta/para position of benzyl  moiety (v895: N1-TIP) for AChE inhibition (DPH8 and 4,   Figure S6A/B, Supplementary material http://www.iqog.",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"The propargylamine moiety creates crucial favorable  interaction with hydrophobic phenyl substituent of the pyri - dine moiety (v803: DRY-TIP) (DPH4, Figure S6B, Supple - mentary material http://www.iqog.csic.es/iqog/sites/default/ files/public/User/Jos%C3%A9%20Luis%20Marco%20 Contelles/Supplementary%20material.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"Since meta position of the phenyl  substituent of the pyridine moiety forms one unfavorable inter - action with N-atom of the pyridine ring (v909: N1-TIP), sub - stitution of the meta position of the phenyl substituent could  result in decrease of AChE inhibiting activity (DPH4, Figure  S6B, Supplementary material http://www.iqog.csic.es/iqog/ sites/default/files/public/User/Jos%C3%A9%20Luis%20 Marco%20Contelles/Supplementary%20material.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"HBD properties of N-bridge forms a very specific favor - able interaction (v785: O-TIP) with the propargylamine  group (DPH8 and 4, Figure S6A/B, Supplementary mate - rial http://www.iqog.csic.es/iqog/sites/default/files/public/ User/Jos%C3%A9%20Luis%20Marco%20Contelles/ Supplementary %20material.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"HBD feature of N-atom in piperidinyl moiety creates  crucial favorable interactions (v690: O-N1) (Figure S7,  Supplementary material http://www.iqog.csic.es/iqog/ sites/default/files/public/User/Jos%C3%A9%20Luis%20 Marco%20Contelles/Supplementary%20material.pdf ) for  BuChE inhibition with the HBA properties of N-atom of the  pyridine ring (DPH3 and 4, Figure  S8A/B, Supplementary  material http://www.iqog.csic.es/iqog/sites/default/files/public/User/Jos%C3%A9%20Luis%20Marco%20Contelles/ Supplementary %20material.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"HBA feature of N-atom in the pyridine ring also creates  a crucial favorable interaction (v984: N1-TIP) with meta/ para position of benzyl moiety (DPH3 and 4, Figure S8 A/B,  Supplementary material http://www.iqog.csic.es/iqog/ sites/default/files/public/User/Jos%C3%A9%20Luis%20 Marco%20Contelles/Supplementary%20material.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"The propargylamine group creates two favorable interac - tions (v334: TIP-TIP, v351: TIP-TIP) with meta/para position  of benzyl moiety (DPH3 and 4, Figure S8 A/B, Supplemen - tary material http://www.iqog.csic.es/iqog/sites/default/files/ public/User/Jos%C3%A9%20Luis%20Marco%20Contelles/ Supplementary%20material.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"The propargylamine (DPH3, Figure S8A, Supplementary  material http://www.iqog.csic.es/iqog/sites/default/files/ public/User/Jos%C3%A9%20Luis%20Marco%20Contelles/ Supplementary%20material.pdf ) or benzyl (DPH4, Figure  S8B, Supplementary material http://www.iqog.csic.es/iqog/ sites/default/files/public/User/Jos%C3%A9%20Luis%20 Marco%20Contelles/Supplementary%20material.pdf ) moi - eties create crucial favorable interactions (v317: TIP-TIP)  with phenyl substituent of the pyridine ring.",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"Since meta position of the phenyl substituent  of the pyridine moiety forms one unfavorable interaction  with N-atom of the pyridine ring (v884: N1-TIP), substitution  of the meta position of the phenyl substituent could result in  decrease of BuChE inhibiting activity (DPH3 and 4, Figure  S8B, Supplementary material http://www.iqog.csic.es/iqog/ sites/default/files/public/User/Jos%C3%A9%20Luis%20 Marco%20Contelles/Supplementary%20material.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"HBA properties of cyano group of compound DPH3  forms a crucial unfavorable interaction (v907: N1-TIP) with  meta position of benzyl moiety, while the compounds with  longer N-alkyl chain (such as compound DHH4) do not  create the v907: N1-TIP unfavorable interaction for BuChE  inhibiting activity (DPH3 and 4, Figure S8A/B, Supplemen - tary material http://www.iqog.csic.es/iqog/sites/default/files/ public/User/Jos%C3%A9%20Luis%20Marco%20Contelles/ Supplementary%20material.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"Next, we have investigated the molecular modeling of  compound DPH14 following the usual methods (Supplemen - tary material http://www.iqog.csic.es/iqog/sites/default/files/ public/User/Jos%C3%A9%20Luis%20Marco%20Contelles/ Supplementary%20material.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"SWISS-MODE,36–38 accesible via the ExPASy web server  (http://swissmodel.expasy.org /), a fully automated protein  structure homology-modeling server was used to design the  receptor.",OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"Compound DPH14 established  more interactions with the MAO B active site than with the  MAO A active site, indicating that DPH14 might interact  more tightly with MAO B.  Absortion, distribution, metabolism,  excretion and toxicity analysis  Absortion, distribution, metabolism, excretion and toxicity  (ADMET; ADMET Predictor, v.6.5, Simulations Plus, Inc.,  Lancaster, CA, USA) analysis has been carried out following the  usual methods (Supplementary material http://www.iqog.csic.es/ iqog/sites/default/files/public/User/Jos%C3%A9%20Luis%20 Marco%20Contelles/Supplementary%20material.pdf ).44Drugs that penetrate the central nervous system (CNS)  should have lower polar surface areas than other kinds of  molecules,45 namely, in the range 60–90 Å2.",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"DPHs4, 6, 9, 14 and 16  show hERG liability.54 On other hand, DPHs1–5, 9–12 could  induce carcinogenicity, whereas none of the molecules is  predicted to present hepatotoxicity.55 To sum up, the structures lacking phenyl substituent  show better druglikeness profiles; in particular, DPHs13–15  present the more suitable ADMET properties of the DPH  compounds studied here (Table S3, Supplementary mate - rial http://www.iqog.csic.es/iqog/sites/default/files/public/ User/Jos%C3%A9%20Luis%20Marco%20Contelles/ Supplementary %20material.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"The 3D-QSAR study of 37 donepezil-indolyl and DPHs  was used to define 3D-pharmacophores for inhibition of  MAO A/B, AChE, and BuChE enzymes and to design  DPHs as novel multipotent ligands (Supplementary mate - rial http://www.iqog.csic.es/iqog/sites/default/files/public/ User/Jos%C3%A9%20Luis%20Marco%20Contelles/ Supplementary%20material.pdf ).",OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
"Drug Design, Development and Therapy 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 1910Bautista-aguilera et al Supplementary material Available from: http://www.iqog.csic.es/iqog/sites/default/ files/public/User/Jos%C3%A9%20Luis%20Marco%20 Contelles/Supplementary%20material.pdf",Non-OADS,/arxiv_data1/oa_pdf/5f/d0/dddt-8-1893.PMC4207550.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b3/4e/dddt-8-1965.PMC4207554.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 1965–1977Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1965Original rESEarCHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6498 9Anticancer efficacy and absorption, distribution,   metabolism, and toxicity studies of Aspergiolide A   in early drug development Yuanyuan Wang Xin Qi Dehai li Tianjiao Zhu Xiaomei Mo Jing li Key Laboratory of Marine Drugs,    Ministry of Education, School of   Medicine and Pharmacy, Ocean   University of China, Qingdao,    People’s Republic of China Correspondence: Jing li   Key Laboratory of Marine Drugs,   Ministry of Education, School of Medicine   and Pharmacy, Ocean University   of China, Qingdao, 266003,   People’s Republic of China   T el +86 532 8203 2066   Fax +86 532 8203 2066   Email ljlilac@163.co mAbstract:  Since the first anthracycline was discovered, many other related compounds have  been studied in order to overcome its defects and improve efficacy.",Non-OADS,/arxiv_data1/oa_pdf/b3/4e/dddt-8-1965.PMC4207554.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/b3/4e/dddt-8-1965.PMC4207554.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/4e/dddt-8-1965.PMC4207554.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a2/d7/dddt-8-1851.PMC4207555.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2014:8 1851–1867Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1851Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/DDDT .S6494 0Preclinical profile of cabazitaxel Patricia vrignaud1 Dorothée Semiond2 veronique Benning2 eric Beys2 Hervé Bouchard3 Sunil Gupta4 1Sanofi Oncology, Vitry-sur-Seine,   France;  2Sanofi DSAR, Alfortville,   France;  3Sanofi LGCR, Vitry-sur-   Seine, France;  4Sanofi Oncology,   Cambridge, MA, USA Correspondence: Patricia Vrignaud   Sanofi Oncology,  13 quai Jules Guesde,  Vitry-sur-Seine,  94403 Cedex, France   Tel +33 1 58 93 36 29  Fax +33 1 58 93 34 71  email patricia.vrignaud77@gmail.co mAbstract:  First-generation taxanes have changed the treatment paradigm for a wide variety  of cancers, but innate or acquired resistance frequently limits their use.",Non-OADS,/arxiv_data1/oa_pdf/a2/d7/dddt-8-1851.PMC4207555.pdf
Available  from: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.,OADS,/arxiv_data1/oa_pdf/a2/d7/dddt-8-1851.PMC4207555.pdf
"Available from: http://www.accessdata.fda.gov/ drugsatfda_docs/label/2013/020449s071lbl.pd f. Accessed July 29, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a2/d7/dddt-8-1851.PMC4207555.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/a2/d7/dddt-8-1851.PMC4207555.pdf
"Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2012/201023s003lbl.pd f. Accessed July 29, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a2/d7/dddt-8-1851.PMC4207555.pdf
Available from:  http://www.ncbi.nlm.nih.gov/gene/524 3.,OADS,/arxiv_data1/oa_pdf/a2/d7/dddt-8-1851.PMC4207555.pdf
"Available from: http://bdipharma.com/MSDS/ Sanofi-Aventis/Taxotere%208-10.pd f. Accessed July 29, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a2/d7/dddt-8-1851.PMC4207555.pdf
Available from: http://www.clinicaltrials.gov/ct2/show/ NCT0175130 8.,Non-OADS,/arxiv_data1/oa_pdf/a2/d7/dddt-8-1851.PMC4207555.pdf
Available from: http://www.accessdata.fda.gov/  drugsatfda_docs/label/2010/020449s059lbl.pd f. Accessed May  2014.,Non-OADS,/arxiv_data1/oa_pdf/a2/d7/dddt-8-1851.PMC4207555.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/a2/d7/dddt-8-1851.PMC4207555.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/d7/dddt-8-1851.PMC4207555.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ce/0b/copd-9-1187.PMC4207568.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2014:9 1187–1196International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1187OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7025 7how do COPD comorbidities affect   ICU outcomes?,Non-OADS,/arxiv_data1/oa_pdf/ce/0b/copd-9-1187.PMC4207568.pdf
"2013  (update) http://www.goldcopd.co m. Accessed April 17, 2014.",Non-OADS,/arxiv_data1/oa_pdf/ce/0b/copd-9-1187.PMC4207568.pdf
"http://www.who.int/entity/gard/e n. Accessed  September 8, 2014.",OADS,/arxiv_data1/oa_pdf/ce/0b/copd-9-1187.PMC4207568.pdf
"Global strategy  for diagnosis, management, and prevention of COPD (updated 2008)  (http://www.goldcopd.org).",OADS,/arxiv_data1/oa_pdf/ce/0b/copd-9-1187.PMC4207568.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/ce/0b/copd-9-1187.PMC4207568.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/0b/copd-9-1187.PMC4207568.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/ce/copd-9-1163.PMC4207569.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2014:9 1163–1186International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1163OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S6828 9Comparing the effectiveness of small-particle  versus large-particle inhaled corticosteroid   in COPD Dirkje s Postma1 nicolas roche2 gene Colice3 elliot Israel4 richard J Martin5 Willem MC van aalderen6 Jonathan grigg7 anne Burden8 elizabeth V hillyer8 Julie von Ziegenweidt8 gokul gopalan9 David Price8,10 1University of groningen, Department  of Pulmonary Medicine and T uberculosis,   University Medical Center groningen,   groningen, the netherlands; 2respiratory  and Intensive Care Medicine, Cochin  hospital group, aPhP, Paris-Descartes  University (ea2511), Paris, France;   3Pulmonary, Critical Care and respiratory  services, Washington hospital Center and  george Washington University school of  Medicine, Washington DC, Usa; 4Pulmonary  and Critical Care Division, Brigham and  Women’s hospital, harvard Medical school,   Boston, M a, Usa; 5Department of Medicine,   national Jewish health, Denver, CO, Usa;   6Dept of Pediatric respiratory Medicine  and allergy, emma Children’s hospital aMC,    amsterdam, the netherlands; 7Blizard  Institute, Queen Mary University london,   london, UK; 8research in real life, ltd,   Cambridge, UK; 9respiratory, global  scientific affairs, T eva Pharmaceuticals,   Frazer, P a, Usa; 10academic Primary  Care, Division of applied health sciences,   University of aberdeen, aberdeen, UK Correspondence: David Price   academic Primary Care, Division of  applied health sciences, University of  aberdeen, Polwarth Building, Foresterhill,  aberdeen aB25 2ZD, UK   Tel +44 160 387 1500   Fax +44 808 280 0792   email dprice@rirl.or gPurpose:  Small airway changes and dysfunction contribute importantly to airway obstruction  in chronic obstructive pulmonary disease (COPD), which is currently treated with inhaled  corticosteroids (ICS) and long-acting bronchodilators at Global initiative for Obstructive Lung  Disease (GOLD) grades 2–4.",Non-OADS,/arxiv_data1/oa_pdf/70/ce/copd-9-1163.PMC4207569.pdf
Available from:  http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/70/ce/copd-9-1163.PMC4207569.pdf
Available from: http://www.optimumpatientcare.org/ Html_Docs/OPCRD.html.,Non-OADS,/arxiv_data1/oa_pdf/70/ce/copd-9-1163.PMC4207569.pdf
Available from: http://www.goldcopd.org/uploads/ users/files/GOLDReport07_0108.pdf.,Non-OADS,/arxiv_data1/oa_pdf/70/ce/copd-9-1163.PMC4207569.pdf
"Available  from: http://www.optimumpatientcare.org/Docs/SOP%20Observational  %20Da tabase%20Studies.pd f. Accessed May 12, 2014.",Non-OADS,/arxiv_data1/oa_pdf/70/ce/copd-9-1163.PMC4207569.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/70/ce/copd-9-1163.PMC4207569.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/ce/copd-9-1163.PMC4207569.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/15/5a/dddt-8-1869.PMC4207570.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2014:8 1869–1892Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1869Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/DDDT .S6599 7synthesis and biological evaluation of novel   indole-2-one and  7-aza-2-oxindole derivatives   as anti-inflammatory agents gaozhi chen1,* lili Jiang2,* lili Dong2 Zhe Wang1 Fengli Xu2 Ting Ding3 lili Fu1 Qilu Fang1 Zhiguo liu1,4 Xiaoou shan2 guang liang1 1chemical Biology research center,   school of Pharmaceutical sciences,   2Department of Pediatrics, The  2nd  affiliated hospital,  3Department of  Pharmacy, The  5th affiliated hospital,   Wenzhou Medical University, lishui,   Zhejiang, People’s republic of china;   4Wenzhou Undersun Biotchnology  co, ltd, Wenzhou, Zhejiang, People’s  republic of china *These authors contribute equally to  this work correspondence: guang liang   chemical Biology research center,   school of Pharmaceutical sciences,   Wenzhou Medical University,   Wenzhou, Zhejiang  325000,   People’s republic of china   Tel +86 577 8669 9396   Fax +86 577 8669 9396   email wzmcliangguang@163.co m    Xiaoou shan   Department of Pediatrics,   The 2nd Affiliated Hospital,   Wenzhou Medical University,   Wenzhou, Zhejiang  325000,   People’s republic of china   Tel +86 137 7777 9922   email sssxooo@sina.co mAbstract:  Sepsis, a typically acute inflammatory disease, is the biggest cause of death in ICU  (intensive care unit).",Non-OADS,/arxiv_data1/oa_pdf/15/5a/dddt-8-1869.PMC4207570.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/15/5a/dddt-8-1869.PMC4207570.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/15/5a/dddt-8-1869.PMC4207570.pdf
http://creativecommons.org/licenses/ by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/5e/64/spa-72-398.PMC4207572.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/89/77/opth-8-2129.PMC4207573.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 2129–2131Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2129Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S7326 5successful treatment of neovascular age-related  macular degeneration following single bevacizumab  failure using aflibercept in a vitrectomized eye paul Hahn Duke eye Center, Duke University  Medical Center, Durham, NC, UsaAbstract:  Intravitreal anti-vascular endothelial growth factor (VEGF) pharmacotherapy in  vitrectomized eyes remains a challenge due to the reduced half-life of these agents.",Non-OADS,/arxiv_data1/oa_pdf/89/77/opth-8-2129.PMC4207573.pdf
"Three months following  an examination recording 20/40 vision and stable findings (10 years following macular Correspondence: paul Hahn Duke eye Center, DUMC 3802,  Durham, NC 27710, Usa tel +1 919 684 5631 Fax +1 919 681 6474 email paul.s.hahn@duke.ed u Journal name: Clinical Ophthalmology Article Designation: Case report Y ear: 2014 Volume: 8 Running head verso: Hahn Running head recto: Aflibercept for vitrectomized ARMD DOI: http://dx.doi.org/10.2147/OPTH.S73265",Non-OADS,/arxiv_data1/oa_pdf/89/77/opth-8-2129.PMC4207573.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/89/77/opth-8-2129.PMC4207573.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/89/77/opth-8-2129.PMC4207573.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/06/e6/oajsm-5-243.PMC4207574.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Journal of Sports Medicine 2014:5 243–248Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  243OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S6870 1effects of a high-intensity intermittent training  program on aerobic capacity and lipid profile   in trained subjects nejmeddine Ouerghi1,2 Marwa Khammassi1 Sami Boukorraa1 Moncef Feki2 naziha Kaabachi2 Anissa Bouassida1,3 1research Unit, Sportive Performance  and Physical rehabilitation, high  institute of Sports and Physical  education of Kef, University of  Jendouba, Kef, T unisia, 2laboratory  of Biochemistry, rabta hospital,   Faculty of Medicine of Tunis, el  Manar University, T unis, 3Physiology  laboratory, Faculty of Medicine ibn el  Jazzar, Sousse, T unisia correspondence: nejmeddine Ouerghi   research Unit, Sportive Performance  and Physical rehabilitation, high institute  of Sports and Physical education of Kef,  University of Jendouba, Kef, Tunisia   Tel +216 2530 0232   email najm_ouerghi@hotmail.co mBackground:  Data regarding the effect of training on plasma lipids are controversial.",Non-OADS,/arxiv_data1/oa_pdf/06/e6/oajsm-5-243.PMC4207574.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/06/e6/oajsm-5-243.PMC4207574.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/06/e6/oajsm-5-243.PMC4207574.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/11/a8/ijn-9-4819.PMC4207575.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 4819–4828International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4819OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S6787 1chitosan-decorated selenium nanoparticles  as protein carriers to improve the in vivo   half-life of the peptide therapeutic B aY 55-9837  for type 2 diabetes mellitus lei rao* Yi Ma* Manjiao Zhuang Tianjie luo Yayu Wang an hong Department of cell Biology,   guangdong Province Key lab of  Bioengineering Medicine, National  engineering research center of gene  engineering Medicine, Institute of  Biological Medicine, Jinan University,   guangzhou, People’s  republic of  china *These authors contributed equally   to this work correspondence: an hong Department of cell Biology, Institute  of Biological Medicine, Jinan University,  601 huangpu West avenue, Tianhe,  guangzhou, guangdong 510632, People’s  republic of china Tel +86 20 8522 3266 Fax +86 20 8522 1983 email anhong0881@163.co m Purpose:  As a potential protein therapeutic for type 2 diabetes mellitus (T2DM), BAY 55-9837  is limited by poor stability and a very short half-life in vivo.",Non-OADS,/arxiv_data1/oa_pdf/11/a8/ijn-9-4819.PMC4207575.pdf
"Unfortunately, these therapies  display limited efficacy and have significant mechanism-based side effects.2 The use of proteins and peptides as human therapeutics has increased rapidly in  recent years, and protein-based products are predicted to represent four of the five  top-selling drugs in the global market over the next few years.3,4Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Rao et al Running head recto: SeNPs as carriers to improve BAY 55-9837 half-life DOI: http://dx.doi.org/10.2147/IJN.S67871",Non-OADS,/arxiv_data1/oa_pdf/11/a8/ijn-9-4819.PMC4207575.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/11/a8/ijn-9-4819.PMC4207575.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 4828rao et al 10.,Non-OADS,/arxiv_data1/oa_pdf/11/a8/ijn-9-4819.PMC4207575.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0c/91/ijwh-6-881.PMC4207576.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2014:6 881–888International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  881OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S7222 9Prevalence and perinatal mortality associated   with preterm births in a tertiary medical   center in south east nigeria chukwuemeka anthony  Iyoke1 Osaheni lucky lawani2 euzebus chinonye ezugwu1 gideon Ilechukwu3 Peter Onubiwe nkwo1 sunday gabriel Mba1 Isaac nwabueze asinobi4 1Department of Obstetrics and  gynaecology, University of nigeria  T eaching Hospital, Ituku-Ozalla,   enugu, nigeria; 2Department of  Obstetrics and gynaecology, Federal  T eaching Hospital, abakaliki, nigeria;   3Department of Paediatrics, Whiston  Hospital, st Helen’s and Knowsley  T eaching Hospitals nHs Trust,   Prescot, lancashire, UK; 4Department  of Paediatrics, University of nigeria  T eaching Hospital, Ituku-Ozalla, enugu,   nigeria correspondence: chukwuemeka  anthony Iyoke   Department of Obstetrics and  gynaecology, University of nigeria  Teaching Hospital, PO Box 4994, enugu,  400001, nigeria   Tel +234 80 8583 1167   email caiyoke@yahoo.co.u kBackground:  Preterm birth is a high risk condition associated with significant mortality and  morbidity in the perinatal, neonatal, and childhood periods, and even in adulthood.",Non-OADS,/arxiv_data1/oa_pdf/0c/91/ijwh-6-881.PMC4207576.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/0c/91/ijwh-6-881.PMC4207576.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0c/91/ijwh-6-881.PMC4207576.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs363/en /.,Non-OADS,/arxiv_data1/oa_pdf/0c/91/ijwh-6-881.PMC4207576.pdf
"Available from: http://www.marchofdimes.com/materials/premature- birth-report-card-united-states.pd f. Accessed June 30, 2014.",Non-OADS,/arxiv_data1/oa_pdf/0c/91/ijwh-6-881.PMC4207576.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bf/e7/ott-7-1911.PMC4207577.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2014:7 1911–1917OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1911Case RepORTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6934 3More than 9 years of continuous trastuzumab  treatment in metastatic breast cancer   without cardiac toxicity: a case report   and literature review Florin Badulescu1 adriana Badulescu2 Doru paul3 Carmen Florina popescu4 Cristina Florescu5 1Department of Oncology,   Universitatea de Medicina si Farmacie,   Craiova, Romania; 2Department of  surgery, Universitatea Titu Maiorescu,   Bucuresti, Romania; 3Monter Cancer  Center, North shore LIJ Cancer  Institute, Lake success, NY, Usa;   4Department of p athology, spitalul  Universitar Clinic de Urgenta,   Craiova, Romania; 5Department of  Cardiology, Universitatea de Medicina  si Farmacie, Craiova, Romania Correspondence: Doru paul   Monter Cancer Center, North shore LIJ  Cancer Institute, 450 Lakeville Road, Lake  success, NY 11042, Usa   T el +1 516 734 8775   Fax +1 516 734 8924   email dpaul4@nshs.ed uAbstract:  The main concern of long-term use of trastuzumab remains its association  with potential cardiac side effects.",Non-OADS,/arxiv_data1/oa_pdf/bf/e7/ott-7-1911.PMC4207577.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/bf/e7/ott-7-1911.PMC4207577.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/e7/ott-7-1911.PMC4207577.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fa/dc/jpr-7-579.PMC4207578.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2014:7 579–588Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  579ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/JPR.S6901 1Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/fa/dc/jpr-7-579.PMC4207578.pdf
"Or use: http://dvpr.es/1mWWDb QUse of the painDETECT tool in rheumatoid  arthritis suggests neuropathic and sensitization  components in pain reporting Saqa Ahmed* T ejal Magan* Mario Vargas Abiola Harrison Nidhi Sofat Infection and Immunity Research  Institute, St George’s, University   of London, London, UK *These authors contributed equally to  this work Correspondence: Nidhi Sofat   Infection and Immunity Research   Institute, St George’s, University   of London, Cranmer Terrace,   London SW17 ORE, UK   Email nsofat@sgul.ac.u kAbstract:  Rheumatoid arthritis (RA) is an inflammatory autoimmune condition typified by  systemic inflammation targeted toward synovial joints.",Non-OADS,/arxiv_data1/oa_pdf/fa/dc/jpr-7-579.PMC4207578.pdf
"Available from: http://www.nao.org.uk/wp-content/ uploads/2009/07/0809823.pd f. Accessed August 27, 2014.",Non-OADS,/arxiv_data1/oa_pdf/fa/dc/jpr-7-579.PMC4207578.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/fa/dc/jpr-7-579.PMC4207578.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/dc/jpr-7-579.PMC4207578.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/fa/dc/jpr-7-579.PMC4207578.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c6/e2/ijn-9-4829.PMC4207579.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 4829–4846International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4829OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S7091 9Docetaxel-loaded solid lipid nanoparticles  suppress breast cancer cells growth with   reduced myelosuppression toxicity Qing Yuan1 Jing han1,2 Wenshu cong1 Ying ge3 Dandan Ma1,3,4 Zhaoxia Dai3,4 Yaping li5 Xiaolin Bi1,3,4 1cas Key laboratory for Biological  effects of Nanomaterials and  Nanosafety, Institute of high energy  Physics, chinese academy of sciences,   Beijing, 2school of life sciences, anhui  University, hefei, 3cancer center,   Institute of cancer stem cell, Dalian  Medical University, Dalian, 4graduate  school, Dalian Medical University,   Dalian, 5shanghai Institute of Materia  Medica, chinese academy of sciences,   shanghai, People’s republic of chinaAbstract:  Docetaxel is an adjuvant chemotherapy drug widely used to treat multiple solid  tumors; however, its toxicity and side effects limit its clinical efficacy.",Non-OADS,/arxiv_data1/oa_pdf/c6/e2/ijn-9-4829.PMC4207579.pdf
"Keywords:  docetaxel, docetaxel-loaded solid lipid nanoparticles, breast cancer, toxicity Introduction Docetaxel is a widely used antitumor drug that is semi-synthesized from  10- deacetylbaccatin III, an inactive taxoid precursor prepared from needles of  the European yew, Taxus baccata .1 It has been used to treat a broad spectrum of  solid tumors such as advanced ovarian cancer, non-small-cell lung cancer, locally  advanced or metastatic breast cancer, and androgen-independent prostate cancer.2–4  Docetaxel belongs to the taxane family that can promote assembly of free tubulin  into microtubules and stabilize them by binding to tubulin to inhibit disassembly of  microtubules.5,6 Docetaxel suppresses tumor cell growth in two different modes: at  high concentration, docetaxel induces G2/M cell cycle arrest and apoptosis, whereas a  very low level of docetaxel causes aberrant mitosis followed by necrosis.7,8 Although  docetaxel has many advantages in cancer therapy, it can cause serious side effects,  such as neutropenia, myelosuppression, anemia, and hypersensitivity reaction, which  limit its clinical applications.9–11 Some of these side effects are simply induced by correspondence: Yaping li shanghai Institute of Materia Medica,  chinese academy of sciences, shanghai  201203, People’s republic of china Tel +86 21 5080 6820 Fax +86 21 5080 6820 email ypli@simm.ac.c n  Xiaolin Bi cas Key laboratory for Biological  effects of Nanomaterials and Nanosafety,  Institute of high energy Physics, chinese  academy of sciences, Beijing 100049,  People’s republic of china Tel +86 10 8823 6709 Fax +86 10 8823 6456 email bixl@ihep.ac.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Yuan et al Running head recto: Tumor suppression and toxicity of DSNs DOI: http://dx.doi.org/10.2147/IJN.S70919",Non-OADS,/arxiv_data1/oa_pdf/c6/e2/ijn-9-4829.PMC4207579.pdf
"Gene enrichment analysis of annotation terms was performed  using the Database for Annotation, Visualization, and Inte - grated Discovery (DAVID) functional annotation program.36  The microarray data from this study have been submitted to  the NCBI Gene Expression Omnibus ( http://www.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/c6/e2/ijn-9-4829.PMC4207579.pdf
"Sequences of the primers were obtained  from PrimerBank ( http://pga.mgh.harvard.edu/primerbank/ index.htm l) and OligoArchitect™ Online tools v3.0 (Sigma- Aldrich Co., St Louis, MO, USA), and the optimal primer  pairs were verified by regular PCR.",OADS,/arxiv_data1/oa_pdf/c6/e2/ijn-9-4829.PMC4207579.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c6/e2/ijn-9-4829.PMC4207579.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/e2/ijn-9-4829.PMC4207579.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b2/60/opth-8-2121.PMC4207580.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 2121–2123Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2121Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S7355 0sequential occlusion of the branch retinal  artery and branch retinal vein in a patient  with hypertension: an interventional case report Norio Okamoto Chota Matsumoto Y oshikazu shimomura Department of Ophthalmology,   Kinki University Faculty of Medicine,   Osakasayama City, Osaka, Japan Background:  There are some cases that reported central retinal vein occlusion accompanied  by ciliary artery occlusion, however, combined branch retinal artery and vein occlusion is a  rare condition that has been infrequently reported.",Non-OADS,/arxiv_data1/oa_pdf/b2/60/opth-8-2121.PMC4207580.pdf
"Fluorescein angiography of the right eye  showed significantly delayed filling of the branches of the superior retinal artery in Correspondence: Norio Okamoto Department of Ophthalmology,  Kinki University Faculty of Medicine,  377-2, Ohonohigashi, Osakasayama City,  Osaka, 589-8511, Japan tel +81 72 366 0221 Fax +81 72 368 2559 email eyedoctor9@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Case report Y ear: 2014 Volume: 8 Running head verso: Okamoto et al Running head recto: Branch retinal artery and vein occlusion DOI: http://dx.doi.org/10.2147/OPTH.S73550",Non-OADS,/arxiv_data1/oa_pdf/b2/60/opth-8-2121.PMC4207580.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b2/60/opth-8-2121.PMC4207580.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b2/60/opth-8-2121.PMC4207580.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e2/c7/jpr-7-589.PMC4207581.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2014:7 589–608Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  589Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S5578 2T oward a systematic approach to opioid rotation Howard S Smith1,† John F Peppin2,3 1Department of Anesthesiology,  Albany Medical College, Albany,  NY, USA; 2Global Scientific Affairs,  Mallinckrodt Pharmaceuticals,  St Louis, MO, USA; 3Center for  Bioethics, Pain Management and  Medicine, St Louis, MO, USA †Author deceased May 18, 2013 Correspondence: John F Peppin   Center for Bioethics, Pain Management  and Medicine, 8013 Presidio Court,  University City, MO, 63130, USA   Tel +1 859 221 3154   email johnpeppin@msn.co mAbstract:  Patients requiring chronic opioid therapy may not respond to or tolerate the first  opioid prescribed to them, necessitating rotation to another opioid.",Non-OADS,/arxiv_data1/oa_pdf/e2/c7/jpr-7-589.PMC4207581.pdf
Available from:  http://www.painmed.org/PatientCenter/Facts_on_Pain.aspx .,Non-OADS,/arxiv_data1/oa_pdf/e2/c7/jpr-7-589.PMC4207581.pdf
Available from: http://www.deadiversion.usdoj.gov/21cfr/21usc/841.,OADS,/arxiv_data1/oa_pdf/e2/c7/jpr-7-589.PMC4207581.pdf
Available from: http://www.fda.gov/downloads/Drugs/ GuidanceCompliance RegulatoryInformation/Guidances/UCM334743.,Non-OADS,/arxiv_data1/oa_pdf/e2/c7/jpr-7-589.PMC4207581.pdf
Available from: http://www.hopweb.org/index.cfm?cfid =4634198&cf token =4651583 7.,OADS,/arxiv_data1/oa_pdf/e2/c7/jpr-7-589.PMC4207581.pdf
Available  from: http://www.globalrph.com/narcoticonv.htm .,Non-OADS,/arxiv_data1/oa_pdf/e2/c7/jpr-7-589.PMC4207581.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/e2/c7/jpr-7-589.PMC4207581.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/c7/jpr-7-589.PMC4207581.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/17/19/vhrm-10-591.PMC4207582.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2014:10 591–597Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  591ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/VHRM.S6884 4consumption of water containing over  3.5 mg  of dissolved hydrogen could improve vascular  endothelial function Takaaki sakai1 Bunpei sato2 Koji Hara3 Yuichi Hara3 Yuji naritomi3 samon Koyanagi1 Hiroshi Hara3 T etsuhiko nagao4 T oru ishibashi5 1Department of cardiology,   Haradoi Hospital, Fukuoka, Japan;   2MiZ company limited, Fujisawa,   Kanagawa, Japan;  3Department of  internal Medicine, Haradoi Hospital,   Fukuoka, Japan;  4Midorino clinic,   aoba, Higashi-ku, Fukuoka, Japan;   5Department of Rheumatology and  Orthopedic surgery, Haradoi Hospital,   Fukuoka, Japan correspondence: Toru ishibashi   Haradoi Hospital, Department of  Rheumatology and Orthopedic surgery,   6-40-8 aoba, Higashi-ku, Fukuoka   813-8588, Japan   Tel +81 92 691 3881  Fax +81 92 691 1059  email toruishi@haradoi-hospital.co mBackground:  The redox imbalance between nitric oxide and superoxide generated in the  endothelium is thought to play a pivotal role in the development of endothelial dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/17/19/vhrm-10-591.PMC4207582.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/17/19/vhrm-10-591.PMC4207582.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/17/19/vhrm-10-591.PMC4207582.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7f/1c/ijn-9-4809.PMC4207583.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 4809–4817International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4809OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S7009 2T oxicity assessment of repeated intravenous  injections of arginine–glycine–aspartic acid peptide  conjugated cdseT e/Zns quantum dots in mice Y ou-Wei Wang Kai Yang hong Tang Dan chen Yun-long Bai Department of Oral and Maxillofacial  surgery, The First affiliated hospital  of chongqing Medical University,   chongqing, People’s republic of chinaBackground:  Nanotechnology-based near-infrared quantum dots (NIR QDs) have many  excellent optical properties, such as high fluorescence intensity, good fluorescence stabil - ity, and strong tissue-penetrating ability.",Non-OADS,/arxiv_data1/oa_pdf/7f/1c/ijn-9-4809.PMC4207583.pdf
"Keywords:  nanotechnology, RGD peptides, integrin αvβ3, quantum dots, intravenous injection,  toxicity Introduction Due to their unique physical and chemical properties, many synthetic nanomaterials  have become important tools for medical research.1,2 Quantum dots (QDs) with unique  optical properties are a class of novel nanomaterials and have been widely used in  medical research.3,4 QDs are nanocrystals (diameter ranges from 2–10  nm) consisting of correspondence: Kai Yang Department of Oral and Maxillofacial  Surgery, The First Affiliated Hospital  of chongqing Medical University,  No 1, Youyi road, Yuzhong District,  chongqing 400016,   People’s republic of china Tel +86 238 901 2569 Fax +86 238 901 2569 email cqfyyk@hotmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Wang et al Running head recto: Toxicity of functionalized quantum dots in mice DOI: http://dx.doi.org/10.2147/IJN.S70092",Non-OADS,/arxiv_data1/oa_pdf/7f/1c/ijn-9-4809.PMC4207583.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/7f/1c/ijn-9-4809.PMC4207583.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/1c/ijn-9-4809.PMC4207583.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8d/3a/oajsm-5-235.PMC4207584.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Journal of Sports Medicine 2014:5 235–241Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  235OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S6349 6People who perceive themselves as active   cannot identify the intensity recommended   by the international physical activity guidelines neal W Prokop1 Travis Jr hrubeniuk1 Martin Sénéchal2,3 Danielle r Bouchard1,4 1Faculty of Kinesiology and  recreation Management, University  of Manitoba, Winnipeg, Manitoba,   canada; 2Manitoba institute of child  health, Winnipeg, Manitoba, canada;   3Department of Pediatrics and child  health, Faculty of Medicine, University  of Manitoba, Winnipeg, Manitoba,   canada; 4health, leisure, and human  Performance research institute,   Winnipeg, Manitoba, canada correspondence: Danielle r Bouchard   Faculty of Kinesiology and recreation  Management, University of Manitoba,  318 Max Bell centre, Winnipeg, Manitoba  r3T 2n2, canada   Tel +1 204 474 8627   Fax +1 204 261 4802   email d anielle_bouchard@umanitoba.c aBackground:  Many national and international organizations recommend that adults achieve  at least 150 minutes of aerobic physical activity (PA) weekly, at a minimum moderate intensity  to optimize health benefits.",Non-OADS,/arxiv_data1/oa_pdf/8d/3a/oajsm-5-235.PMC4207584.pdf
Or use: http://dvpr.es/1pnZWm T,Non-OADS,/arxiv_data1/oa_pdf/8d/3a/oajsm-5-235.PMC4207584.pdf
Available from:  http://www.who.int/dietphysicalactivity/ factsheet_ recommendations / en/.,Non-OADS,/arxiv_data1/oa_pdf/8d/3a/oajsm-5-235.PMC4207584.pdf
Available  from: http://www.cdc.gov/physicalactivity /everyone/guidelines/adults.,Non-OADS,/arxiv_data1/oa_pdf/8d/3a/oajsm-5-235.PMC4207584.pdf
"Available from: http://www.gov.uk/ government/publications/uk-physical-activity-guideline s. Accessed  February 12, 2014.",Non-OADS,/arxiv_data1/oa_pdf/8d/3a/oajsm-5-235.PMC4207584.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/8d/3a/oajsm-5-235.PMC4207584.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/3a/oajsm-5-235.PMC4207584.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/13/e8/jbm-5-207.PMC4207585.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Blood Medicine 2014:5 207–218Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  207Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S5064 4Optimal management of hemophilic   arthropathy and hematomas Sébastien Lobet1,2 Cedric Hermans1 Catherine Lambert1 1Hemostasis-Thrombosis Unit,   Division of Hematology,  2Division of  Physical Medicine and Rehabilitation,   Cliniques Universitaires Saint-Luc,   Brussels, Belgium Correspondence: Sébastien Lobet   Cliniques Universitaires St-Luc, Service  de Médecine Physique et Réadaptation,  Avenue Hippocrate  10, B-1200 Brussels,  Belgium   Tel +32 2764 1657  email sebastien.lobet@uclouvain.b eAbstract:  Hemophilia is a hematological disorder characterized by a partial or complete   deficiency of clotting factor VIII or IX.",Non-OADS,/arxiv_data1/oa_pdf/13/e8/jbm-5-207.PMC4207585.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/13/e8/jbm-5-207.PMC4207585.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/13/e8/jbm-5-207.PMC4207585.pdf
"This is an Open Access article distribu ted under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/50/mdu383.PMC4207730.pdf
"http://www.registri-tumori.it/cms/?q=Rapp2010 (28 August 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/c5/50/mdu383.PMC4207730.pdf
"http://www.registri- tumori.it/cms/Rapp2011 (28 August 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/c5/50/mdu383.PMC4207730.pdf
All rights reserved.http://dx.doi.org/10.1016/j.bjhh.2014.05.011,Non-OADS,/arxiv_data1/oa_pdf/e1/b4/main.PMC4207905.pdf
"http://dx.doi.org/10.1016/j.bjhh.2014.03.004 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/1e/d9/main.PMC4207906.pdf
"http://dx.doi.org/10.1016/j.bjhh.2014.05.003 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/5f/09/main.PMC4207907.pdf
Available at:http://bases.bireme.br/cgibin/wxislind.exe/iah/online/?IsisScript=iah/iah.xis&src=google&base=LILACS&lang=p&nextAction=lnk&exprSearch=587541&indexSearch=ID[cited 16.05.13].,OADS,/arxiv_data1/oa_pdf/5f/09/main.PMC4207907.pdf
"http://dx.doi.org/10.1016/j.bjhh.2014.05.004 1516-8484/© 2014 Associac ¸ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/9c/7c/main.PMC4207911.pdf
"http://dx.doi.org/10.1016/j.bjhh.2014.05.008 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/c9/48/main.PMC4207912.pdf
"3,11–16 One of the articles published this year in the Revista Brasileira de Hematologia e Hemoterapia contributes to this discussion.17The article entitled “Genetic evaluation of mes- enchymal stem cells through G-band karyotyping in a Cell DOI of original article: http://dx.doi.org/10.1016/j.bjhh.2014.03.006 .",Non-OADS,/arxiv_data1/oa_pdf/74/ae/main.PMC4207913.pdf
"By analyzing the arti-cles concerning the genetic stability of MSCs, it highlightsthe existence of several variables such as cell origin, useof different protocols to isolate and expand MSCs, time ofexpansion and techniques used to analyze the stability.There are a lot of techniques that can be used to assessgenetic stability of MSCs, including conventional karyotyping,spectral karyotyping (SKY), ﬂuorescent in situ hybridiza- tion (FISH), genome-wide array comparative genomic http://dx.doi.org/10.1016/j.bjhh.2014.05.014 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",OADS,/arxiv_data1/oa_pdf/74/ae/main.PMC4207913.pdf
"21Another important point to consider in stem cell therapy is the genetic stability of these cells after cryopreservation.Cryopreservation is necessary when the use of these cells willnot occur immediately after their isolation, and so banks ofMSCs are being created all around the world, but the researchon chromosome instability is not proportional to this increase.Almost 2300 studies were performed with cryopreservationrelated to stem cells but the majority of them look at the main-tenance of stem cell properties ( http://www.ncbi.nlm.nih.gov/ pmc/?term=cryopreservation+stem+cell by 03/13/2014).",Non-OADS,/arxiv_data1/oa_pdf/74/ae/main.PMC4207913.pdf
Only ﬁve articles were found addressing the question of MSC cyto-genetic instability ( http://www.ncbi.nlm.nih.gov/pubmed/?,OADS,/arxiv_data1/oa_pdf/74/ae/main.PMC4207913.pdf
Available from: http://cgap.nci.nih.gov/Chromosomes/Mitelman 22.,OADS,/arxiv_data1/oa_pdf/74/ae/main.PMC4207913.pdf
"http://dx.doi.org/10.1016/j.bjhh.2014.05.001 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/b6/c2/main.PMC4207915.pdf
10] Available from: http://portal.saude.gov.br/portal/ saude/Gestor/visualizar texto.cfm?idtxt=27777 8.,Non-OADS,/arxiv_data1/oa_pdf/b6/c2/main.PMC4207915.pdf
[cited 2012 Jun 10] Availablefrom: http://www2.datasus.gov.br/DATASUS/index.php?,OADS,/arxiv_data1/oa_pdf/b6/c2/main.PMC4207915.pdf
"http://dx.doi.org/10.1016/j.bjhh.2014.05.006 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/24/f3/main.PMC4207916.pdf
All rights reserved.http://dx.doi.org/10.1016/j.bjhh.2014.05.009,Non-OADS,/arxiv_data1/oa_pdf/38/0f/main.PMC4207917.pdf
"http://dx.doi.org/10.1016/j.bjhh.2014.05.010 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/b9/35/main.PMC4207918.pdf
"http://dx.doi.org/10.1016/j.bjhh.2014.05.007 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/2d/ff/main.PMC4207919.pdf
DOI of original article: http://dx.doi.org/10.1016/j.bjhh.2014.03.008 .,OADS,/arxiv_data1/oa_pdf/46/e2/main.PMC4207920.pdf
"http://dx.doi.org/10.1016/j.bjhh.2014.06.003 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/46/e2/main.PMC4207920.pdf
4 DOI of original article: http://dx.doi.org/10.1016/j.bjhh.2014.05.004 .,OADS,/arxiv_data1/oa_pdf/f4/0b/main.PMC4207921.pdf
"However, this approachmakes data analysis more difﬁcult because the restrictiveness http://dx.doi.org/10.1016/j.bjhh.2014.05.013 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/f4/0b/main.PMC4207921.pdf
"http://dx.doi.org/10.1016/j.bjhh.2014.05.002 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/23/d1/main.PMC4207922.pdf
DOI of original article: http://dx.doi.org/10.1016/j.bjhh.2014.05.001 .,OADS,/arxiv_data1/oa_pdf/05/45/main.PMC4207923.pdf
"The data reported by Soares et al., 14together with those from previous studies,19–21as well as the indicators recorded in the NNSP management system, can help to deﬁne new carestrategies for Brazilian children with hemoglobinopathies.The training and certiﬁcation of pediatricians of governmenthealth clinics to treat these patients in their residentialareas, greater integration of the Family Health Programwith the NNSP , investment in infrastructure to allow greater http://dx.doi.org/10.1016/j.bjhh.2014.05.012 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/05/45/main.PMC4207923.pdf
"There was a moderate response to the http://dx.doi.org/10.1016/j.bjhh.2014.03.001 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/7f/c3/main.PMC4207924.pdf
"http://dx.doi.org/10.1016/j.bjhh.2014.06.004 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/cf/d0/main.PMC4207925.pdf
"DOI: XXXXXXXXXXXReview article Concentrations of blood folate in Brazilian studies prior to  and after fortification of wheat and cornmeal (maize flour) with folic acid: a review Jéssica Carrilho Brittoa, Rodolfo Cançadob, Elvira Maria Guerra-Shinoharaa,* a Faculdade de Ciências Farmacêuticas da Universidade de São Paulo (FCF-USP), São Paulo, SP, Brazil  b Faculdade de Ciências Médicas da Santa Casa de São Paulo (FCMSCSP), São Paulo, SP, Brazil ARTICLE INFO Article history:   Received 26 June 2013 Accepted 26 July 2013 Keywords: Adult BloodBrazilFood, fortificationFolic acid http://dx.doi.org/10.1016/j.bjhh.2014.03.018© 2014 Associac ¸ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/9c/a4/main.PMC4207926.pdf
Available from: http://www.scielo.br/pdf/jbchs/v19n1/a09v19n1.pdf,Non-OADS,/arxiv_data1/oa_pdf/9c/a4/main.PMC4207926.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/openhrt-2014- 000155).,Non-OADS,/arxiv_data1/oa_pdf/34/e2/openhrt-2014-000155.PMC4207938.pdf
Guide to the methods of technology appraisal 2013. http://www.nice.org.uk/media/D45/1E/GuideToMethodsTechnologyAppraisal2013.pdf(accessed 23 Jun 2013).,Non-OADS,/arxiv_data1/oa_pdf/34/e2/openhrt-2014-000155.PMC4207938.pdf
http://www.bnf.org/bnf/index.htm (accessed 23 Jun 2013).,Non-OADS,/arxiv_data1/oa_pdf/34/e2/openhrt-2014-000155.PMC4207938.pdf
http://www.pssru.ac.uk/ (accessed 23 Jun 2013).,Non-OADS,/arxiv_data1/oa_pdf/34/e2/openhrt-2014-000155.PMC4207938.pdf
2011. http://kce.fgov.be/publication/report/transcatheter-aortic-valve-implantation-tavi-a-health-technology-assessment-update(accessed 24 Jun 2013).,Non-OADS,/arxiv_data1/oa_pdf/34/e2/openhrt-2014-000155.PMC4207938.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Figure 3 |Ultra-large elastic deformation of Nb nanowires accompanied by the martensitic phase transformation of the NiTi matrix during the second cycle.",Non-OADS,/arxiv_data1/oa_pdf/b0/18/srep06753.PMC4208026.pdf
"With regard to the identification of biomarkers, the ion spectrum of potential biomarkers was matched with the structure message of metabolites acquired from available biochemical databases, such as HMDB, http:// www.hmdb.ca/; KEGG, http://www.genome.jp/kegg/; METLIN, http://metlin.",OADS,/arxiv_data1/oa_pdf/43/86/srep06768.PMC4208028.pdf
"scripps.edu/; Chemical Entities of Biological Interest (http://www.ebi.ac.uk/Databases/); MassBank, http://www.massbank.jp/; Scripps Center for Mass Spectrometry (http://masspec.scripps.edu/index.php) and Lipidmaps (http://www.",Non-OADS,/arxiv_data1/oa_pdf/43/86/srep06768.PMC4208028.pdf
All authors reviewed the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/43/86/srep06768.PMC4208028.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6768 | DOI: 10.1038/srep06768 8",Non-OADS,/arxiv_data1/oa_pdf/43/86/srep06768.PMC4208028.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6760 | DOI: 10.1038/srep06760 8",Non-OADS,/arxiv_data1/oa_pdf/b3/7a/srep06760.PMC4208029.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2c/13/srep06767.PMC4208030.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6767 | DOI: 10.1038/srep06767 10",Non-OADS,/arxiv_data1/oa_pdf/2c/13/srep06767.PMC4208030.pdf
Data were analyzed with the online tool PeptideMass (http://web.expasy.org/peptide_ mass/).,OADS,/arxiv_data1/oa_pdf/6e/e6/srep06750.PMC4208033.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Li, B. et al.",Non-OADS,/arxiv_data1/oa_pdf/6e/e6/srep06750.PMC4208033.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6750 | DOI: 10.1038/srep06750 5",Non-OADS,/arxiv_data1/oa_pdf/6e/e6/srep06750.PMC4208033.pdf
Phylogenetic and promoter sequence analysis .The structural domain of the predicted polypeptide was annotated using SMART 5 software (http://smart.embl.,OADS,/arxiv_data1/oa_pdf/d8/f7/srep06694.PMC4208034.pdf
The promoter sequence was scanned by PLACE software (http://www.dna.affrc.go.jp/ PLACE/) to identify plant cis-acting elements28.,OADS,/arxiv_data1/oa_pdf/d8/f7/srep06694.PMC4208034.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d8/f7/srep06694.PMC4208034.pdf
All authors discussed the results and commented on the manuscript at all stages.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7d/fd/srep06758.PMC4208036.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6758 | DOI: 10.1038/srep06758 9",Non-OADS,/arxiv_data1/oa_pdf/7d/fd/srep06758.PMC4208036.pdf
All authors reviewedthe manuscript Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/34/54/srep06751.PMC4208037.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6751 | DOI: 10.1038/srep06751 8",Non-OADS,/arxiv_data1/oa_pdf/34/54/srep06751.PMC4208037.pdf
Tree analyses wereperformed using Los Alomos tools (http://www.hiv.lanl.gov/content/sequence/ HEATMAP/heatmap_mainpage.html).,OADS,/arxiv_data1/oa_pdf/88/37/srep06690.PMC4208038.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6690 | DOI: 10.1038/srep06690 8",Non-OADS,/arxiv_data1/oa_pdf/88/37/srep06690.PMC4208038.pdf
Available: http://www.grc.nasa.gov/WWW/BGH/airsim.html (Date of access: 03/ 15/2014).,Non-OADS,/arxiv_data1/oa_pdf/3d/8b/srep06762.PMC4208039.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3d/8b/srep06762.PMC4208039.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6762 | DOI: 10.1038/srep06762 5",Non-OADS,/arxiv_data1/oa_pdf/3d/8b/srep06762.PMC4208039.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fc/bd/srep06729.PMC4208041.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6a/f0/srep06759.PMC4208042.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006701).,Non-OADS,/arxiv_data1/oa_pdf/28/9f/bmjopen-2014-006701.PMC4208046.pdf
http://biostat.mc.vanderbilt.edu/wiki/Main/Hmisc (accessed Sep 2014).30.,Non-OADS,/arxiv_data1/oa_pdf/28/9f/bmjopen-2014-006701.PMC4208046.pdf
ISBN 3-900051-07-0. http://www.R-project.org 31.,Non-OADS,/arxiv_data1/oa_pdf/28/9f/bmjopen-2014-006701.PMC4208046.pdf
http://www23.statcan.,OADS,/arxiv_data1/oa_pdf/28/9f/bmjopen-2014-006701.PMC4208046.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005627).,Non-OADS,/arxiv_data1/oa_pdf/d2/af/bmjopen-2014-005627.PMC4208047.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 006120).,Non-OADS,/arxiv_data1/oa_pdf/f0/bc/bmjopen-2014-006120.PMC4208048.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005447).,Non-OADS,/arxiv_data1/oa_pdf/11/fa/bmjopen-2014-005447.PMC4208049.pdf
"Lyon, France: IARC, 2010. http://globocan.iarc.fr (accessed 27 Mar 2013).",Non-OADS,/arxiv_data1/oa_pdf/11/fa/bmjopen-2014-005447.PMC4208049.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006359).,Non-OADS,/arxiv_data1/oa_pdf/b7/e5/bmjopen-2014-006359.PMC4208050.pdf
depression32) despite receiving antidepressant treatment at an adequate therapeutic dose (based on package insert; see: http://www.info.pmda.go.jp/info/iyaku_index.html) for at least 8 weeks as part of usual depres- sion care; and (4) they are competent and able to give informed consent.,Non-OADS,/arxiv_data1/oa_pdf/b7/e5/bmjopen-2014-006359.PMC4208050.pdf
"Intervention phase (16 week) CBTTherapists will follow the CBT treatment manual for depression developed by the authors (YO, DF , AN, TK and MS) (available at the Japanese Ministry of Health,Labour and Welfare website: http://www.mhlw.go.jp/ bunya/shougaihoken/kokoro/dl/01.pdf).",Non-OADS,/arxiv_data1/oa_pdf/b7/e5/bmjopen-2014-006359.PMC4208050.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b7/e5/bmjopen-2014-006359.PMC4208050.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-006543).,Non-OADS,/arxiv_data1/oa_pdf/0d/9d/bmjopen-2014-006543.PMC4208051.pdf
http://www.hqip.org.uk/assets/NCAPOP-Library/NCAPOP-2014 –15/NHFD-extended-report-2014-FINAL.pdf (accessed 23 Sep 2014).,Non-OADS,/arxiv_data1/oa_pdf/0d/9d/bmjopen-2014-006543.PMC4208051.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006618).,Non-OADS,/arxiv_data1/oa_pdf/6a/34/bmjopen-2014-006618.PMC4208052.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006608).,Non-OADS,/arxiv_data1/oa_pdf/2f/6b/bmjopen-2014-006608.PMC4208053.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006326).,Non-OADS,/arxiv_data1/oa_pdf/ac/cf/bmjopen-2014-006326.PMC4208054.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6722 | DOI: 10.1038/srep06722 5",Non-OADS,/arxiv_data1/oa_pdf/2f/db/srep06722.PMC4208056.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6763 | DOI: 10.1038/srep06763 7",Non-OADS,/arxiv_data1/oa_pdf/05/d7/srep06763.PMC4208057.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ff/6b/srep06711.PMC4208058.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6761 | DOI: 10.1038/srep06761 4",Non-OADS,/arxiv_data1/oa_pdf/26/b5/srep06761.PMC4208059.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6756 | DOI: 10.1038/srep06756 8",Non-OADS,/arxiv_data1/oa_pdf/3a/58/srep06756.PMC4208062.pdf
See http://creativecommons.org/licenses/by-nc/2.0/de/ NIH Public Access Author Manuscript Demogr Res .,Non-OADS,/arxiv_data1/oa_pdf/72/0d/nihms634282.PMC4208072.pdf
"2005. http://www.bls.gov/nls/handbook/2005/nlshc3.pdf U.S. Census, Bureau.",OADS,/arxiv_data1/oa_pdf/72/0d/nihms634282.PMC4208072.pdf
"2012. http://www.census.gov/newsroom/releases/archives/population/cb12-90.html U.S. Department, of Health and Human Services.",OADS,/arxiv_data1/oa_pdf/72/0d/nihms634282.PMC4208072.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/00/main.PMC4208085.pdf
"The N-terminal region of long- STOPP PH1510 (residues 16–236, 1510-N) is a serine protease with http://dx.doi.org/10.1016/j.fob.2014.09.002 2211-5463/ /C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dc/00/main.PMC4208085.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: 1510-C, residues 371–441 of PH1510; 1510-N, residues 16–236 of PH1510; 471-C, residues 72–143 of PH0471; OB-fold, oligosaccharide/oligonu- cleotide-binding fold; r.m.s.d., root-mean-square deviation; STOPP, stomatinoperon partner protein ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/dc/00/main.PMC4208085.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.09.002 .",OADS,/arxiv_data1/oa_pdf/dc/00/main.PMC4208085.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/67/main.PMC4208086.pdf
"AhR forms a complex with the molecular chaperone HSP90, co-chaperone p23, and the hepatitis B virus X-associated protein XAP2 in the http://dx.doi.org/10.1016/j.fob.2014.09.003 2211-5463/ /C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/70/67/main.PMC4208086.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: 17-DMAG, 17-(dimethylaminoethylamino)-17-demethoxygel- danamycin, dimethylsulfoxide; 3-MC, 3-methylcholanthrene; AhR, aryl hydrocar- bon receptor; Arnt, AhR nuclear translocator; bHLH, basic helix-loop-helix; CYP1A1,cytochrome P450 1A1; DAPI, 4 0,6-diamidino-2-phenylindole; DEPC, dihydrochlo- ride, diethylpyrocarbonated; GST, glutathione, glutathione S-transferase; HSP90,90-kDa of heat shock protein; IPTG, isopropyl-1-thio- b- D-galactopyranoside; IPTG, isopropyl-1-thio- b-D-galactopyranoside; NLS, nuclear localization signal; PAS, per- arnt-sim; PLA, proximity ligation assay; RT-PCR, reverse transcription-polymerasechain reaction; TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; XAP2, hepatitis B virus X-associated protein; XRE, xenobiotic responsible element; b-NF, b-naphthoﬂavone ⇑Corresponding author at: Department of Life Science, Graduate School and Faculty of Engineering Science, Akita University, 1-1 Tegata Gakuen Town, AkitaUniversity, Akita 010-8502, Japan.",Non-OADS,/arxiv_data1/oa_pdf/70/67/main.PMC4208086.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/ae/main.PMC4208087.pdf
This treatment resulted in a rapid induction of HSPA1 (Hsp70) protein and its levels http://dx.doi.org/10.1016/j.fob.2014.09.004 2211-5463/ /C2112014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/70/ae/main.PMC4208087.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: ER, endoplasmic reticulum; HS, heat shock; TG, thapsigargin; TM, tunicamycin; UPR, unfolded protein response ⇑Corresponding author at: Apoptosis Research Centre, Biosciences Research Building, NUI Galway, Dangan, Galway, Ireland.",Non-OADS,/arxiv_data1/oa_pdf/70/ae/main.PMC4208087.pdf
URL: http://www.apoptosis.ie (A. Samali).FEBS Open Bio 4 (2014) 813–821 journal homepage: www.elsevier .com/locate/febsopenbio,Non-OADS,/arxiv_data1/oa_pdf/70/ae/main.PMC4208087.pdf
"Institute (Boston, MA, USA) based on different criteria for shRNA design ( http://www.broad.mit.edu/genome_bio/trc/rnai.html ).",OADS,/arxiv_data1/oa_pdf/70/ae/main.PMC4208087.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/81/main.PMC4208088.pdf
"The toxicity of APAP is ascribed to N-acetyl-p- benzoquinone imine (NAPQI), a highly reactive metabolite of APAP, which reacts with glutathione (GSH) and leads to a profound depletion of hepatocellular GSH [4], resulting in mitochondrial http://dx.doi.org/10.1016/j.fob.2014.08.007 2211-5463/ /C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/de/81/main.PMC4208088.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: ABTS, 2,20-azino-bis (3-ethylbenzothiazoline)-6-sulfonic acid; ALF, acute liver failure; ALT, alanine aminotransferase; APAP, acetaminophen; AST,aspartate aminotransferase; bFGF, basic ﬁbroblast growth factor; CM-H 2DCFDA, 5- (and-6)-chloromethyl-20,70-dichlorodihydroﬂuorescein diacetate, acetyl ester; CXCL1, chemokine (C-X-C motif) ligand 1; CYP2E1, cytochrome P450 2E1; DMSO,dimethyl sulfoxide; Drp1, dynamin-related protein 1; FBS, fetal bovine serum; GSH,glutathione; LDH, lactate dehydrogenase; NAPQI, N-acetyl-p-benzoquinone; Nec-1,necrostatin-1; NO, nitric oxide; PGAM5, phosphoglycerate mutase family member 5;PI, propidium iodide; RIPK, receptor-interacting protein kinase; ROS, reactive oxygenspecies; SNAP, S-nitroso-N-acetyl- DL-penicillamine; WST-8, 2-(2-methoxy-4-nitro- phenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium; kPP, lambda pro- tein phosphatase ⇑Corresponding authors.",Non-OADS,/arxiv_data1/oa_pdf/de/81/main.PMC4208088.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
http://dx.doi.org/10.1016/j.fob.2014.08.002 2211-5463/ /C2112014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: COPD, chronic obstructive pulmonary disorder; FACTp140, FACT complex subunit SPT16; K18, keratin type 1 cytoskeletal 18; AFABP, adipocyte fattyacid-binding protein; OSF3, peroxiredoxin-1; SPTBN1, spectrin bchain brain 1; STAT, signal transducer and activator of transcription; IL, interleukin; K8, keratintype 2 cytoskeletal 8; PRP19, pre-mRNA-processing factor 19; CRP1, cysteine and glycine-rich protein 1; Jak2, tyrosine-protein kinase JAK2; pSTAT3-Tyr705, phos- phorylated STAT3; TIM, mitochondrial import inner membrane translocase subunitTim9; HIP1, Huntingtin-interacting protein 1; 60s-RP, 60s ribosomal protein L10E;TNF, tumor necrosis factor; ALDH2, aldehyde dehydrogenase, mitochondrial;PRP19, pre-mRNA-processing factor 19; ROS, reactive oxygen species; TNFR2,tumor necrosis factor receptor 2; JNK, c-Jun NH 2-terminal kinase; ERK(1/2), extracellular signal regulated kinase 1/2; NF- jB, nuclear factor-kappa B; PKC- a, protein kinase C- a; p100, serine protease P100; MAPK3, mitogen-activated protein kinase 3; TGF- b, Transforming growth factor- b; TRAP1, heat shock protein 75 kDa; LIM, LIM/homeobox protein ⇑Corresponding authors.",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Eur Respir J 29, 438–445, http://dx.doi.org/ 10.1183/09031936.00124506 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Pulm Pharmacol Ther 23, 376–383, http://dx.doi.org/10.1016/ j.pupt.2010.04.003 .",OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Respiration 68, 557–561, http://dx.doi.org/ 10.1159/000063541 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"J Thorac Oncol 8, 6–11, http://dx.doi.org/10.1097/JTO.0b013e318274a7dc .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"J Natl Cancer Inst 91, 675–690, http://dx.doi.org/10.1093/jnci/91.8.675 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"J Natl Cancer Inst 89, 1580–1586, http://dx.doi.org/10.1093/jnci/89.21.1580 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Respiration 81, 265–284, http://dx.doi.org/10.1159/000324601 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Toxicol Sci 131, 596–611, http://dx.doi.org/ 10.1093/toxsci/kfs312 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Am J Physiol Lung Cell Mol Physiol 294, 612–631, http://dx.doi.org/10.1152/ajplung.00390.2007 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Thorax 59, 713–721, http://dx.doi.org/10.1136/thx.2003.012468 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Am J Respir Cell Mol Biol 27, 36874, http://dx.doi.org/10.1165/ rcmb.4791 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"J Proteome Res 10, 3720–3731, http://dx.doi.org/10.1021/pr200345y .",OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Nat Rev Immunol 2, 372–377, http://dx.doi.org/10.1038/nri803 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Eur Respir J 31, 1334–1356, http://dx.doi.org/10.1183/09031936.00018908 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Toxicol Appl Pharmacol 254, 72–85, http://dx.doi.org/ 10.1016/j.taap.2009.10.022 .",OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Respir Physiol Neurobiol 182, 9–17, http://dx.doi.org/ 10.1016/j.resp.2012.02.001 .",OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"J Natl Cancer Inst 91, 1194–1210, http://dx.doi.org/10.1093/jnci/91.14.1194 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Int J Cancer 131, 2724–2732, http://dx.doi.org/10.1002/ijc.27816 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Oncogene 21, 7421–7434, http://dx.doi.org/10.1038/sj.onc.1205802 .",OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Inhal Toxicol 22, 234–244, http://dx.doi.org/10.3109/08958370903191437 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Int J Cancer 131, 2754–2762, http://dx.doi.org/10.1002/ijc.27829 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Lancet Oncol 13, 1188, http://dx.doi.org/10.1016/S1470- 2045(12)70523-5 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Mutat Res 659, 221–231, http://dx.doi.org/10.1016/ j.mrrev.2008.04.002 .",OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Am J Respir Crit Care Med 172, 168–172, http://dx.doi.org/10.1164/rccm.200409-1174OC .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"J Autoimmun 34, 258–265, http://dx.doi.org/10.1016/j.jaut.2009.12.003 .",OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Eur Respir J 2, 36–44, http://dx.doi.org/10.1183/09031936.02.00062002 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Eur Respir J 32, 472–486, http://dx.doi.org/10.1183/ 09031936.00116107 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Carcinogenesis 25, 169–178, http://dx.doi.org/ 10.1093/carcin/bgg193 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Int J Cancer 131, 2763– 2773, http://dx.doi.org/10.1002/ijc.27814 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"(2011) Moving towards a new generation of animal models for asthma and COPD with improved clinical relevance.Pharmacol Ther 130, 93–105, http://dx.doi.org/10.1016/ j.pharmthera.2010.10.008 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Exp Biol Med 237, 1449–1456, http://dx.doi.org/10.1258/ebm.2012.012103 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"BMC Med Genomics 2, 56, http://dx.doi.org/10.1186/1755-8794-2-56 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Biochim Biophys Acta 1399, 181– 186, http://dx.doi.org/10.1016/S0167-4781(98)00115-8 .",OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Am J Physiol Lung Cell Mol Physiol 291, 966–975, http://dx.doi.org/10.1152/ ajplung.00045.2006 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Science 299, 574–577, http://dx.doi.org/10.1126/ science.1075994 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"J Biol Chem 287, 16699–16708, http://dx.doi.org/10.1074/jbc.M111.315333 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Biol Chem 383, 347–364, http://dx.doi.org/10.1515/BC.2002.040 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Trends Biochem Sci 28, 32–40, http://dx.doi.org/10.1016/S0968-0004(02)00003-8 .",OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Pathol Int 49, 91–102, http://dx.doi.org/10.1046/ j.1440-1827.1999.00829 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Toxicol Lett 178, 191–196, http://dx.doi.org/10.1016/j.toxlet.2008 .",OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Arthritis Rheum 50, 976–984, http://dx.doi.org/10.1002/art.20201 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Exp Cell Res 219, 348–357, http://dx.doi.org/10.1006/ excr.1995.1238 .",OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"J Cell Biol 131, 1291– 1301, http://dx.doi.org/10.1083/jcb.131.5.1291 .",OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"J Cell Biol 149, 17–22, http://dx.doi.org/10.1083/jcb.149.1.17 .",OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Toxicol Pathol 38, 402–415, http://dx.doi.org/10.1177/0192623310364028 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"J Toxicol Pathol 25, 201–207, http://dx.doi.org/10.1293/ tox.25.201 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"J Biol Chem 280, 12888–12895, http://dx.doi.org/10.1074/ jbc.M413788200 .",OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Nat Rev Mol Cell Biol 10, 373–384, http://dx.doi.org/10.1038/nrm2693 .",OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"EMBO J 21, 4950–4958, http://dx.doi.org/ 10.1093/emboj/cdf463 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
"Anat Rec (Hoboken) 293, 1010–1016, http://dx.doi.org/10.1002/ar.21143 .",Non-OADS,/arxiv_data1/oa_pdf/5f/17/main.PMC4208089.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8c/86/main.PMC4208090.pdf
"Consistently, induced or genetic deﬁciency of PCSK9 expression or activity has http://dx.doi.org/10.1016/j.fob.2014.08.003 2211-5463/ /C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/8c/86/main.PMC4208090.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: ABCA1, ATP-binding cassette transporter A1; ApoB, apolipopro- tein B; HMGCoAR, 3-hydroxy-3-methylglutaryl-CoA reductase; LDL-C, low-densitylipoprotein-cholesterol; LDLR, low-density lipoprotein receptor; PCSK9, proproteinconvertase subtilisin/kexin 9; Q3G, quercetin-3- b- D-glucoside; SREBP-2, sterol regulatory element-binding protein 2; TGN, trans Golgi network ⇑Corresponding author at: Ottawa Hospital Research Institute, Civic Campus, 725 Parkdale Avenue, Ottawa, Ontario K1Y 4E9, Canada.",Non-OADS,/arxiv_data1/oa_pdf/8c/86/main.PMC4208090.pdf
"Xenobiotica, 1–9, http://dx.doi.org/10.3109/00498254.2014.932032 .762 M. Mbikay et al.",Non-OADS,/arxiv_data1/oa_pdf/8c/86/main.PMC4208090.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/a5/main.PMC4208091.pdf
http://dx.doi.org/10.1016/j.fob.2014.08.001 2211-5463/ /C2112014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/85/a5/main.PMC4208091.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: AMADID, agilent microarray design identiﬁers; CFU, colony forming units; MOI, multiplicity of infection; RD1, region of difference 1 ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/85/a5/main.PMC4208091.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.08.001 .",OADS,/arxiv_data1/oa_pdf/85/a5/main.PMC4208091.pdf
"8, e1002769, http://dx.doi.org/10.1371/journal.ppat.1002769 .",Non-OADS,/arxiv_data1/oa_pdf/85/a5/main.PMC4208091.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/68/main.PMC4208092.pdf
It has been suggested that ROS have important signaling http://dx.doi.org/10.1016/j.fob.2014.08.005 2211-5463/ /C2112014 The Authors.,OADS,/arxiv_data1/oa_pdf/ae/68/main.PMC4208092.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: AMPK, adenosine monophosphate-activated protein kinase; Cur, curcumin; GSH, glutathione; LKB1, liver kinase B1; mTOR, mammalian target ofrapamycin; NAC, N-acetylcysteine; p70S6K, p70S6 kinase; Par-4, prostate apoptosisresponse 4; PARP, poly (ADP-ribose) polymerase; ROS, reactive oxygen species; z-VAD-fmk, N-benzyloxycarbonyl-Val-Ala-Asp ﬂuoromethylketone ⇑Corresponding author at: Cell Signaling Laboratory, Department of Biochemis- try, College of Medicine and Health Sciences, UAE University, P.O.",Non-OADS,/arxiv_data1/oa_pdf/ae/68/main.PMC4208092.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.08.005 .",OADS,/arxiv_data1/oa_pdf/ae/68/main.PMC4208092.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/55/54/main.PMC4208093.pdf
"In 2010, a single nucleotide polymorphism (SNP) analysis using GWAS [12] established a strong link between high plasma levels of http://dx.doi.org/10.1016/j.fob.2014.08.004 2211-5463/ /C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/55/54/main.PMC4208093.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: ANGPTL3, angiopoietin-like 3; ANGPTL4, angiopoietin-like 4; ApoF, apolipoprotein-F; GOF, gain of function; GWAS, genome-wide associationstudy; HDL, high-density lipoprotein; hTfR1, human PC7-substrates: transferrin receptor 1; KO, knockout; LDL, low-density lipoprotein; PCs, proprotein conver- tases; SNP, single nucleotide polymorphism; TGN, trans Golgi network; TMD, transmembrane domain; VLDL, very low-density lipoprotein ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/55/54/main.PMC4208093.pdf
The reads were then aligned to an embryonic A. burtoni reference transcriptome assembled by Broad Institute (http://www.broadinstitute.org/models/tilapia).,OADS,/arxiv_data1/oa_pdf/59/d8/ncomms6149.PMC4208096.pdf
Transposable element sequences were identiﬁed using the Repeat Masking function of REPBASE UNIT (http://www.girinst.org/censor/index.php) against all sequence sources and the bl2seq function of BLASTn49.,OADS,/arxiv_data1/oa_pdf/59/d8/ncomms6149.PMC4208096.pdf
"Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Santos, M. E. et al.",Non-OADS,/arxiv_data1/oa_pdf/59/d8/ncomms6149.PMC4208096.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6149 ARTICLE NATURE COMMUNICATIONS | 5:5149 | DOI: 10.1038/ncomms6149 | www.nature.com/naturecommunications 11 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/59/d8/ncomms6149.PMC4208096.pdf
"Keywords: Hyperthyroidism, Graves’ disease, Antithyroid agentsHae Sang Lee, MD, Jin Soon Hwang, MD, PhD Department of Pediatrics, Ajou  University Hospital, Ajou University School of Medicine, Suwon, Koreahttp://dx.doi.org/10.6065/apem.2014.19.3.122 Ann Pediatr Endocrinol Metab 2014;19:122-126 ©2014 Annals of Pediatric Endocrinology & MetabolismReceived: 15 September, 2014Accepted: 17 September, 2014 Address for correspondence:  Jin Soon Hwang, MD, PhDDepartment of Pediatrics, Ajou University Hospital, Ajou University School of Medicine, 164 World cup-ro, Yeongtong-gu, Suwon 443-380, KoreaTel: +82-31-219-5166     Fax: +82-31-219-5169E-mail: pedhwang@ajou.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ISSN: 2287-1012(Print)  ISSN: 2287-1292(Online) Introduction Graves’ disease (GD) occurs less frequently in childhood than in adults, affecting from 0.1  per 100,000 children and 3.0 per 100,000 adolescents per year.",Non-OADS,/arxiv_data1/oa_pdf/27/3e/apem-19-122.PMC4208256.pdf
http://dx.doi.org/10.1055/s-0034-1384649.,Non-OADS,/arxiv_data1/oa_pdf/27/3e/apem-19-122.PMC4208256.pdf
"Keywords: Pituitary ACTH hypersecretion, Petrosal sinus sampling, HypopituitarismInsook Jeong, MD, Moonyeon Oh, MD, Ja Hye Kim, MD,Ja Hyang Cho, MD, Jin-Ho Choi, MD, PhD, Han-Wook Yoo, MD, PhD Department of Pediatrics, Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, Seoul, Koreahttp://dx.doi.org/10.6065/apem.2014.19.3.164Ann Pediatr Endocrinol Metab 2014;19:164-168 ©2014 Annals of Pediatric Endocrinology & MetabolismReceived: 7 August, 2014Revised: 3 September, 2014Accepted: 16 September, 2014 Address for correspondence:  Han-Woo Yoo, MD, PhDDepartment of Pediatrics, Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, KoreaTel: +82-2-3010-3374     Fax: +82-2-473-3725E-mail: hwyoo@amc.seoul.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ISSN: 2287-1012(Print)  ISSN: 2287-1292(Online) Introduction Cushing syndrome is defined as the clinical manifestations resulting from prolonged  exposure to excessive glucocorticoid, whereas Cushing disease specifies Cushing syndrome that is caused by excessive secretion of adrenocorticotropic hormone (ACTH) from a pituitary tumor, usually an adenoma 1).",Non-OADS,/arxiv_data1/oa_pdf/26/3f/apem-19-164.PMC4208257.pdf
"Keywords: Birth weight, Gestational age, Growth charts, Small for gestational age  infant, KoreansJung Sub Lim, MD1, Se Won Lim, MD1, Ju Hyun Ahn, MD1, Bong Sub Song, MD1, Kye Shik Shim, MD2, Il Tae Hwang, MD, PhD3 1Department of Pediatrics, Korea  Cancer Center Hospital, Seoul,   2Department of Pediatrics, Kyung Hee  University School of Medicine, Seoul,  3Department of Pediatrics, Hallym  University College of Medicine, Seoul,  Koreahttp://dx.doi.org/10.6065/apem.2014.19.3.146Ann Pediatr Endocrinol Metab 2014;19:146-153 ©2014 Annals of Pediatric Endocrinology & MetabolismReceived: 12 September, 2014 Revised: 29 September, 2014 Accepted: 1 October, 2014 Address for correspondence:  Il Tae Hwang, MD, PhDDepartment of Pediatrics, Hallym  University Kangdong Sacred  Heart Hospital, Hallym University College of Medicine, 150 Seongan- ro, Gangdong-gu, Seoul 134-701,  KoreaTel: +82-2-2224-2308 Fax: +82-2-482-8334 E-mail: ithwang83@hallym.or.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ISSN: 2287-1012(Print)  ISSN: 2287-1292(Online) Introduction Small for gestational age (SGA) means a developing fetus in the uterus or an infant is smaller  in size than normal babie's adjusted for sex and gestational age (GA).",Non-OADS,/arxiv_data1/oa_pdf/e0/32/apem-19-146.PMC4208258.pdf
http://dx.doi.org/10.1111/ped.12331.,Non-OADS,/arxiv_data1/oa_pdf/e0/32/apem-19-146.PMC4208258.pdf
Available from: http://kosis.kr/.,Non-OADS,/arxiv_data1/oa_pdf/e0/32/apem-19-146.PMC4208258.pdf
"Keywords: Gynecomastia, Child, PrepubertyMin Kang, MD1, Chan Jae Lee, MD1, Il Tae Hwang, MD, PhD2, Kwanseop Lee, MD, PhD3, Min Jae Kang, MD1 1Department of Pediatrics, Hallym  University Sacred Heart Hospital,  Hallym University College of Medicine, Anyang,  2Department of Pediatrics,  Hallym University Kangdong Sacred Heart Hospital, Hallym University C o l l e g e  o f  M e d i c i n e ,  S e o u l ,  3Department Diagnostic Radiology,  Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Koreahttp://dx.doi.org/10.6065/apem.2014.19.3.159Ann Pediatr Endocrinol Metab 2014;19:159-163 ©2014 Annals of Pediatric Endocrinology & MetabolismReceived: 30 July, 2014Revised: 20 August, 2014Accepted: 28 August, 2014 Address for correspondence:  Min Jae Kang, MDDepartment of Pediatrics, Hallym University Sacred Heart Hospital, 22 Gwanpyeong-ro 170beon-gil, Dongan-gu, Anyang 431-796, KoreaTel: +82-31-380-3730     Fax: +82-31-380-1900E-mail: mjkang@hallym.or.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ISSN: 2287-1012(Print)  ISSN: 2287-1292(Online) Introduction Gynecomastia is the benign glandular proliferation of male breast tissue which accounts  for 60% of all disorders of male breast1).",Non-OADS,/arxiv_data1/oa_pdf/e9/3f/apem-19-159.PMC4208259.pdf
"Keywords: Congenital hypothyroidism (CH), Neonatal screening, Thyrotropin (TSH),  IGSF1Toshihiro Tajima, MD, PhD, Akie Nakamura, MD, Shuntaro Morikawa, MD, Katsura Ishizu, MD Department of Pediatrics, Hokkaido  University School of Medicine,  Sapporo, Japanhttp://dx.doi.org/10.6065/apem.2014.19.3.117 Ann Pediatr Endocrinol Metab 2014;19:117-121 ©2014 Annals of Pediatric Endocrinology & MetabolismReceived: 3 August, 2014Accepted: 14 August, 2014 Address for correspondence:  Toshihiro Tajima, MD, PhDDepartment of Pediatrics, Hokkaido University School of Medicine, N15, W7, Kita-Ku, Sapporo 060-8638, JapanTel: +81-11-716-1161     Fax: +81-11-706-7898E-mail: tajeari@med.hokudai.ac.jp This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ISSN: 2287-1012(Print)  ISSN: 2287-1292(Online) Introduction Congenital central hypothyroidism (C-CH) is an unusual condition characterized by low  levels of both thyroid hormones and of thyroid-stimulating hormone (TSH).",Non-OADS,/arxiv_data1/oa_pdf/06/42/apem-19-117.PMC4208260.pdf
"Keywords: Drug-related side effects and adverse reactions, Central precocious  puberty, Leuprolide, TriptorelinJi Woo Lee, MD1, Hyung Jin Kim, MD1, Yun Mee Choe, MD2, Hee Suk Kang, RN1, Soon Ki Kim, MD1, Yong Hoon Jun, MD1, Ji Eun Lee, MD1 Department of 1Pediatrics and 2 Surgery, Inha University Hospital,  Grauduate School of Medicine,  Inha University, Incheon, Koreahttp://dx.doi.org/10.6065/apem.2014.19.3.135Ann Pediatr Endocrinol Metab 2014;19:135-140 ©2014 Annals of Pediatric Endocrinology & MetabolismReceived: 8 August, 2014 Revised: 6 September, 2014 Accepted: 20 September, 2014 Address for correspondence:  Ji Eun Lee, MD Department of Pediatrics, Inha University Hospital, Grauduate  School of Medicine, Inha University, of Medicine, 27 Inhang-ro, Jung-gu, Incheon 400-711, Korea Tel: +82-32-890-3617 Fax: +82-32-890-2844E-mail: anicca@inha.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ISSN: 2287-1012(Print)  ISSN: 2287-1292(Online) Introduction Precocious puberty is defined as the occurrence of sexual maturation before the age of  8 years in girls and 9 years in boys.",Non-OADS,/arxiv_data1/oa_pdf/c2/ce/apem-19-135.PMC4208261.pdf
"Keywords: Turner syndrome, Growth hormone, X chromosome, Y chromosome,  Genomic imprintingHye Jin Lee, MD1,  Hae Woon Jung, MD1, Gyung Min Lee, MD2, Hwa Young Kim, MD1, Jae Hyun Kim, MD3, Sun Hee Lee, MD4, Ji Hyun Kim, MD5, Young Ah Lee, MD, PhD1, Choong Ho Shin, MD, PhD1, Sei Won Yang, MD, PhD1 1Department of Pediatrics, Seoul  National University Children’s Hospital,  Seoul National University College of Medicine, Seoul,  2Department  of Pediatrics, Konyang University Hospital, Daejeon,  3Department of  Pediatrics, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Goyang,  4Department  of Pediatrics, Gachon University Gil Medical Center, Incheon,  5Department  of Pediatrics, Dongguk University Ilsan Hospital, Goyang, Koreahttp://dx.doi.org/10.6065/apem.2014.19.3.127Ann Pediatr Endocrinol Metab 2014;19:127-134 ©2014 Annals of Pediatric Endocrinology & MetabolismReceived: 16 June, 2014 Revised: 17 July, 2014 Accepted: 3 September, 2014 Address for correspondence:  Young Ah Lee, MD, PhDDivision of Endocrinology and  Metabolism, Department of  Pediatrics, Seoul National University Children’s Hospital, Seoul National  University College of Medicine, 101  Daehak-ro, Jongno-gu, Seoul110-744, Korea Tel: +82-2-2072-2308 Fax: +82-2-743-3455E-mail: nina337@snu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ISSN: 2287-1012(Print)  ISSN: 2287-1292(Online) Introduction Growth failure is a problem for all girls with Turner syndrome (TS), with untreated  individuals achieving an average adult stature 20 cm shorter than their peers1).",Non-OADS,/arxiv_data1/oa_pdf/89/0c/apem-19-127.PMC4208262.pdf
"Keywords: Congenital hypothyroidism, Thyroxine, Thyroid glandMin Sun Cho, MD1, Gyung Sun Cho, MD2, So Hyun Park, MD, PhD3, Min Ho Jung, MD, PhD4, Byung Kyu Suh, MD, PhD5, Dae Gyun Koh, MD, PhD3 1Department of Pediatrics, The  Catholic University of Korea, St. Paul's  Hospital, Seoul, 2Department of  Pediatrics, The Catholic University of Korea, Bucheon St. Mary's Hospital, Bucheon,  3Department of Pediatrics,  The Catholic University of Korea, St. Vincent's Hospital, Suwon,  4Depart- ment of Pediatrics, The Catholic University of Korea, Yeouido St. Mary's Hospital, Seoul,  5Department of  Pediatrics, The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Korea http://dx.doi.org/10.6065/apem.2014.19.3.141Ann Pediatr Endocrinol Metab 2014;19:141-145 ©2014 Annals of Pediatric Endocrinology & MetabolismReceived: 27 August, 2014 Revised: 15 September, 2014 Accepted: 24 September, 2014 Address for correspondence:  So Hyun Park, MD, PhD Department of Pediatrics, The Catholic University of Korea, St.  Vincent's Hospital, 93 Jungbu- daero, Paldal-gu, Suwon 442-723, Korea Tel: +82-31-249-8312 Fax: +82-31-257-9111E-mail: nicedoc@catholic.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ISSN: 2287-1012(Print)  ISSN: 2287-1292(Online) Introduction In developed countries, the introduction of screening programs for congenital hypothyroi- dism (CH) has enabled effective detection of this condition in neonates.",Non-OADS,/arxiv_data1/oa_pdf/54/fc/apem-19-141.PMC4208263.pdf
"Keywords: Graves’ disease, Hyperthyroidism, ChildYo Han Ho, MD, Eun Cho Chung, MD, Sin-Ae Park, MD Department of Pediatrics, Presbyterian Medical Center, Jeonju, Koreahttp://dx.doi.org/10.6065/apem.2014.19.3.154 Ann Pediatr Endocrinol Metab 2014;19:154-158 ©2014 Annals of Pediatric Endocrinology & MetabolismReceived: 7 August, 2014Revised: 10 September, 2014Accepted: 19 September, 2014 Address for correspondence:  Sin-Ae Park, MDDepartment of Pediatrics,Presbyterian Medical Center, 365Seowon-ro, Wansan-gu, Jeonju560-750, KoreaTel: +82-63-230-1390Fax: +82-63-230-1399E-mail: psinai@hanmail.net This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ISSN: 2287-1012(Print)  ISSN: 2287-1292(Online) Introduction Hyperthyroidism is uncommon in the pediatric age range and particularly rare in young  children.",Non-OADS,/arxiv_data1/oa_pdf/31/79/apem-19-154.PMC4208264.pdf
"Keywords: Thyrotoxic periodic paralysis, Graves’ disease, Adolescent, KoreanSe Yong Jung, MD1, Kyung Chul Song, MD1, Jae Il Shin, MD2, Hyun Wook Chae, MD1, Ho-Seong Kim, MD, PhD1, Ah Reum Kwon, MD1 Departments of 1Pediatric  Endocrinology and 2Pediatric  Neprhology, Yonsei University College  of Medicine, Seoul, Koreahttp://dx.doi.org/10.6065/apem.2014.19.3.169Ann Pediatr Endocrinol Metab 2014;19:169-173 ©2014 Annals of Pediatric Endocrinology & MetabolismReceived: 12 August, 2014Revised: 9 September, 2014Accepted: 19 September, 2014 Address for correspondence:  Ah Reum Kwon, MD Department of Pediatric Endocrinology, Severance Children’s Hospital, YonseiUniversity College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, KoreaTel: +82-2-2228-8203Fax: +82-2-393-9118E-mail: arema@yuhs.ac This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ISSN: 2287-1012(Print)  ISSN: 2287-1292(Online) Introduction Thyrotoxic periodic paralysis (TPP) consists of episodes of muscle paralysis due to the  hypokalemia that is associated with hyperthyroidism1).",Non-OADS,/arxiv_data1/oa_pdf/2b/ce/apem-19-169.PMC4208265.pdf
2011. http://www.nice.org.uk/nicemedia/live/13465/54208/54208.pdf.,Non-OADS,/arxiv_data1/oa_pdf/35/bc/rju109.PMC4208298.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Huang D, Swanson EA, Lin CP, et al.",Non-OADS,/arxiv_data1/oa_pdf/37/ee/bjophthalmol-2013-304326.PMC4208340.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Huang D, Swanson EA, Lin CP, et al.",Non-OADS,/arxiv_data1/oa_pdf/d6/5a/bjophthalmol-2013-304299.PMC4208341.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Pulia ﬁto CA, Hee MR, Lin CP, et al.",Non-OADS,/arxiv_data1/oa_pdf/b3/f9/bjophthalmol-2013-304447.PMC4208342.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Quigley HA.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/bjophthalmol-2013-304751.PMC4208343.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Zangwill LM, Bowd C. Retinal nerve ﬁber layer analysis in the diagnosis of glaucoma.",Non-OADS,/arxiv_data1/oa_pdf/2e/7e/bjophthalmol-2014-305156.PMC4208344.pdf
"The scan time was 2 s. Image processing The routine used in our previous studies was applied to the present image set.15Brieﬂy , images were blurred and contrast enhanced by local contrast enhancement using adaptive histo-gram ﬁltering in Fiji (ImageJ 1.45q, NIH, http://imagej.nih.gov/ ij/).",OADS,/arxiv_data1/oa_pdf/bd/2c/bjophthalmol-2013-304629.PMC4208345.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Quigley HA, Broman AT.",Non-OADS,/arxiv_data1/oa_pdf/bd/2c/bjophthalmol-2013-304629.PMC4208345.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Morris AT, Sanders MD.",Non-OADS,/arxiv_data1/oa_pdf/ca/65/bjophthalmol-2013-304301.PMC4208346.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Huang D, Swanson EA, Lin CP, et al.",Non-OADS,/arxiv_data1/oa_pdf/d2/c2/bjophthalmol-2014-305305.PMC4208347.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6d/23/btt-8-243.PMC4208348.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBiologics: Targets and Therapy 2014:8 243–254Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  243Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S5073 4Resistant mutations in CML and Ph+ALL –   role of ponatinib Geoffrey D Miller Benjamin J Bruno Carol S Lim Department of Pharmaceutics and  Pharmaceutical Chemistry, College   of Pharmacy, University of Utah,   Salt Lake City, Utah, USA Correspondence: Carol S Lim   University of Utah, 30 South 2000 east,  Room 2916, Salt Lake City, UT 84112,  USA  Tel +1 801 587 9711   email carol.lim@pharm.utah.ed uAbstract:  In 2012, ponatinib (Iclusig®), an orally available pan-BCR-ABL tyrosine kinase  inhibitor (TKI) developed by ARIAD Pharmaceuticals, Inc., was approved by the US Food and  Drug Administration for use in resistant or intolerant chronic myeloid leukemia (CML) and  Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).",Non-OADS,/arxiv_data1/oa_pdf/6d/23/btt-8-243.PMC4208348.pdf
Available  from: http://www.cancer.gov/cancertopics/pdq/treatment/CML/Patient/ page 2.,Non-OADS,/arxiv_data1/oa_pdf/6d/23/btt-8-243.PMC4208348.pdf
Available from: http://www.patient.co.uk/ doctor / chronic-myeloid-leukaemia-pro #.,Non-OADS,/arxiv_data1/oa_pdf/6d/23/btt-8-243.PMC4208348.pdf
"Avail - able from: http://www.cancer.org/cancer/leukemia- chronicmyeloidcml /  detailedguide/leukemia-chronic-myeloid-myelogenous-stagin g.  Accessed July 14, 2014.",Non-OADS,/arxiv_data1/oa_pdf/6d/23/btt-8-243.PMC4208348.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/6d/23/btt-8-243.PMC4208348.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/6d/23/btt-8-243.PMC4208348.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b6/4c/dmso-7-481.PMC4208349.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 481–486Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  481Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S5077 7T estosterone levels and type 2 diabetes in men:  current knowledge and clinical implications Anne M Beatrice Deep Dutta Manoj Kumar Kumbenahalli Siddegowda  Shivaprasad Ankur Sinha Sayantan Ray Subhankar Chowdhury Department of endocrinology  and Metabolism, institute of Post  Graduate Medical education and  Research and Seth Sukhlal Karnani  Memorial Hospital, Calcutta, india Correspondence: Manoj Kumar   Room 9A, 4th Floor, Ronald Ross   Building, Department of endocrinology   and Metabolism, institute of Post   Graduate Medical education   and Research and Seth Sukhlal Karnani   Memorial Hospital, 244 AJC Bose Road,  Calcutta 700020, india   email manojkattu@gmail.co mAbstract:  The relationship between testosterone and diabetes is an important issue, given the  fact that diabetes is becoming a fast-growing epidemic, the morbidity associated with which is  more disabling than the disease itself.",Non-OADS,/arxiv_data1/oa_pdf/b6/4c/dmso-7-481.PMC4208349.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/b6/4c/dmso-7-481.PMC4208349.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/4c/dmso-7-481.PMC4208349.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bb/a5/ahmt-5-191.PMC4208350.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdolescent Health, Medicine and Therapeutics 2014:5 191–198Adolescent Health, Medicine and Therapeutics Dove press submit your manuscript | www.dovepress.co m Dove press  191OriginAl reseArcHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/AHMT .S6794 3experiences of health care transition voiced   by young adults with type 1 diabetes:   a qualitative study Katharine c garvey1,5 Margaret g Beste2 Donna luff3,5 Astrid Atakov-castillo2 Howard A Wolpert2,5 Marilyn D ritholz4–6 1Division of endocrinology, Boston  children’s Hospital, Boston, MA,   UsA; 2Adult section, Joslin Diabetes  center, Boston, MA, UsA; 3institute  for Professionalism and ethical  Practice, Boston children’s Hospital,   Boston, MA, UsA; 4Behavioral and  Mental Health Unit, Joslin Diabetes  center, Boston, MA, UsA; 5Harvard  Medical school, Boston, MA, UsA;   6Department of Psychiatry, Boston  children’s Hospital, Boston, MA, UsA correspondence: Katharine c garvey   Division of endocrinology, Boston  children’s Hospital, 300 longwood  Avenue, Boston, MA 02115, UsA   Tel +1 617 919 3045   email katharine.garvey@childrens.",Non-OADS,/arxiv_data1/oa_pdf/bb/a5/ahmt-5-191.PMC4208350.pdf
"Adolescent Health, Medicine and Therapeutics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/adolescent-health-medicine-and-therapeutics-journa lAdolescent Health, Medicine and Therapeutics is an international,  peer-reviewed, open access journal focusing on health, pathology,  and treatment issues specific to the adolescent age group.",Non-OADS,/arxiv_data1/oa_pdf/bb/a5/ahmt-5-191.PMC4208350.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/a5/ahmt-5-191.PMC4208350.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/88/18/ppa-8-1437.PMC4208351.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1437–1447Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1437Methodologyopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/ 10.2147/PPA.S6692 2how to study determinants related to medication  adherence in newly diagnosed polyarthritis  patients for the development of a prediction  instrument  Annelieke Pasma1,2 Johanna MW hazes1 Jolanda J luime1 Jan JV Busschbach2 Adriaan van ’t Spijker2 1department of Rheumatology,  erasmus MC, University Medical  Center Rotterdam, 2department  of Psychiatry, Section of Medical  Psychology and Psychotherapy,  erasmus MC, University Medical  Center Rotterdam, Rotterdam,  the NetherlandsIntroduction:  For patients with a chronic disease, the appropriate use of medication is the  key to manage their illness.",Non-OADS,/arxiv_data1/oa_pdf/88/18/ppa-8-1437.PMC4208351.pdf
"When rheumatologists get better insight into patients  who are potentially nonadherent, unnecessary switches to other therapies might be  prevented.5 Correspondence: Annelieke Pasma department of Rheumatology, erasmus  MC, University Medical Center,  Po Box 2040, 3000 CA, Rotterdam,  the Netherlands tel +31 10 703 4543 email a.pasma@erasmusmc.n lJournal name: Patient Preference and Adherence Journal Designation: Methodology Y ear: 2014 Volume: 8 Running head verso: Pasma et al Running head recto: How to study determinants of adherence DOI: http://dx.doi.org/10.2147/PPA.S66922",Non-OADS,/arxiv_data1/oa_pdf/88/18/ppa-8-1437.PMC4208351.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/88/18/ppa-8-1437.PMC4208351.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/db/56/dmso-7-487.PMC4208352.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 487–494Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  487REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/DMSO.S3909 2Significance of HbA1c and its measurement   in the diagnosis of diabetes mellitus:   US experience Deborah Taira Juarez Kendra M Demaris Roy Goo Christina Louise  Mnatzaganian Helen Wong Smith Daniel K Inouye College of Pharmacy,   University of Hawaii at Hilo,    Honolulu, HI, USA Correspondence: Deborah Taira Juarez   Daniel K Inouye College of Pharmacy,  University of Hawaii at Hilo, 677 Ala  Moana Boulevard, Suite 1025, Honolulu,  HI 96813, USA   Email dtjuarez@hawaii.ed uAbstract:  The 2014 American Diabetes Association guidelines denote four means of diagnosing  diabetes.",Non-OADS,/arxiv_data1/oa_pdf/db/56/dmso-7-487.PMC4208352.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/db/56/dmso-7-487.PMC4208352.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/db/56/dmso-7-487.PMC4208352.pdf
"Available from:  http://www.endocrinologia.org.mx/descargas/guias_endos/The% 20 Endocrine %20Society%20Statement%20on%20A1c%20use.pd f.  Accessed September 4, 2014.",Non-OADS,/arxiv_data1/oa_pdf/db/56/dmso-7-487.PMC4208352.pdf
"Available from: http://www.who.int/diabetes/publications/report- hba1c_2011.pd f. Accessed October 1, 2013.",Non-OADS,/arxiv_data1/oa_pdf/db/56/dmso-7-487.PMC4208352.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/56/03/dddt-8-1993.PMC4208353.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 1993–2007Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1993Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/DDDT .S6865 9immunomodulatory effects of 17- O- acetylacuminolide in ra W264.7 cells and hUVecs:  involvement of MaPK and nF- κB pathways Mouna achoui1 Karen heyninck2 chung Yeng looi1 ali Mohd Mustafa1 guy haegeman2 Mohd rais Mustafa1 1Department of Pharmacology, Faculty  of Medicine, University of Malaya,   Kuala lumpur, Malaysia; 2Department  of Physiology, laboratory of  eukaryotic gene expression and  signal Transduction, ghent, BelgiumAbstract:  The terpenoid 17- O-acetylacuminolide (AA) was shown to inhibit the production  of several inflammatory mediators.",Non-OADS,/arxiv_data1/oa_pdf/56/03/dddt-8-1993.PMC4208353.pdf
"The IκBα  inhibits correspondence: Mohd rais Mustafa Department of Pharmacology, Faculty  of Medicine, University of Malaya,  50603 Kuala lumpur, Malaysia  Tel +60 379 677 952  email rais@um.edu.m y Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Achoui et al Running head recto: Immunomodulatory effects of AA in RAW264.7 cells and HUVECs DOI: http://dx.doi.org/10.2147/DDDT.S68659",Non-OADS,/arxiv_data1/oa_pdf/56/03/dddt-8-1993.PMC4208353.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/56/03/dddt-8-1993.PMC4208353.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/03/dddt-8-1993.PMC4208353.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c4/fc/opth-8-2125.PMC4208417.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 2125–2128Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2125CASE REPORTopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S6077 9Spectral domain optical coherence tomography  imaging in optic disk pit associated with outer  retinal dehiscence Chee Wai Wong1,2 Doric Wong1,2 Ranjana Mathur1,2 1Singapore National Eye Centre,   Singapore; 2Singapore Eye Research  Institute, SingaporeAbstract:  A 37-year-old Bangladeshi male presented with an inferotemporal optic disk pit  and serous macular detachment in the left eye.",Non-OADS,/arxiv_data1/oa_pdf/c4/fc/opth-8-2125.PMC4208417.pdf
"The anterior segment Correspondence: Ranjana Mathur  Singapore National Eye Centre, 11 Third  Hospital Avenue, Singapore 168751 Fax +6562263395 Email ranjana.mathur@snec.com.s g Journal name: Clinical Ophthalmology Article Designation: CASE REPORT Y ear: 2014 Volume: 8 Running head verso: Wong et al Running head recto: SD-OCT imaging in optic disk pit maculopathy DOI: http://dx.doi.org/10.2147/OPTH.S60779",Non-OADS,/arxiv_data1/oa_pdf/c4/fc/opth-8-2125.PMC4208417.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/c4/fc/opth-8-2125.PMC4208417.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/fc/opth-8-2125.PMC4208417.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/40/aa/opth-8-2133.PMC4208419.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 2133–2139Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2133Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S4970 8T opography of retinal recovery processes   in humans Babac e Mazinani elke Merx niklas Plange Peter Walter gernot F roessler rWTh aachen University,    aachen, germanyBackground:  The purpose of this study was to examine retinal recovery processes   to pographically by the application of three flash sequences with specific interstimulus  intervals.",Non-OADS,/arxiv_data1/oa_pdf/40/aa/opth-8-2133.PMC4208419.pdf
"Light-emitting diode (LED) stimulators have been used previously  to record multifocal ERGs, and can be driven with variable frame rates and generate  dark and bright steps of the desired duration.5 The aim of this study was to examine the Correspondence: Babac e Mazinani Universitätsklinikum, augenklinik,  Pauwelsstrasse 30, 52068 aachen,  germany T el +49 24 1808 8191 Fax +49 24 1808 2408 email bmazinani@gmx.d eJournal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Mazinani et al Running head recto: Triple-flash multifocal electroretinography DOI: http://dx.doi.org/10.2147/OPTH.S49708",Non-OADS,/arxiv_data1/oa_pdf/40/aa/opth-8-2133.PMC4208419.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/40/aa/opth-8-2133.PMC4208419.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 2139Triple-flash multifocal electroretinography  27.,Non-OADS,/arxiv_data1/oa_pdf/40/aa/opth-8-2133.PMC4208419.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/35/awu169.PMC4208460.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e2/d4/idr-7-261.PMC4208492.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInfection and Drug Resistance 2014:7 261–271Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  261REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S4435 7Optimizing antimicrobial therapy in critically   ill patients Virginie Vitrat1 Serge Hautefeuille2 Cécile Janssen1 David Bougon2 Michel Sirodot2 Leonardo Pagani1,3 1Antimicrobial Stewardship Program,   Infectious Diseases Unit,  2Intensive  Care Unit, Annecy-Genevois Hospital  Center (CHANGE), Annecy, France;   3Infectious Diseases Unit, Bolzano  Central Hospital, Bolzano, Italy Correspondence: Leonardo Pagani  Infectious Diseases Unit, Bolzano   Central Hospital, Via L. Boehler 5,  I-39100, Bolzano, Italy   Tel +39 0471 908131   Fax +39 0471 908552   Email lpagani.",Non-OADS,/arxiv_data1/oa_pdf/e2/d4/idr-7-261.PMC4208492.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/e2/d4/idr-7-261.PMC4208492.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/d4/idr-7-261.PMC4208492.pdf
http://www.R-project.org/ .,Non-OADS,/arxiv_data1/oa_pdf/30/b3/jiu293.PMC4208622.pdf
"R package version 4.1–3,2014 .http://CRAN.R-project.org/package=rms .",Non-OADS,/arxiv_data1/oa_pdf/30/b3/jiu293.PMC4208622.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9e/a6/ijwh-6-899.PMC4208630.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2014:6 899–912International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  899RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S6713 0Associations of consumption of fruits   and vege tables during pregnancy with infant   birth weight or small for gestational age births:   a systematic review of the literature Mary M Murphy1 Nicolas Stettler1,2 Kimberly M Smith1 Richard Reiss3 1exponent, Inc., Center for   Chemical Regulation and Food   Safety, Washington, DC, USA; 2The   Lewin Group, Falls Church, vA,    USA; 3exponent, Inc., Center for   Chemical Regulation and Food   Safety, Alexandria, vA, USA Correspondence: Mary M Murphy   exponent, Inc., Center for Chemical  Regulation and Food Safety,   1150 Connecticut Avenue NW,   Suite 1100, Washington, DC 20036, USA   Tel +1 202 772 4953   Fax +1 202 772 4979   email mmurphy@exponent.co mAbstract:  Maternal nutrition is recognized as one of the determinants of fetal growth.",Non-OADS,/arxiv_data1/oa_pdf/9e/a6/ijwh-6-899.PMC4208630.pdf
"Available from: http://www.who.int/nutrition/topics/fetal_dev_ report_EN.pd f. Accessed December 27, 2012.",Non-OADS,/arxiv_data1/oa_pdf/9e/a6/ijwh-6-899.PMC4208630.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/9e/a6/ijwh-6-899.PMC4208630.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/a6/ijwh-6-899.PMC4208630.pdf
Available from:  http://hdr.undp.org/sites/default/files/reports/14/hdr2013_en_complete.,OADS,/arxiv_data1/oa_pdf/9e/a6/ijwh-6-899.PMC4208630.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ed/3a/ijwh-6-889.PMC4208631.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2014:6 889–897International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  889OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S6633 3a framework for analyzing sex-selective   abortion: the example of changing sex   ratios in southern caucasus sophie a Hohmann1 cécile a lefèvre2,3 Michel l garenne4–6 1cnrs, cercec , Paris, France;   2Université Paris Descartes, UM r  cePeD, P res sorbonne Paris cité,   Paris, France;  3IneD, Paris, France;   4Institut Pasteur, epidémiologie des  Maladies emergentes, Paris, France;   5IrD, UMI résiliences, Bondy, France;   6Medical research council /Wits  rural Public Health and Health  Transitions research Unit (agincourt),   school of Public Health, Faculty of  Health sciences, University of the  Witwatersrand, Johannesburg, south  africa correspondence: Michel l garenne   Institut Pasteur, epidémiologie des  Maladies emergentes,  25 rue du   Dr roux, Paris, France   Tel +33 1 40 61 38 28  email m ichel.garenne@pasteur.f rAbstract:  The paper proposes a socioeconomic framework of supply, demand, and regulation to  explain the development of sex-selective abortion in several parts of the world.",Non-OADS,/arxiv_data1/oa_pdf/ed/3a/ijwh-6-889.PMC4208631.pdf
Or use: http://dvpr.es/1uFrJD w,Non-OADS,/arxiv_data1/oa_pdf/ed/3a/ijwh-6-889.PMC4208631.pdf
"Avail - able from: http://www.stat.gov.az/source/demoqraphy/indexen.ph p.  Accessed October 15, 2013.",OADS,/arxiv_data1/oa_pdf/ed/3a/ijwh-6-889.PMC4208631.pdf
Available from: http://blog.practicalethics.ox.ac.,Non-OADS,/arxiv_data1/oa_pdf/ed/3a/ijwh-6-889.PMC4208631.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/ed/3a/ijwh-6-889.PMC4208631.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/3a/ijwh-6-889.PMC4208631.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6b/87/mder-7-343.PMC4208632.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2014:7 343–355Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  343REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/MDER.S4604 4Carotid artery stenting: current   and emerging options Simon Morr1,4 Ning Lin1,4 Adnan H Siddiqui1–5 1Department of Neurosurgery,   2Department of Radiology, School of  Medicine and Biomedical Sciences,   3Toshiba Stroke and vascular Research  Center, University at Buffalo, State  University of New Y ork, 4Department  of Neurosurgery, Gates vascular  institute, Kaleida Health, 5Jacobs  institute, Buffalo, NY, USA Correspondence: Adnan H Siddiqui   University at Buffalo Neurosurgery,   100 High Street, Suite B4, Buffalo,   NY 14203, USA   T el 1+ 716 218 1000   Fax 1+ 716 859 7479   Email asiddiqui@ubns.co mAbstract:  Carotid artery stenting technologies are rapidly evolving.",Non-OADS,/arxiv_data1/oa_pdf/6b/87/mder-7-343.PMC4208632.pdf
Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa l Medical Devices: Evidence and Research 2014:7submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 355Current options for carotid artery stenting  84.,Non-OADS,/arxiv_data1/oa_pdf/6b/87/mder-7-343.PMC4208632.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJune 2014 |  88  | e51622 | Page 1 of 16Video Article Proton Transfer and Protein Conformation Dynamics in Photosensitive Proteins by Time-resolved Step-scan Fourier-transform Infrared Spectroscopy Víctor A. Lórenz-Fonfría1, Joachim Heberle1 1Experimental Molecular Biophysics, Freie Universität Berlin Correspondence to: Joachim Heberle at jheberle@physik.fu-berlin.de URL: http://www.jove.com/video/51622 DOI: doi:10.3791/51622 Keywords: Biophysics, Issue 88, bacteriorhodopsin, channelrhodopsin, attenuated total reflection, proton transfer, protein dynamics, infrared spectroscopy, time-resolved spectroscopy, step-scan, membrane proteins, singular value decomposition Date Published: 6/27/2014 Citation: Lórenz-Fonfría, V.A., Heberle, J. Proton Transfer and Protein Conformation Dynamics in Photosensitive Proteins by Time-resolved Step- scan Fourier-transform Infrared Spectroscopy.",Non-OADS,/arxiv_data1/oa_pdf/f5/f4/jove-88-51622.PMC4208678.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51622/ Introduction To fully elucidate how proteins perform their function, it is required to measure them as they work, i.e.",Non-OADS,/arxiv_data1/oa_pdf/f5/f4/jove-88-51622.PMC4208678.pdf
Reproduced mass extinction coefficient spectra at 25 °C for liquid water (http://www.ualberta.ca/~jbertie/ JBDownload.HTM#Spectra) and for a hydrated film of the ADP/ATP carrier (AAC)64.,Non-OADS,/arxiv_data1/oa_pdf/f5/f4/jove-88-51622.PMC4208678.pdf
"(B) For the taxa shown in A, the number of ESTs and nucleotide sequences deposited at NCBI (http://www.ncbi.nlm.nih.gov; reference day is May 7, 2012) is indicated as logarithmic bar graph, along with the number of available genome sequences (right column).",OADS,/arxiv_data1/oa_pdf/6a/43/evo0067-2945.PMC4208683.pdf
"To test whether this result is a consequence of insuf- ficient BLAST sensitivity, we generated from the members of the insect GAGA cluster two representative HMM pro- files (full length and BTB domain only) and performed a more sensitive profile–profile search on the HHpred server (http://toolkit.tuebingen.mpg.de/hhpred).",OADS,/arxiv_data1/oa_pdf/6a/43/evo0067-2945.PMC4208683.pdf
1997) searches were conducted in publicly available sequence databases at NCBI (http://blast.ncbi.nlm.nih.gov/).,OADS,/arxiv_data1/oa_pdf/6a/43/evo0067-2945.PMC4208683.pdf
SUCCESSIVE GAIN OF INSULATOR PROTEINS IN ARTHROPOD Likelihood trees were visualized and arranged with FigTree (http://tree.bio.ed.ac.uk/software/figtree/) and then graphically edited with Adobe Illustrator software.,OADS,/arxiv_data1/oa_pdf/6a/43/evo0067-2945.PMC4208683.pdf
"HMM-BASED CANDIDATE SEARCH AND MCL-CLUSTERING OF ORTHOLOGOUS GROUPS To verify our results with an independent method, we combined a search on the basis of insulator-specific hidden Markov models (http://hmmer.org/) with the Markov cluster algorithm (van Dongen 2000).",OADS,/arxiv_data1/oa_pdf/6a/43/evo0067-2945.PMC4208683.pdf
2003) as described else- where (http://orthomcl.org/common/downloads/software/v2.0/ UserGuide.txt).,OADS,/arxiv_data1/oa_pdf/6a/43/evo0067-2945.PMC4208683.pdf
"HHpred-BASED SEARCH FOR GAGA FACTOR ORTHOLOGS Like described above, we constructed two multiple sequence alignments from representative members of the GAGA cluster (full length and BTB domain only) and uploaded these alignments to HHpred (http://toolkit.tuebingen.mpg.de/hhpred) for highly sensitive profile–profile searches.",OADS,/arxiv_data1/oa_pdf/6a/43/evo0067-2945.PMC4208683.pdf
"The genome sequences of Capitella teleta andLottia gi- gantea were produced by the U.S. Department of Energy Joint Genome Institute, http://www.jgi.doe.gov/, in collaboration with the user commu- nity.",OADS,/arxiv_data1/oa_pdf/6a/43/evo0067-2945.PMC4208683.pdf
"Preliminary sequence data for Schmidtea mediterranea were ob- tained from the Genome Institute at Washington University, St. Louis (http://genome.wustl.edu/pub/organism/Invertebrates/).",OADS,/arxiv_data1/oa_pdf/6a/43/evo0067-2945.PMC4208683.pdf
Preliminary se- quence data for Strigamia maritima were obtained from the Baylor College of Medicine Human Genome Sequencing Center website at http://www.hgsc.bcm.edu/.,OADS,/arxiv_data1/oa_pdf/6a/43/evo0067-2945.PMC4208683.pdf
"Preliminary sequence data for Ixodes scapu- laris,Rhodnius prolixus ,a n d Glossina morsitans were obtained from http://www.vectorbase.org.",OADS,/arxiv_data1/oa_pdf/6a/43/evo0067-2945.PMC4208683.pdf
These se- quence data were produced by The Center for Genomics and Bioinformat- ics at Indiana University and distributed via wFleaBase in collaboration with the Daphnia Genomics Consortium http://daphnia.cgb.indiana.edu.,OADS,/arxiv_data1/oa_pdf/6a/43/evo0067-2945.PMC4208683.pdf
"T o submit a comment, go to: http://ep.physoc.org/ letters/submit/expphysiol;99/1/16.",Non-OADS,/arxiv_data1/oa_pdf/28/5f/eph0099-0016.PMC4208685.pdf
IAS website http://www.athero.org/ commentaries/comm770.pdf.,Non-OADS,/arxiv_data1/oa_pdf/28/5f/eph0099-0016.PMC4208685.pdf
URL http://www.scribd.com/doc/38194439/SPADE-UserGuide.,Non-OADS,/arxiv_data1/oa_pdf/11/94/emi0016-0430.PMC4208686.pdf
"Supplemental searches: grey literature (abstracts, conferences) and Internet Conferences Websites ASCO (American Society of Clinical Oncology) http://www.asco.org/ASCOv2/Meetings/Abstracts ASHP (American Society of Health-System Pharmacists) http://www.ashp.org/meetings/AMCP (Academy of Managed Care Pharmacy) http://www.amcp.org/ENETS (European Neuroendocrine Tumor Society) http://www.neuroendocrine.net/ESMO (European Society of Medical Oncology) http://www.esmo.org/education-research/abstracts-virtual-meetings- and-meeting-reports.html ISPE (International Society for Pharmacoepidemiology) http://www.pharmacoepi.org/ISPOR (International Society for Pharmacoeconomics and Outcomes Research)http://www.ispor.org/meetings/PastInternational.aspx http://www.ispor.org/meetings/PastEuro.aspx NANETS (North American Neuroendocrine Tumor Society) http://www.nanets.net/NCRI (National Cancer Research Institute) http://www.ncri.org.uk/ncriconference/#Systematic review of QoL in NET © 2013 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/8e/a7/ecc0022-0714.PMC4208687.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f3/93/ndt-10-1987.PMC4208702.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1987–1996Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1987OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S6965 2Brain structural abnormalities in behavior  therapy-resistant obsessive-compulsive disorder  revealed by voxel-based morphometry Nobuhiko hashimoto1 shutaro Nakaaki2 akiko Kawaguchi1 Junko sato1 harumasa Kasai3 Takashi Nakamae4 Jin Narumoto4 Jun Miyata5 T oshi a Furukawa6,7 Masaru Mimura2 1Department of Psychiatry  and cognitive-Behavioral Medicine,   Nagoya city University graduate  school of Medical sciences,   Nagoya, Japan; 2Department of  Neuropsychiatry, Keio University  school of Medicine, T okyo, Japan;   3Department of central radiology,   Nagoya city University hospital,   Nagoya, Japan; 4Department  of Psychiatry, graduate school  of Medical science, Kyoto Prefectural  University of Medicine, Kyoto, Japan;   5Department of Psychiatry, graduate  school of Medicine, Kyoto University,   Kyoto, Japan; 6Department of health  Promotion and human Behavior,   7Department of clinical epidemiology,   Kyoto University graduate school  of Medicine/ school of Public health,   Kyoto, JapanBackground:  Although several functional imaging studies have demonstrated that behavior  therapy (BT) modifies the neural circuits involved in the pathogenesis of obsessive-compulsive  disorder (OCD), the structural abnormalities underlying BT-resistant OCD remain unknown.",Non-OADS,/arxiv_data1/oa_pdf/f3/93/ndt-10-1987.PMC4208702.pdf
"A recent meta-analysis of gray  matter (GM) changes based on voxel-based morphometry (VBM), an automated and  widely used, whole brain analysis method, has provided evidence of bilateral regional  GM volume increases in the lenticular nucleus as well as bilateral regional GM volume  decreases in the dorsal medial frontal/anterior cingulate gyri in patients with OCD, com - pared with healthy controls.1 In contrast, another meta-analysis of GM changes based  on VBM demonstrated that OCD patients exhibit several areas with smaller volumes correspondence: shutaro Nakaaki Department of Neuropsychiatry,  Keio University school of Medicine,  35 shinanomachi, shinjuku-ku, Tokyo  160-8582, Japan Tel +81 3 5363 3829 Fax +81 3 5379 0187 email hzi05510@nifty.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Hashimoto et al Running head recto: Brain structural abnormalities in behavior therapy-resistant OCD DOI: http://dx.doi.org/10.2147/NDT.S69652",OADS,/arxiv_data1/oa_pdf/f3/93/ndt-10-1987.PMC4208702.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f3/93/ndt-10-1987.PMC4208702.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/93/ndt-10-1987.PMC4208702.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/83/2d/ndt-10-1997.PMC4208703.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s © 2014 Hager et al.,Non-OADS,/arxiv_data1/oa_pdf/83/2d/ndt-10-1997.PMC4208703.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/83/2d/ndt-10-1997.PMC4208703.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1997Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1997CorrigeNDumopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S7154 0Effects of galantamine in a 2-year, randomized, placebo-controlled study   in Alzheimer’s disease [Corrigendum] Hager K, Baseman AS, Nye JS, Brashear HR, Han J,  Sano M, Davis B, Richards HM.",Non-OADS,/arxiv_data1/oa_pdf/83/2d/ndt-10-1997.PMC4208703.pdf
"The correct figure is shown below.Journal name: Neuropsychiatric Disease and Treatment Journal Designation: Corrigendum Y ear: 2014 Volume: 10 Running head verso: Hager et al Running head recto:  DOI: http://dx.doi.org/10.2147/NDT.S71540 Screening n=2,225 Placeb o n=1,023Galantamin e n=1,028Did not receive  study drugb n=2Did no t receiv e  study drug n=4 Received study dru g n=1,021 (safety analysis set)Received study dru g n=1,024 (safety analysis set) Completed:   Withdrawn: Withdrew consent : Adverse event : Death: Death: Lost to follow-up: Early terminationCompleted:   Withdrawn: Withdrew consent Adverse event : Lost to follow-up: Early termination  of study:bDouble-b lind efficacy phas e n=2,051  Random ization 1:1Pretreatment phase (day –28 to –1 ) Baseline (day 0) Treatment phase Titration period (day 1 to 84) – Gal 8 mg/day: day 1 to day 28  – Gal 16 mg/day: day 29 to day 56 – Gal up to 24 mg/day: day 57  to day 84a – Matching placebo Maintena nce period (month 4 to 24)       – Gal at stable dose (at least 16 mg/day)        as achieved on day 84c – Matching placebo   – End-of-study/early withdrawal (month 24) Posttreatment/follow-up (+1 month  [month 25])of study:b322 (32% ) 274 (27% ) 168 (17% ) 43 (4%) 41 (4%) 22 (2%) 425 (42% )339 (33% ) 280 (28% ) 172 (17% ) 53 (5%) 29 (3%) 26 (3%) 405 (40% ) Notes:  auptitration (from 16 mg/day to 24 mg/day) or downtitration (from 24 mg/day to 16 mg/day) of dose was allowed, based on tolerability and the investigator’s  judgment.",Non-OADS,/arxiv_data1/oa_pdf/83/2d/ndt-10-1997.PMC4208703.pdf
"Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or trans- formed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/2b/pit085.PMC4208730.pdf
Available at: http://www.cdc.gov/ std/treatment/2010/sexual-assault.htm .,Non-OADS,/arxiv_data1/oa_pdf/e0/2b/pit085.PMC4208730.pdf
Available at: http://www.bashh.org/documents/2674.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e0/2b/pit085.PMC4208730.pdf
Available at: http://silverbook.health.wa.gov.au/Default.asp?Pub licationID=1&sectionID=42 .,Non-OADS,/arxiv_data1/oa_pdf/e0/2b/pit085.PMC4208730.pdf
Available at: http://www.health.qld.gov.au/cdcg/index/sti_child.,Non-OADS,/arxiv_data1/oa_pdf/e0/2b/pit085.PMC4208730.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2c/f0/oajsm-5-249.PMC4208738.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOpen Access Journal of Sports Medicine 2014:5 249–255Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  249Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S6049 0Science of floorball: a systematic review Taru T ervo1 Anna Nordström2 1Department of Surgical and  Perioperative Sciences, Sports  Medicine, Floorball Research and  Development Center, Umeå School  of Sport Sciences, 2Department of  Surgical and Perioperative Sciences,   Sports Medicine, Umeå School of  Sport Sciences, Umeå University,   Umeå, Sweden Correspondence: Taru Tervo   Umeå School of Sports Sciences, Umeå  University, 90185 Umeå, Sweden   Tel +467 0577 9294  Fax +46 9013 5692  email taru.tervo@umu.s eBackground:  The purpose of this study was to comprehensively review the scientific research  on floorball at the competitive and recreational levels according to field of study.",Non-OADS,/arxiv_data1/oa_pdf/2c/f0/oajsm-5-249.PMC4208738.pdf
Available from: http://www.innebandy.se/Statis - tikHistorik/Innebandyn-i-siffror /.,Non-OADS,/arxiv_data1/oa_pdf/2c/f0/oajsm-5-249.PMC4208738.pdf
Available from:  http://www.floorball.org/default.asp?kieli=826&sivu=205&alasivu=20 5.,Non-OADS,/arxiv_data1/oa_pdf/2c/f0/oajsm-5-249.PMC4208738.pdf
Avail - able from: http://www.scb.se/BE0101 /.,Non-OADS,/arxiv_data1/oa_pdf/2c/f0/oajsm-5-249.PMC4208738.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/2c/f0/oajsm-5-249.PMC4208738.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/f0/oajsm-5-249.PMC4208738.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/2a/sfu039.PMC4208784.pdf
"Hum Biol 2000; 72: 155 –177 3.Economic and Social Panorama of the Community of Latin American and Caribbean States , 2013. http://www.cepal.org/ publicaciones/xml/5/52075/EconomicandSocialPanorama.pdf(1 March 2013, date last accessed) 4.",Non-OADS,/arxiv_data1/oa_pdf/6c/2a/sfu039.PMC4208784.pdf
http://www.eclac.org/publicaciones/xml/1/50561/Observatorio Demogra ﬁco2012.pdf.pdf .,Non-OADS,/arxiv_data1/oa_pdf/6c/2a/sfu039.PMC4208784.pdf
"http://data.worldbank.org/region/latin- americaand-caribbean (1 March 2013, date last accessed) 6.",Non-OADS,/arxiv_data1/oa_pdf/6c/2a/sfu039.PMC4208784.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/37/sfu064.PMC4208785.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/77/sfu046.PMC4208786.pdf
"The Canadian Society of Muslims: Muslim population statistics [article online], 2000. http://muslimcanada.org/muslimstats.",Non-OADS,/arxiv_data1/oa_pdf/d5/77/sfu046.PMC4208786.pdf
"http://en.wikipedia.org/ wiki/Islamic_calendar (2012, date last accessed) 8.",Non-OADS,/arxiv_data1/oa_pdf/d5/77/sfu046.PMC4208786.pdf
"http://en.wikipedia.org/wiki/ Ramadan (2012, date last accessed) 9.",Non-OADS,/arxiv_data1/oa_pdf/d5/77/sfu046.PMC4208786.pdf
"http://www.bbc.co.uk/weather/360630 (2012, date last accessed) 10.",Non-OADS,/arxiv_data1/oa_pdf/d5/77/sfu046.PMC4208786.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJune 2014 |  88  | e51278 | Page 1 of 17Video Article Setting-up an In Vitro Model of Rat Blood-brain Barrier (BBB): A Focus on BBB Impermeability and Receptor-mediated Transport Yves Molino1, Françoise Jabès1, Emmanuelle Lacassagne2, Nicolas Gaudin2, Michel Khrestchatisky2 1VECT-HORUS SAS 2Aix-Marseille Université, CNRS, NICN UMR 7259 Correspondence to: Michel Khrestchatisky at michel.khrestchatisky@univ-amu.fr URL: http://www.jove.com/video/51278 DOI: doi:10.3791/51278 Keywords: Medicine, Issue 88, rat brain endothelial cells (RBEC), mouse, spinal cord, tight junction (TJ), receptor-mediated transport (RMT), low density lipoprotein (LDL), LDLR, transferrin, TfR, P-glycoprotein (P-gp), transendothelial electrical resistance (TEER), Date Published: 6/28/2014 Citation: Molino, Y., Jabès, F., Lacassagne, E., Gaudin, N., Khrestchatisky, M. Setting-up an In Vitro Model of Rat Blood-brain Barrier (BBB): A Focus on BBB Impermeability and Receptor-mediated Transport.",Non-OADS,/arxiv_data1/oa_pdf/c3/da/jove-88-51278.PMC4208856.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51278/ Introduction Many drugs developed to treat Central Nervous System (CNS) disorders are unable to reach the brain parenchyma in therapeutically relevant concentrations.,Non-OADS,/arxiv_data1/oa_pdf/c3/da/jove-88-51278.PMC4208856.pdf
Clinical Trials database.Available at: http://clinicaltrials.gov/ct2/show/NCT01291576?term /H11005 NCT01291576&rank /H110051.,OADS,/arxiv_data1/oa_pdf/7f/cb/e2014.00002.PMC4208885.pdf
2. http://www.medtronic.com/p atients/gastroparesis/device/what- is-it.,Non-OADS,/arxiv_data1/oa_pdf/41/9e/e2014.00400.PMC4208911.pdf
"For accurate mass determination, the sample was dried under vacuum and sent out to the Vincent Coates FoundationMass Spectrometry Laboratory at Stanford University (http://mass-spec.stanford.edu).",Non-OADS,/arxiv_data1/oa_pdf/ef/7c/bio0029-1135.PMC4208949.pdf
URL: http://www.allergan.com/assets/pdf/ lastacaft_pi.pdf .,OADS,/arxiv_data1/oa_pdf/e5/7b/12325_2014_Article_155.PMC4209090.pdf
URL: http://ecatalog.alcon.co m/PI/Pataday_us_en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e5/7b/12325_2014_Article_155.PMC4209090.pdf
2013. http://www.medicines.org.,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2013. http://www.ema.europa.eu/ docs/en_GB/document_library/EPAR_-_Product_Information/human/000323/WC500041563.pdf .,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2012. http://www.medicines.org.uk/ emc/medicine/22743/SPC/Synﬂorix ?suspension ?,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2014. https://www.gov.uk/ government/publication s/pneumococcal-disease- caused-by-strains-in-prevenar-13-and-not-in-prevenar-7-vaccine/pneumococcal-dise ase-infections-caused-by- serotypes-in-prevenar-13-and-not-in-prevenar-7 .,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2013. http://www.health.belgium.,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2013. http://www.health.belgium.be/Adv Ther (2014) 31:1011–1044 1041,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2012. http://www.ssi.dk/ English/News/EPI-NEWS/2012/No%2051b%20-%202012.aspx .,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2013. http://www.thl.ﬁ/ ﬁ_FI/web/rokottajankasikirja-ﬁ/pneumokokkiroko-tukset .,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2013. http://www.hcsp.fr/Explore.c gi/avisrapportsdomaine?,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
Empfehlungen der Sta ¨ndigen Impfkommission (STIKO) am Robert Koch- Institut/Stand: August 2014. http://www.rki.de/ DE/Content/Infekt/EpidBull/Archiv/2014/Ausgaben/34_14.pdf?__blob=publicationFile .,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2014. http://www.gesunde.sachsen.de/ download/lua/LUA_HM_Impfempfehlungen_E1.pdf .,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
Available: http://static.diavgeia.gov.gr/doc/45%CE %A8%CE%A8%CE%98-2%CE%98%CE%9C .,OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2013. http://www.immunisation.ie/en/ HealthcareProfessionals/ImmunisationGuidelines/ .,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2013. http://www.regione.taa.it/bur/pdf/I-II/2013/21/S1/S121130184418.pdf .,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
PG 2014/240655 del 19.06.2014.2014. http://www.saluter.it/documentazione/leggi/ regionali/comunicazioni/malattie_batteriche_ indicazioni_2014.pdf/view .,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2012. http://www.medicoeleggi.com/ argomenti02/fvg/bur/600929.htm .,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
Bollettino UfﬁcialeDella Regione Lazio 2012. http://www.regione.,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
Gazzetta Ufﬁciale Della Regione Siciliana 2012. http://www.gurs.regione.sicilia.it/1042 Adv Ther (2014) 31:1011–1044,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
"2012.http://www.epicentro.iss.it/temi/vaccinazioni/pdf/Normative/Trentino%20Alto%20Adige/Trentino,% 20Trento%20-%20Dicembre%202012/PPPVPT% 2012-14%20DGR%20n%C2%B0%2017%20del%2013.01.2012%20Testo.pdf .",Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2012. http://www.epicentro.iss.it/temi/ vaccinazioni/pdf/Normative/Umbria_Maggio%202012/PNPV%2012-14%20 ?%20PNEMoRc%2010-15% 20%20DGR%20n%C2%B0%20607%20del%202012.,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2005. http://www.salute.gov.it/portale/ documentazione/p6_2_2_1.jsp?lingua=italiano&id= 543.,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2008. http://www.sante.public.lu/ fr/recommandations/conseil-maladies-infectieuses/pneumonie/recommandations-vaccinations-2008/pneumonie-recommandations-vaccinatin-pneumo- coque-23valent-2008.pdf .,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2011. http://www.sante.public.lu/ fr/recommandations/conseil-maladies-infectieuses/pneumonie/recommandations-vaccinations-2011/2011-02-vaccination-nourrissons-streptococcus- pneumoniae.pdf .,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2007. http://www.lovdata.,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2014. http://www20.gencat.cat /docs/canalsalut/Home% 20Canal%20Salut/Professionals/Temes_de_salut/Vacunacions/documents/Arxius/Prevencio_neumo_ Catalunya_adults.pdf .,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2012. http://www.sergas.es/gal/ DocumentacionTecnica/docs/SaudePublica/vacunas/ PNEUMO_conxugada_adultos_ﬁrmada.pdf .,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2013. http://www.coegi.org/ Contenidos/Ficha.aspx?IdMenu=09870026-02f2- 4de1-b6b5-4d1b087c2bdd .,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2013. http://www.sp.san.gva.es/DgspPortal/docs/ instruccionesdevacunacion_18anyos_11nov_2013.,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2013. http://www.madrid.org/cs/Satellite?c=PTSA_ Multimedia_FA&cid=1354263566935&pagename=PortalSalud%2FPTSA_Multimedia_FA%2FPTSA_documentoWebeditpro .,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2013. http://www.navarra.es/ NR/rdonlyres/AECCD760-AB2A-4841-818A-FA53478 FD6DC/255921/BOL72INT.pdf .,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2013. http://www.janusinfo.,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
1994. http://www.socialstyrelsen.se/publikationer 1994/1994-10-26 .,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2013. https://www.gov.uk/ government/publications/pneumococcal-the-green- book-chapter-25 .,Non-OADS,/arxiv_data1/oa_pdf/88/8d/12325_2014_Article_157.PMC4209094.pdf
2013. http://www.myeloma- euronet.org/en/multiple-myeloma/treatment-with- bortezomibphp .,Non-OADS,/arxiv_data1/oa_pdf/42/74/12325_2014_Article_159.PMC4209095.pdf
Available from: http://www.en.,Non-OADS,/arxiv_data1/oa_pdf/2e/40/12325_2014_Article_160.PMC4209096.pdf
2010.http://www.psgconsults.com/Understanding_Specialty_Pharmacy_ Management_and_Cost_Control_FINAL.pdf .,Non-OADS,/arxiv_data1/oa_pdf/68/28/40273_2014_Article_196.PMC4209107.pdf
November 2013. http://www.imshealth.,Non-OADS,/arxiv_data1/oa_pdf/68/28/40273_2014_Article_196.PMC4209107.pdf
April 2014. http://www.imshealth.com/ portal/site/imshealth/menuitem.762a961826aad98f53c753c71ad8 c22a/?vgnextoid=2684d47626745410VgnVCM10000076192ca2RCRD .,Non-OADS,/arxiv_data1/oa_pdf/68/28/40273_2014_Article_196.PMC4209107.pdf
April 2014.http://lab.expressscripts.com/ */media/pdfs/drug%20trend%20 report/express%20scripts%202013%20drug%20trend%20report.,Non-OADS,/arxiv_data1/oa_pdf/68/28/40273_2014_Article_196.PMC4209107.pdf
22 April 2014. http://investors.gilead.,Non-OADS,/arxiv_data1/oa_pdf/68/28/40273_2014_Article_196.PMC4209107.pdf
April 2012. http://www.amcp.org/prior_authorization/ .,Non-OADS,/arxiv_data1/oa_pdf/68/28/40273_2014_Article_196.PMC4209107.pdf
http://www.kff.org/medicare/upload/8237.pdf .,Non-OADS,/arxiv_data1/oa_pdf/68/28/40273_2014_Article_196.PMC4209107.pdf
2009. http://www.imshealth.com/imshealth/ Global/Content/IMS%20Institute/Do cuments/Changing_the_Channel.,Non-OADS,/arxiv_data1/oa_pdf/68/28/40273_2014_Article_196.PMC4209107.pdf
Available at: http://www.cms.gov/Medicare/ Prescription-DrugCoverage/PrescriptionDrugCovGenIn/Downloads/ Memo-Contract-Year-2013-Medication-Therapy-Management-MTM-Program-Submission-v041012.pdf .,Non-OADS,/arxiv_data1/oa_pdf/68/28/40273_2014_Article_196.PMC4209107.pdf
November 2012. http://www.imshealth.com/ims/Global/Content/Insights/IMS %20Institute%20for%20Healthcare%20Informatics/NICE%20report/IMS_Health_Bridging_the_Gap_2012.pdf .,Non-OADS,/arxiv_data1/oa_pdf/68/28/40273_2014_Article_196.PMC4209107.pdf
2009. http://www.fda.gov/downloads/Drugs/Guidance ComplianceRegulatoryInformation/UCM216146.pdf .,Non-OADS,/arxiv_data1/oa_pdf/68/28/40273_2014_Article_196.PMC4209107.pdf
28 June 2013. http://www.ema.europa.eu/ema/ index.jsp?curl=pages/news_and_events/news/2013/06/news_detail_ 001837.jsp&mid=WC0b01ac058004d5c1 .,Non-OADS,/arxiv_data1/oa_pdf/68/28/40273_2014_Article_196.PMC4209107.pdf
2013. http://www.imshealth.,Non-OADS,/arxiv_data1/oa_pdf/68/28/40273_2014_Article_196.PMC4209107.pdf
http://beta.congress.,Non-OADS,/arxiv_data1/oa_pdf/68/28/40273_2014_Article_196.PMC4209107.pdf
http://www.gpo.gov/fdsys/pkg/BILLS-113hr460ih/pdf/BILLS- 113hr460ih.pdf .,Non-OADS,/arxiv_data1/oa_pdf/68/28/40273_2014_Article_196.PMC4209107.pdf
August 2013. https://www.arthritis.org/ ﬁles/sections/advocacy/docs/Impact_of_HR_460.pdf .,Non-OADS,/arxiv_data1/oa_pdf/68/28/40273_2014_Article_196.PMC4209107.pdf
2014. http://www.avalerehealth.,Non-OADS,/arxiv_data1/oa_pdf/68/28/40273_2014_Article_196.PMC4209107.pdf
February 2012. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM 291128.pdf .,Non-OADS,/arxiv_data1/oa_pdf/68/28/40273_2014_Article_196.PMC4209107.pdf
"ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommonsAttributionNon-CommercialLicense(http://creativecommons.org/licenses/by-nc/.0/),which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/d9/euu032.PMC4209127.pdf
"http://www.nhs.uk/livewell/healthyhearts/ pages/arrhythmias.aspx (26 September 2013, accessed).",Non-OADS,/arxiv_data1/oa_pdf/a9/d9/euu032.PMC4209127.pdf
http://www.euroqol.org/about-eq-5d/ valuation-of-eq-5d/eq-5d-5l-value-sets.html (11 September 2013 accessed).14.,Non-OADS,/arxiv_data1/oa_pdf/a9/d9/euu032.PMC4209127.pdf
"2012. https://catalogue.ic.nhs.uk/publications/hospital/proms/proms-eng-apr-10-mar-11-ﬁnal/ﬁna-prom-eng-apr-10-mar-11-pre-post-rep1.pdf (27 September 2013,accessed).",Non-OADS,/arxiv_data1/oa_pdf/a9/d9/euu032.PMC4209127.pdf
The full-length version of this report can be viewed at: http://www.escardio.org/communities/EHRA/publications/ep-case-reports/ Documents/Peritricuspid-reentrant-ventricular.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a9/d9/euu032.PMC4209127.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Att ribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial repro duction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/55/msu228.PMC4209132.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/49/msu232.PMC4209133.pdf
Supplementary Material Supplementary ﬁgures S1–S7 and table S1 a r ea v a i l a b l ea t Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/3f/49/msu232.PMC4209133.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/2c/msu237.PMC4209135.pdf
"DNA probes to scan a BAC library, which had been previously constructed using an individual snake from Benton County,OR ( http://www.genome.gov/11008350 , last accessed April 2, 2014).",OADS,/arxiv_data1/oa_pdf/69/2c/msu237.PMC4209135.pdf
"2005 ; http://uprobe.genetics.emory.edu , last accessed April 2, 2014).",OADS,/arxiv_data1/oa_pdf/69/2c/msu237.PMC4209135.pdf
Supplementary Material Supplementary ﬁgure S1 and tables S1–S6 a r ea v a i l a b l ea t Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/69/2c/msu237.PMC4209135.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/4f/msu241.PMC4209136.pdf
Supplementary Material Supplementary tables S1–S3 and ﬁgures S1–S4 are available at Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/d5/4f/msu241.PMC4209136.pdf
"Our work beneﬁts from and contributes to the Fundulus Genomics Consortium ( http://www.fundu- lus.org , last accessed August 25, 2014).",Non-OADS,/arxiv_data1/oa_pdf/d5/4f/msu241.PMC4209136.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/b8/msu247.PMC4209139.pdf
"A. Cade, Dr. M. J. Ingleson School of Chemistry, The University of ManchesterOxford Road, Manchester, M13 9PL (UK) E-mail: michael.ingleson@manchester.ac.uk Supporting information for this article is available on the WWW under http://dx.doi.org/10.1002/chem.201403614.",Non-OADS,/arxiv_data1/oa_pdf/ee/19/chem0020-12874.PMC4209141.pdf
http://seer.cancer.gov/csr/1975_2011/ .,Non-OADS,/arxiv_data1/oa_pdf/c4/13/cro-0007-0638.PMC4209257.pdf
http://www.cancer.gov .,Non-OADS,/arxiv_data1/oa_pdf/ea/41/cro-0007-0621.PMC4209269.pdf
http://endocrinediseases.org .,Non-OADS,/arxiv_data1/oa_pdf/ea/41/cro-0007-0621.PMC4209269.pdf
"5 Abraxane® prescribing information, October 2013. http://abraxane.com/ .",Non-OADS,/arxiv_data1/oa_pdf/c6/f1/cro-0007-0648.PMC4209279.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2014.17.3.135 Pediatr Gastroenterol Hepatol Nutr 2014 September 17(3):135-139PGHN Review Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Nutritional State of Children in the Democratic People’s  Republic of Korea (DPRK): Based on the DPRK Final Report o f the National Nutrition Survey 2012 Jeong Eun Kim Department of Pediatrics, Shincheo n Union Hospital, Siheung, Korea   A nationwide nutrition survey began when the Democratic People’s Republic of Korea (DPRK) requested assistance  from international relief organizations in 1997 due to flooding in 1995-1996, followed by the worsening food shortage  peak in 1997.",Non-OADS,/arxiv_data1/oa_pdf/b1/eb/pghn-17-135.PMC4209317.pdf
"Tel: +82-31-310-6357, Fax: +82-31-310-6400, E-mail: galmuae1@na ver.com Copyright ⓒ 2014 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　The Democratic People’s Republic of Korea (DPRK)  has conducted a Nutritional Examination Survey ev-ery two years since 1998, together with the aid of the  United Nations Children’s Fund (UNICEF) and World  Food Program.",Non-OADS,/arxiv_data1/oa_pdf/b1/eb/pghn-17-135.PMC4209317.pdf
Available from: http://www.unicef.org/eapro/DPRK_National_Nutrition_ Survey_2012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b1/eb/pghn-17-135.PMC4209317.pdf
Available from: http://www.pwdigby.co.uk/pdf/Report_on_the_ DPRK_ Nutrition_Assessment_1998.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b1/eb/pghn-17-135.PMC4209317.pdf
Available from: http://www.childinf-o.org/files/dprk.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b1/eb/pghn-17-135.PMC4209317.pdf
Available from: http://www.unicef.org/ dprk/nutrition_assessment.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b1/eb/pghn-17-135.PMC4209317.pdf
Available from: http://www.unicef.org/dprk/dprk_na-tional_nutrition_assessment_2004_final_report_ 07_03_05.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b1/eb/pghn-17-135.PMC4209317.pdf
Available from: http://planipolis.iiep.unesco.,Non-OADS,/arxiv_data1/oa_pdf/b1/eb/pghn-17-135.PMC4209317.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2014.17.3.140 Pediatr Gastroenterol Hepatol Nutr 2014 September 17(3):140-146PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION High Incidence of Staphylococcus aureus  and Norovirus  Gastroenteritis in Infancy: A Si ngle-Center, 1-Year Experience Kyoung Sung, Ji Yong Kim, Yeoun Joo Lee, Eun Ha Hwang and Jae Hong Park Department of Pediatrics, Pusan National Univ ersity Children’s Hospital, Yangsan, Korea  Purpose: The etiology of acute gastroenteritis (AGE) has changed since the introduction of the rotavirus vaccination.",Non-OADS,/arxiv_data1/oa_pdf/8e/cf/pghn-17-140.PMC4209318.pdf
"Tel: +82-55-360-3162, Fax: +82-55-360-2 181, E-mail: moonmissing@gmail.com Copyright ⓒ 2014 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Diarrhea is one of the most common symptoms of  illness during childhood, and many children experi-ence diarrheal episodes on average one to five times per year [1-3].",Non-OADS,/arxiv_data1/oa_pdf/8e/cf/pghn-17-140.PMC4209318.pdf
"3, September 2014Pediatr Gastroenterol Hepatol Nutr rheal disease surveillance study with whole age  group, S. aureus, E. coli, and Salmonella were 4.77%,  4.23%, and 2.38%, respectively (http://www.cdc.go.",Non-OADS,/arxiv_data1/oa_pdf/8e/cf/pghn-17-140.PMC4209318.pdf
"However, according  to the surveillance data of acute diarrhea in children  younger than age 5 years from the Korea Centers for Disease Control and Prevention, norovirus (12.9%)  was comparable to rotavirus (13.5%) in the past 5  years, and norovirus showed a higher prevalence than rotavirus in 2010 and 2012 (http://www.cdc.",Non-OADS,/arxiv_data1/oa_pdf/8e/cf/pghn-17-140.PMC4209318.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2014.17.3.147 Pediatr Gastroenterol Hepatol Nutr 2014 September 17(3):147-154PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Received：May 12, 2014, Revised：July 24, 2014, Accepted：August 1 9, 2014 Corresponding author: Christian P .",Non-OADS,/arxiv_data1/oa_pdf/5c/d9/pghn-17-147.PMC4209319.pdf
"Tel: +41-26-426-7406, Fax: +41 -26-426-7409, E-mail: christian.braegger@kispi.uzh.ch  Copyright ⓒ 2014 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.Gender Differences in Paedia tric Patients of the Swiss  Inflammatory Bowel Disease Cohort Study Denise Herzog, Patrick Buehr *, Rebekka Koller *, Vanessa Rueger *, Klaas Heyland *, Andreas Nydegger†, Johannes Spalinger‡, Susanne Schibli§, Christian P. Braegger *,∥ and The Swiss IBD Cohort Study Group  Division of Gastroenterology, Department of Paediatrics, Cantons Hospital of Fribourg, Fribourg, *Division of Gastroenterolog y and Nutrition, University Childr en’s Hospital Zurich, Zurich, †Division of Gastroenterology, University Children’s Hos pital  of Lausanne, Lausanne, ‡Division of Gastroenterology, Children ’s Hospital of Lucerne, Lucerne, §Division of Gastroenterolog y, University Children’s Hospital of Bern, Bern, ∥Children’s Research Center, University Children’s Hospital Zurich, Zurich,  Switzerland Purpose: Gender differences in paediatric patients with infla mmatory bowel disease (IBD) are frequently reported  as a secondary outcome and the results are divergent.",Non-OADS,/arxiv_data1/oa_pdf/5c/d9/pghn-17-147.PMC4209319.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2014.17.3.155 Pediatr Gastroenterol Hepatol Nutr 2014 September 17(3):155-161PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Clinical Characteristics of Pediatric Constipation in South  Jordan Eyad Altamimi Department of Pediatrics, Mu`t ah University, Al Karak, Jordan Purpose: Constipation is a common pediatric problem worldwide.",Non-OADS,/arxiv_data1/oa_pdf/ae/16/pghn-17-155.PMC4209320.pdf
"Tel: +962-779126857,  Fax: +962-3-2386105, E-mail: eyadtamimi@gmail.com Copyright ⓒ 2014 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Constipation is a commo n problem in children.",Non-OADS,/arxiv_data1/oa_pdf/ae/16/pghn-17-155.PMC4209320.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2014.17.3.162 Pediatr Gastroenterol Hepatol Nutr 2014 September 17(3):162-169PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Serum Liver Enzyme Pattern in Birth Asphyxia Associated Liver  Injury  Nanda Chhavi, Kiran Zutshi, Niranj an Kumar Singh, Ashish Awasthi * and Amit Goel† Department of Pediatrics, Vivekananda Polyclinic and Institute of Medical Sciences, Departments of *Biostatistics & Healt h Informatics and †Gastroenterology, Sanjay Gandhi Postgraduate Inst itute of Medical Sciences, Lucknow, UP, India Purpose: To study temporal pattern of serum liver enzymes levels in newborns with hepatic injury associated with  birth asphyxia (BA).",Non-OADS,/arxiv_data1/oa_pdf/f5/41/pghn-17-162.PMC4209321.pdf
"Tel: +91-876-597-4037, Fax: +91-522-2668078, E-m ail: agoel.ag@gmail.com Copyright ⓒ 2014 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Birth asphyxia (BA), defined as Apgar score of be- low 7 at 1 minute after birth [1], is a common cause of neonatal morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/f5/41/pghn-17-162.PMC4209321.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2014.17.3.170 Pediatr Gastroenterol Hepatol Nutr 2014 September 17(3):170-177PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Relationship between Anomalous Pancreaticobiliary Ductal  Union and Pathologic Inflammation of Bile Duct  in Choledochal Cyst So Won Park, Hong Koh, Jung-Tak Oh *, Seok Joo Han * and Seung Kim Division of Gastroenterology, Hepatology a nd Nutrition, Department  of Pediatrics and *Department of Pediatric Surger y, Severance Children’s Hospital, Yonsei Univ ersity College of Medicine, Seoul, Korea Purpose: Choledochal cyst is a cystic dilatation of common bile duct.",Non-OADS,/arxiv_data1/oa_pdf/fd/4f/pghn-17-170.PMC4209322.pdf
"Tel: +82-2-2228-2050, Fa x: +82-2-393-  9118, E-mail: pedks@yuhs.ac  Copyright ⓒ 2014 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Choledochal cyst, first de scribed in 1723 by Vater and Ezler [1], is a cystic di latation of the extra- and  intrahepatic bile ducts that can cause various hep-atobiliary and pancreatic di sorders.",Non-OADS,/arxiv_data1/oa_pdf/fd/4f/pghn-17-170.PMC4209322.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2014.17.3.178 Pediatr Gastroenterol Hepatol Nutr 2014 September 17(3):178-185PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION The Status of Dietary Supplement s Intake in Korean Preschool  Children: Data from the Korea National Health and Nutrition  Examination Survey 2010-2012   Dong Soo Kang and Kun Song Lee Department of Pediatrics, Dankook Universi ty College of Medicine, Cheonan, Korea Purpose: The use of dietary supplements (DS) has increased in most nations.",Non-OADS,/arxiv_data1/oa_pdf/d4/22/pghn-17-178.PMC4209323.pdf
"Tel: +82-41-550-3968, Fax: +82-41-550-3949, E-m ail: pdlks@hanmail.net Copyright ⓒ 2014 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION     Dietary supplements (DS) or nutritional supple- ments contain vitamins, mine rals, fiber, fatty acids, and amino-acid products, for meal replacement [1].",Non-OADS,/arxiv_data1/oa_pdf/d4/22/pghn-17-178.PMC4209323.pdf
Detailed descriptions of a classification method in this survey have been able to identify on the  KNHANES website (http://knhanes.cdc.go.kr/).,OADS,/arxiv_data1/oa_pdf/d4/22/pghn-17-178.PMC4209323.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2014.17.3.186 Pediatr Gastroenterol Hepatol Nutr 2014 Septmeber 17(3):186-190PGHN Case Report PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Helicobacter pylori  Associated Lymphocytic Gastritis in a Child  Min Jeong Kim, Dae Woon Eom * and Kieyoung Park† Department of Pediatrics, Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, Seoul,  Departments of *Pathology and †Pediatrics, Gangneung Asan Hospital, University of Ulsan College of Medicine,  Gangneung, Korea Lymphocytic gastritis (LG) is a rare subtype of chronic gastritis.",Non-OADS,/arxiv_data1/oa_pdf/33/77/pghn-17-186.PMC4209324.pdf
"Tel: +82-33-610-3179, Fax: +82-33-641-8148, E-m ail: drped@naver.com Copyright ⓒ 2014 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Lymphocytic gastritis (LG), the first described in  1986, is a rare histopathologic subtype of chronic  gastritis [1,2].",Non-OADS,/arxiv_data1/oa_pdf/33/77/pghn-17-186.PMC4209324.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2014.17.3.191 Pediatr Gastroenterol Hepatol Nutr 2014 September 17(3):191-195PGHN Case Report PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Hemorrhagic Diathesis as the Presenting Symptom of Neonatal  Cholestasis Liesbeth Claire Faverey and Yvan Vandenplas * Free University of Brussels, *Department of Pediatri cs, Universitair Ziekenhuis Brussel, Brussels, Belgium  A 4-week-old infant presented with a coagulation disorder resulting from a vitamin K def iciency.",Non-OADS,/arxiv_data1/oa_pdf/4e/e0/pghn-17-191.PMC4209325.pdf
"Tel: +32-2-477-57-81, Fax: +32-2-477-57-83, E-mail: yvan.vanden plas@uzbrussel.be  Copyright ⓒ 2014 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION  　Vitamin K deficiency and impaired coagulation in  cholestasis result from ma labsorption of fat soluble  vitamins caused by reduced bile drainage.",Non-OADS,/arxiv_data1/oa_pdf/4e/e0/pghn-17-191.PMC4209325.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2014.17.3.196 Pediatr Gastroenterol Hepatol Nutr 2014 September 17(3):196-200PGHN Case Report PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION How Should the Pyloric Submucosal Mass Coexisting with  Hypertrophic Pyloric Stenosis Be Treated?",Non-OADS,/arxiv_data1/oa_pdf/13/83/pghn-17-196.PMC4209326.pdf
"Tel: +82-2-2072-2478, Fax: +82 -2-747-5130, E-mail: spkhy02@snu.ac.kr Copyright ⓒ 2014 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Hypertrophic pyloric stenosis (HPS) is an im- portant differential diagnosis of emesis in infants aged 2 to 12 weeks.",Non-OADS,/arxiv_data1/oa_pdf/13/83/pghn-17-196.PMC4209326.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2014.17.3.201 Pediatr Gastroenterol Hepatol Nutr 2014 September 17(3):201PGHN Correction PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Correction: Middle East Consensus Statement on the Prevention, Diagnosis, and Management of Cow’s Milk Protein Allergy  Yvan Vandenplas, Ahmed Abuabat *, Suleiman Al-Hammadi†, Gamal Samy Aly‡,  Mohamad S Miqdady§, Sanaa Youssef Shaaban∥ and Paul-Henri Torbey¶ Table 2.",Non-OADS,/arxiv_data1/oa_pdf/99/8d/pghn-17-201.PMC4209327.pdf
"Tel: +32-2-477-57-81, Fax: +32-2-477-57 -83, E-mail: yvan.vandenplas@uzbrussels.be Copyright ⓒ 2014 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.Erratum to: Pediatr Gastroenterol Hepatol Nutr 2014;17:61~73.",Non-OADS,/arxiv_data1/oa_pdf/99/8d/pghn-17-201.PMC4209327.pdf
http://dx.doi.org/10.5223/pghn.2014.17.2.61  Table 2 contains a typographical error.,Non-OADS,/arxiv_data1/oa_pdf/99/8d/pghn-17-201.PMC4209327.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/e2/main.PMC4209343.pdf
"In this way, nucleic acid aptamers have the ability to bind analytes with speciﬁcities previously reserved for http://dx.doi.org/10.1016/j.fob.2014.08.008 2211-5463/ /C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/5b/e2/main.PMC4209343.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: CD, circular dichroism; GQS, G-quartet sequence; TBA, thrombin binding aptamer ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/5b/e2/main.PMC4209343.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.08.008 .",OADS,/arxiv_data1/oa_pdf/5b/e2/main.PMC4209343.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/e7/dmj-38-321.PMC4209345.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:321-329 Molecular Links between Caloric Restriction and   Sir2/SIRT1 Activation Yu Wang Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong, China Ageing is the most signiﬁcant risk factor for a range of prevalent diseases, including cancer, cardiovascular disease, and diabetes.",Non-OADS,/arxiv_data1/oa_pdf/c3/e7/dmj-38-321.PMC4209345.pdf
Review Pathophysiology http://dx.doi.org/10.4093/dmj.2014.38.5.321 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/c3/e7/dmj-38-321.PMC4209345.pdf
"322Wang Y Diabetes Metab J 2014;38:321-329 http://e-dmj.orgCaloric restriction without malnutrition is a nongenetic inter - vention that consistently promotes the extension of maximum  lifespan in model organisms including yeast, worms, flies, mice,  and nonhuman primates [1-3].",Non-OADS,/arxiv_data1/oa_pdf/c3/e7/dmj-38-321.PMC4209345.pdf
"323Activation of Sir2/SIRT1 by caloric restriction  Diabetes Metab J 2014;38:321-329 http://e-dmj.orgmeostasis and insulin sensitivity, lowered serum glucose and  cholesterol levels, decreased oxygen consumption and body  temperature, all of which contribute to delayed onset of age-re - lated diseases [10,12,13].",Non-OADS,/arxiv_data1/oa_pdf/c3/e7/dmj-38-321.PMC4209345.pdf
"324Wang Y Diabetes Metab J 2014;38:321-329 http://e-dmj.orgcaloric restriction, while those of white adipose tissue and skel - etal muscle are enhanced.",Non-OADS,/arxiv_data1/oa_pdf/c3/e7/dmj-38-321.PMC4209345.pdf
"325Activation of Sir2/SIRT1 by caloric restriction  Diabetes Metab J 2014;38:321-329 http://e-dmj.orgsalvage pathway for NAD biosynthesis begins with either nico - tinamide or nicotinic acid, collectively referred to as niacin or  vitamin B3 [61].",Non-OADS,/arxiv_data1/oa_pdf/c3/e7/dmj-38-321.PMC4209345.pdf
326Wang Y Diabetes Metab J 2014;38:321-329 http://e-dmj.orgprotein as a Sir2 homolog [72].,Non-OADS,/arxiv_data1/oa_pdf/c3/e7/dmj-38-321.PMC4209345.pdf
327Activation of Sir2/SIRT1 by caloric restriction  Diabetes Metab J 2014;38:321-329 http://e-dmj.orgfile studies of aging and caloric restriction.,Non-OADS,/arxiv_data1/oa_pdf/c3/e7/dmj-38-321.PMC4209345.pdf
"328Wang Y Diabetes Metab J 2014;38:321-329 http://e-dmj.orgDP , Johnson RJ, Lavu S, Iffland A, Elliott PJ, Lambert PD, Ellis - ton KO, Jirousek MR, Milne JC, Boss O.",Non-OADS,/arxiv_data1/oa_pdf/c3/e7/dmj-38-321.PMC4209345.pdf
329Activation of Sir2/SIRT1 by caloric restriction  Diabetes Metab J 2014;38:321-329 http://e-dmj.org63.,Non-OADS,/arxiv_data1/oa_pdf/c3/e7/dmj-38-321.PMC4209345.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/1c/dmj-38-330.PMC4209346.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:330-336 Hyperglycemia as a Risk Factor for Cancer Progression Tae Y oung Ryu1, Jiyoung Park1, Philipp E. Scherer2 1Department of Biological Sciences, Ulsan National Institute of Science and Technology School of Life Sciences, Ulsan, Korea 2Touchstone Diabetes Center, Department of Internal Medicine, Cell Biology and Simmons Cancer, University of Texas Southwestern Medical Center, Dallas,  TX, USA As the prevalence of diabetes mellitus is substantially increasing worldwide, associated diseases such as renal failure, cardiovas - cular diseases, fatty liver, and cancers have also increased.",Non-OADS,/arxiv_data1/oa_pdf/86/1c/dmj-38-330.PMC4209346.pdf
"Additionally, the Review Pathophysiology http://dx.doi.org/10.4093/dmj.2014.38.5.330 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/86/1c/dmj-38-330.PMC4209346.pdf
331Hyperglycemia and cancer  Diabetes Metab J 2014;38:330-336 http://e-dmj.orgincrease of systemic insulin resistance in type 2 DM leads to  hyperglycemia as well [1].,Non-OADS,/arxiv_data1/oa_pdf/86/1c/dmj-38-330.PMC4209346.pdf
Diabetes Metab J 2014;38:330-336 http://e-dmj.orgsupplies during rapid anabolic cell proliferation [29].,Non-OADS,/arxiv_data1/oa_pdf/86/1c/dmj-38-330.PMC4209346.pdf
"333Hyperglycemia and cancer  Diabetes Metab J 2014;38:330-336 http://e-dmj.orgexpression of cancer stem cell markers in basal luminal breast  carcinoma, which leads to reduced reactive oxygen species  (ROS) generation and increased cell survival.",Non-OADS,/arxiv_data1/oa_pdf/86/1c/dmj-38-330.PMC4209346.pdf
Diabetes Metab J 2014;38:330-336 http://e-dmj.orgassociated epigenetic alterations in key oncogenic pathways in  cancer cells.,Non-OADS,/arxiv_data1/oa_pdf/86/1c/dmj-38-330.PMC4209346.pdf
335Hyperglycemia and cancer  Diabetes Metab J 2014;38:330-336 http://e-dmj.org345-52.,Non-OADS,/arxiv_data1/oa_pdf/86/1c/dmj-38-330.PMC4209346.pdf
Diabetes Metab J 2014;38:330-336 http://e-dmj.orgpact of the plasminogen activation system in tumor invasion  and metastasis: prognostic relevance and target for therapy.,Non-OADS,/arxiv_data1/oa_pdf/86/1c/dmj-38-330.PMC4209346.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/63/dmj-38-337.PMC4209347.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:337-345 Diabetic Cardiomyopathy and Its Prevention by Nrf2:  Current Status Jing Chen1, Zhiguo Zhang1,2, Lu Cai1 1Kosair Children’s Hospital Research Institute, Department of Pediatrics, the University of Louisville School of Medicine, Louisville, KY , USA, 2The Center of Cardiovascular Diseases, the First Hospital of Jilin University, Changchun, China Diabetic cardiomyopathy (DCM), as one of the major cardiac complications in diabetic patients, is known to related with oxida - tive stress that is due to a severe imbalance between reactive oxygen species (ROS) and/or reactive nitrogen species (RNS) genera - tion and their clearance by antioxidant defense systems.",Non-OADS,/arxiv_data1/oa_pdf/46/63/dmj-38-337.PMC4209347.pdf
"Due to low contents of antioxidants in the  normal heart compared to other organs, the heart is a highly Review Complications http://dx.doi.org/10.4093/dmj.2014.38.5.337 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/46/63/dmj-38-337.PMC4209347.pdf
"Diabetes Metab J 2014;38:337-345 http://e-dmj.orgsusceptible organ to oxidative stress and damage [7,8].",Non-OADS,/arxiv_data1/oa_pdf/46/63/dmj-38-337.PMC4209347.pdf
"339Diabetic cardiomyopathy and its prevention by Nrf2  Diabetes Metab J 2014;38:337-345 http://e-dmj.orgteract ROS-, RNS-, or electrophile-mediated injury.",Non-OADS,/arxiv_data1/oa_pdf/46/63/dmj-38-337.PMC4209347.pdf
"Diabetes Metab J 2014;38:337-345 http://e-dmj.orgducers blooming evidence has indicated the protection by  Nrf2 from diabetes [31,32] and from various diabetic compli - cations [33-37].",Non-OADS,/arxiv_data1/oa_pdf/46/63/dmj-38-337.PMC4209347.pdf
341Diabetic cardiomyopathy and its prevention by Nrf2  Diabetes Metab J 2014;38:337-345 http://e-dmj.orgcose-stimulated insulin secretion in β-cell.,Non-OADS,/arxiv_data1/oa_pdf/46/63/dmj-38-337.PMC4209347.pdf
Diabetes Metab J 2014;38:337-345 http://e-dmj.orgcardiomyopathy.,Non-OADS,/arxiv_data1/oa_pdf/46/63/dmj-38-337.PMC4209347.pdf
343Diabetic cardiomyopathy and its prevention by Nrf2  Diabetes Metab J 2014;38:337-345 http://e-dmj.org29.,Non-OADS,/arxiv_data1/oa_pdf/46/63/dmj-38-337.PMC4209347.pdf
"Diabetes Metab J 2014;38:337-345 http://e-dmj.orgSun J, Cai L. Inhibition of JNK by compound C66 prevents  pathological changes of the aorta in STZ-induced diabetes.",Non-OADS,/arxiv_data1/oa_pdf/46/63/dmj-38-337.PMC4209347.pdf
345Diabetic cardiomyopathy and its prevention by Nrf2  Diabetes Metab J 2014;38:337-345 http://e-dmj.orgtioxid Redox Signal 2011;14:957-71.,Non-OADS,/arxiv_data1/oa_pdf/46/63/dmj-38-337.PMC4209347.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/c1/dmj-38-346.PMC4209348.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:346-348 Screening of Autonomic Neuropathy in Patients with  Type 2 Diabetes Bo Kyung Koo1,2 1Department of Internal Medicine, Boramae Medical Center, Seoul National University College of Medicine, Seoul,  2Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea Corresponding author: Bo Kyung Koo Department of Internal Medicine, Boramae Medical Center, Seoul National  University College of Medicine, 20 Boramae-ro 5-gil, Dongjak-gu,   Seoul 156-707, Korea E-mail: bokyungkoomd@gmail.comDiabetic autonomic neuropathy (DAN) causes morbidity and  mortality in patients with diabetes mellitus [1-4]; and among  DAN, cardiac autonomic neuropathy (CAN) is an independent  risk factor for cardiovascular mortality [5,6].",Non-OADS,/arxiv_data1/oa_pdf/f7/c1/dmj-38-346.PMC4209348.pdf
Editorial Complications http://dx.doi.org/10.4093/dmj.2014.38.5.346 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/f7/c1/dmj-38-346.PMC4209348.pdf
"347Diabetic autonomic neuropathy  Diabetes Metab J 2014;38:346-348 http://e-dmj.org Considering the lack of intervention to alter the DAN  pathogenic process, the need for DAN screening should be re- evaluated.",Non-OADS,/arxiv_data1/oa_pdf/f7/c1/dmj-38-346.PMC4209348.pdf
DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f7/c1/dmj-38-346.PMC4209348.pdf
"348Koo BK Diabetes Metab J 2014;38:346-348 http://e-dmj.orgHeart rate variability: standards of measurement, physiological  interpretation and clinical use.",Non-OADS,/arxiv_data1/oa_pdf/f7/c1/dmj-38-346.PMC4209348.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/89/a2/dmj-38-349.PMC4209349.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:349-355 Relationship between the Korean Version Survey of the  Autonomic Symptoms Score and Cardiac Autonomic  Neuropathy Parameters in Patients with Diabetic  Peripheral Neuropathy Sun Hee Kim, Kyung Ae Lee, Heung Y ong Jin, Hong Sun Baek, Tae Sun Park Division of Endocrinology and Metabolism, Department of Internal Medicine, Research Institute of Clinical Medicine, Chonbuk National University Hospital,  Chonbuk National University Medical School, Jeonju, Korea Background:  The Survey of Autonomic Symptom (SAS) scale was reported as an easy instrument to assess the autonomic symp - toms in patients with early diabetic neuropathy.",Non-OADS,/arxiv_data1/oa_pdf/89/a2/dmj-38-349.PMC4209349.pdf
"Previously, various instruments were developed to measure Original Article Complications http://dx.doi.org/10.4093/dmj.2014.38.5.349 pISSN 2233-6079 · eISSN 2233-6087 Corresponding author: Tae Sun Park Division of Endocrinology and Metabolism, Department of Internal  Medicine, Research Institute of Clinical Medicine, Chonbuk National  University Hospital, Chonbuk National University Medical School,   20 Geonji-ro, Deokjin-gu, Jeonju 561-712, Korea E-mail: pts@jbnu.ac.kr Received: Jan. 6, 2014; Accepted: Mar.",Non-OADS,/arxiv_data1/oa_pdf/89/a2/dmj-38-349.PMC4209349.pdf
Diabetes Metab J 2014;38:349-355 http://e-dmj.orgthese autonomic symptoms [2].,Non-OADS,/arxiv_data1/oa_pdf/89/a2/dmj-38-349.PMC4209349.pdf
"351SAS score and cardiac autonomic neuropathy  Diabetes Metab J 2014;38:349-355 http://e-dmj.orgtesting was performed using the device (TSH II; Medoc, Ra - mat Yishai, Israel).",Non-OADS,/arxiv_data1/oa_pdf/89/a2/dmj-38-349.PMC4209349.pdf
"Diabetes Metab J 2014;38:349-355 http://e-dmj.orgaddition, the orthostatic dysfunction item (Q1a-1) was also  significantly associated with the valsalva ratio and postural hy - potension ( P<0.05).",Non-OADS,/arxiv_data1/oa_pdf/89/a2/dmj-38-349.PMC4209349.pdf
353SAS score and cardiac autonomic neuropathy  Diabetes Metab J 2014;38:349-355 http://e-dmj.orgTable 4.,Non-OADS,/arxiv_data1/oa_pdf/89/a2/dmj-38-349.PMC4209349.pdf
Diabetes Metab J 2014;38:349-355 http://e-dmj.orgthan 93.3% sensitivity and 68.3% specificity.,Non-OADS,/arxiv_data1/oa_pdf/89/a2/dmj-38-349.PMC4209349.pdf
"355SAS score and cardiac autonomic neuropathy  Diabetes Metab J 2014;38:349-355 http://e-dmj.orgful to assess diabetic autonomic neuropathy, particularly CAN  compared with TSS for DPN in clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/89/a2/dmj-38-349.PMC4209349.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/cb/dmj-38-356.PMC4209350.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:356-365 Adipose Gene Expression Profiles Related to Metabolic  Syndrome Using Microarray Analyses in Two Different  Models Hye Jin Y oo, Hwan-Jin Hwang, Tae Woo Jung, Ja Y oung Ryu, Ho Cheol Hong, Hae Y oon Choi, Sei Hyun Baik,   Kyung Mook Choi Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea Background:  Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist has a wide-ranging influence on multiple compo - nents of metabolic syndrome.",Non-OADS,/arxiv_data1/oa_pdf/8c/cb/dmj-38-356.PMC4209350.pdf
The Otsuka Long-Evans Tokushima Fatty (OLETF) rat is a Original Article Obesity and Metabolic Syndrome http://dx.doi.org/10.4093/dmj.2014.38.5.356 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/8c/cb/dmj-38-356.PMC4209350.pdf
"357Adipose gene expression profiles related to metabolic syndrome  Diabetes Metab J 2014;38:356-365 http://e-dmj.orguseful animal model of metabolic syndrome, as these rats are  characterized by abdominal obesity, insulin resistance, hyper - tension, and dyslipidemia [7].",Non-OADS,/arxiv_data1/oa_pdf/8c/cb/dmj-38-356.PMC4209350.pdf
Diabetes Metab J 2014;38:356-365 http://e-dmj.org(Agilent Technologies) according to the manufacturer’s instruc - tions.,Non-OADS,/arxiv_data1/oa_pdf/8c/cb/dmj-38-356.PMC4209350.pdf
"359Adipose gene expression profiles related to metabolic syndrome  Diabetes Metab J 2014;38:356-365 http://e-dmj.orgAdipose tissue sampling Using a cold knife, small pieces (5 to 10 g wet weight) of sub - cutaneous adipose tissue were obtained from the abdominal  incision site.",Non-OADS,/arxiv_data1/oa_pdf/8c/cb/dmj-38-356.PMC4209350.pdf
"Diabetes Metab J 2014;38:356-365 http://e-dmj.orgwas identified as the pathway most down-regulated by PPAR- γ  agonist followed by cytokine-cytokine receptor interactions,  natural killer cell-mediated cytotoxicity, and B-cell receptor  signaling pathways.",Non-OADS,/arxiv_data1/oa_pdf/8c/cb/dmj-38-356.PMC4209350.pdf
361Adipose gene expression profiles related to metabolic syndrome  Diabetes Metab J 2014;38:356-365 http://e-dmj.orgRT-PCR.,Non-OADS,/arxiv_data1/oa_pdf/8c/cb/dmj-38-356.PMC4209350.pdf
Diabetes Metab J 2014;38:356-365 http://e-dmj.org3.,Non-OADS,/arxiv_data1/oa_pdf/8c/cb/dmj-38-356.PMC4209350.pdf
"363Adipose gene expression profiles related to metabolic syndrome  Diabetes Metab J 2014;38:356-365 http://e-dmj.org40 30 20 10 Lipocalin-2/ β-actin mRNAr=0.68, P=0.015 0.4 0.8 1.2 1.6BMI (kg/m2) A9 7 5 3 Lipocalin-2/ β-actin mRNAr=0.72, P=0.008 0.4 0.8 1.2 1.6WBC (103cells/mL) B 60 40 20 0 Lipocalin-2/ β-actin mRNAr=0.59, P=0.044 0.4 0.8 1.2 1.6IL-6 (pg/mL) C18 15 12 9 6 Lipocalin-2/ β-actin mRNAr=0.60, P=0.040 0.4 0.8 1.2 1.6A-FABP (ng/mL) D Fig.",Non-OADS,/arxiv_data1/oa_pdf/8c/cb/dmj-38-356.PMC4209350.pdf
"Diabetes Metab J 2014;38:356-365 http://e-dmj.orgdicted the circulating levels of that cytokine in the present  study, positive correlation of lipocalin-2 expression in visceral  adipose tissue with various metabolic parameters might be  more meaningful.",Non-OADS,/arxiv_data1/oa_pdf/8c/cb/dmj-38-356.PMC4209350.pdf
365Adipose gene expression profiles related to metabolic syndrome  Diabetes Metab J 2014;38:356-365 http://e-dmj.org9.,Non-OADS,/arxiv_data1/oa_pdf/8c/cb/dmj-38-356.PMC4209350.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/2b/dmj-38-366.PMC4209351.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:366-374 Effect of Livingstone Potato ( Plectranthus esculenthus   N.E.Br) on Diabetes and Its Complications in  Streptozotocin Induced Diabetes in Rats Chinedum Ogbonnaya Eleazu1, Kate Chinedum Eleazu2, Adanma Ironkwe1, Mercy Amarachi Iroaganachi3 1National Root Crops Research Institute, Umudike,  2Abia State Specialist and Diagnostic Center, Umuahia,  3Department of Food Science and Technology, Abia State Polytechnic, Aba, Nigeria Background:  The effect of livingstone potato ( Plectranthus esculenthus  N.E.Br) on diabetes and its complications in Streptozoto - cin induced diabetic rats was investigated.",Non-OADS,/arxiv_data1/oa_pdf/59/2b/dmj-38-366.PMC4209351.pdf
"In many countries of the world, much attention has been  paid to find novel types of natural antidiabetic drugs from var -Original Article Pathophysiology http://dx.doi.org/10.4093/dmj.2014.38.5.366 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/59/2b/dmj-38-366.PMC4209351.pdf
367Antidiabetic potentials of livingstone potato  Diabetes Metab J 2014;38:366-374 http://e-dmj.orgious medicinal plants.,Non-OADS,/arxiv_data1/oa_pdf/59/2b/dmj-38-366.PMC4209351.pdf
Diabetes Metab J 2014;38:366-374 http://e-dmj.orgger (polyphagia).,Non-OADS,/arxiv_data1/oa_pdf/59/2b/dmj-38-366.PMC4209351.pdf
"369Antidiabetic potentials of livingstone potato  Diabetes Metab J 2014;38:366-374 http://e-dmj.org The diabetic rats fed livingstone potato incorporated feeds  recorded 15.64% decrease in body weights, compared with di - abetic control rats that recorded 52.68% decrease in body  weights unlike the nondiabetic rats that recorded 20.39% in -crease in body weights (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/59/2b/dmj-38-366.PMC4209351.pdf
Diabetes Metab J 2014;38:366-374 http://e-dmj.orgters were significantly reduced in the serum of the diabetic rats  given livingstone potato incorporated feeds compared with  the diabetic control rats (Table 5).,Non-OADS,/arxiv_data1/oa_pdf/59/2b/dmj-38-366.PMC4209351.pdf
"371Antidiabetic potentials of livingstone potato  Diabetes Metab J 2014;38:366-374 http://e-dmj.orgurine samples of the diabetic control rats and the diabetic rats  administered livingstone potato incorporated feeds by the first  week of experimentation, compared with the nondiabetic rats,  could be attributed to their elevated levels of urinary glucose as  well as proteins and shows in addition, the possibilities of other  substances that may have permeated the membrane of the glo - merular filtrate as a result of renal complications.",Non-OADS,/arxiv_data1/oa_pdf/59/2b/dmj-38-366.PMC4209351.pdf
Diabetes Metab J 2014;38:366-374 http://e-dmj.orgmoieties that are absorbed in the small intestine and trans - ported to the blood stream [31].,Non-OADS,/arxiv_data1/oa_pdf/59/2b/dmj-38-366.PMC4209351.pdf
373Antidiabetic potentials of livingstone potato  Diabetes Metab J 2014;38:366-374 http://e-dmj.org10.,Non-OADS,/arxiv_data1/oa_pdf/59/2b/dmj-38-366.PMC4209351.pdf
Diabetes Metab J 2014;38:366-374 http://e-dmj.org36.,Non-OADS,/arxiv_data1/oa_pdf/59/2b/dmj-38-366.PMC4209351.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/38/dmj-38-375.PMC4209352.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:375-387 Genome-Wide Association Study Identifies Two Novel  Loci with Sex-Specific Effects for Type 2 Diabetes  Mellitus and Glycemic Traits in a Korean Population Min Jin Go, Joo-Y eon Hwang, Tae-Joon Park, Y oung Jin Kim, Ji Hee Oh, Y eon-Jung Kim, Bok-Ghee Han, Bong-Jo Kim Division of Structural and Functional Genomics, Center for Genome Science, Korea National Institute of Health, Cheongwon, Korea Background:  Until recently, genome-wide association study (GW AS)-based findings have provided a substantial genetic contri - bution to type 2 diabetes mellitus (T2DM) or related glycemic traits.",Non-OADS,/arxiv_data1/oa_pdf/b9/38/dmj-38-375.PMC4209352.pdf
Recent studies  have demonstrated that genetic factors play an important role Original Article Others http://dx.doi.org/10.4093/dmj.2014.38.5.375 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/b9/38/dmj-38-375.PMC4209352.pdf
"Diabetes Metab J 2014;38:375-387 http://e-dmj.orgin fasting glucose variation, β-cell function, and insulin sensi - tivity as well as T2DM [5-8].",Non-OADS,/arxiv_data1/oa_pdf/b9/38/dmj-38-375.PMC4209352.pdf
"377GW AS for T2DM and glycemic traits  Diabetes Metab J 2014;38:375-387 http://e-dmj.orging for age, sex, BMI, and recruitment area.",Non-OADS,/arxiv_data1/oa_pdf/b9/38/dmj-38-375.PMC4209352.pdf
HOMA values  were estimated by the HOMA Calculator v2.2.2 program  (http://www.dtu.ox.ac.uk/index.php?maindoc=/homa/index.php)  using FPG and insulin concentrations.,OADS,/arxiv_data1/oa_pdf/b9/38/dmj-38-375.PMC4209352.pdf
Diabetes Metab J 2014;38:375-387 http://e-dmj.org 8 6 4 2 08 6 4 2 0-log 10 (P)T2DM chromosome 12 [12q24] A B Fig.,Non-OADS,/arxiv_data1/oa_pdf/b9/38/dmj-38-375.PMC4209352.pdf
"379GW AS for T2DM and glycemic traits  Diabetes Metab J 2014;38:375-387 http://e-dmj.org95% CI, 1.25 to 1.56; P=9.43×10–9) in intron 9 of CCDC63  (coiled-coil domain containing 63) and the other on 12q24.13  (rs2074356; OR, 1.43; 95% CI, 1.27 to 1.62; P=1.12×10–8) in  intron 30 ofC12orf51 (Fig.",Non-OADS,/arxiv_data1/oa_pdf/b9/38/dmj-38-375.PMC4209352.pdf
"Diabetes Metab J 2014;38:375-387 http://e-dmj.orgDISCUSSION Considering the effect of common diseases of major public  health, the genetic architecture of T2DM has been intensively  studied using GW A analyses for many years [10,13,25-29].",Non-OADS,/arxiv_data1/oa_pdf/b9/38/dmj-38-375.PMC4209352.pdf
381GW AS for T2DM and glycemic traits  Diabetes Metab J 2014;38:375-387 http://e-dmj.orgsex-biased genetic effects on gene regulation [50].,Non-OADS,/arxiv_data1/oa_pdf/b9/38/dmj-38-375.PMC4209352.pdf
"Diabetes Metab J 2014;38:375-387 http://e-dmj.orgnycastle LL, Borch-Johnsen K, Bottcher Y , Brunner E, Bump - stead SJ, Charpentier G, Chen YD, Chines P , Clarke R, Coin LJ,  Cooper MN, Cornelis M, Crawford G, Crisponi L, Day IN, de  Geus EJ, Delplanque J, Dina C, Erdos MR, Fedson AC, Fischer- Rosinsky A, Forouhi NG, Fox CS, Frants R, Franzosi MG, Ga - lan P , Goodarzi MO, Graessler J, Groves CJ, Grundy S, Gwil - liam R, Gyllensten U, Hadjadj S, Hallmans G, Hammond N,  Han X, Hartikainen AL, Hassanali N, Hayward C, Heath SC,  Hercberg S, Herder C, Hicks AA, Hillman DR, Hingorani AD,  Hofman A, Hui J, Hung J, Isomaa B, Johnson PR, Jorgensen T,  Jula A, Kaakinen M, Kaprio J, Kesaniemi YA, Kivimaki M,  Knight B, Koskinen S, Kovacs P , Kyvik KO, Lathrop GM, Law - lor DA, Le Bacquer O, Lecoeur C, Li Y , Lyssenko V , Mahley R,  Mangino M, Manning AK, Martinez-Larrad MT, McAteer JB,  McCulloch LJ, McPherson R, Meisinger C, Melzer D, Meyre D,  Mitchell BD, Morken MA, Mukherjee S, Naitza S, Narisu N,  Neville MJ, Oostra BA, Orru M, Pakyz R, Palmer CN, Paolisso  G, Pattaro C, Pearson D, Peden JF, Pedersen NL, Perola M, Pfei - ffer AF, Pichler I, Polasek O, Posthuma D, Potter SC, Pouta A,  Province MA, Psaty BM, Rathmann W , Rayner NW , Rice K,  Ripatti S, Rivadeneira F, Roden M, Rolandsson O, Sandbaek A,  Sandhu M, Sanna S, Sayer AA, Scheet P , Scott LJ, Seedorf U,  Sharp SJ, Shields B, Sigurethsson G, Sijbrands EJ, Silveira A,  Simpson L, Singleton A, Smith NL, Sovio U, Swift A, Syddall H,  Syvanen AC, Tanaka T, Thorand B, Tichet J, Tonjes A, Tuomi T,  Uitterlinden AG, van Dijk KW , van Hoek M, Varma D, Visvi - kis-Siest S, Vitart V , Vogelzangs N, Waeber G, Wagner PJ, Wal - ley A, Walters GB, Ward KL, Watkins H, Weedon MN, Wild  SH, Willemsen G, Witteman JC, Y arnell JW , Zeggini E, Zeleni - ka D, Zethelius B, Zhai G, Zhao JH, Zillikens MC; DIAGRAM  Consortium; GIANT Consortium; Global BPgen Consortium,  Borecki IB, Loos RJ, Meneton P , Magnusson PK, Nathan DM,  Williams GH, Hattersley AT, Silander K, Salomaa V , Smith  GD, Bornstein SR, Schwarz P , Spranger J, Karpe F, Shuldiner  AR, Cooper C, Dedoussis GV , Serrano-Rios M, Morris AD,  Lind L, Palmer LJ, Hu FB, Franks PW , Ebrahim S, Marmot M,  Kao WH, Pankow JS, Sampson MJ, Kuusisto J, Laakso M,  Hansen T, Pedersen O, Pramstaller PP , Wichmann HE, Illig T,  Rudan I, Wright AF, Stumvoll M, Campbell H, Wilson JF; An - ders Hamsten on behalf of Procardis Consortium; MAGIC in - vestigators, Bergman RN, Buchanan TA, Collins FS, Mohlke  KL, Tuomilehto J, Valle TT, Altshuler D, Rotter JI, Siscovick  DS, Penninx BW , Boomsma DI, Deloukas P , Spector TD, Fray - ling TM, Ferrucci L, Kong A, Thorsteinsdottir U, Stefansson K,  van Duijn CM, Aulchenko YS, Cao A, Scuteri A, Schlessinger D, Uda M, Ruokonen A, Jarvelin MR, Waterworth DM, Vol - lenweider P , Peltonen L, Mooser V , Abecasis GR, Wareham NJ,  Sladek R, Froguel P , Watanabe RM, Meigs JB, Groop L, Boehn - ke M, McCarthy MI, Florez JC, Barroso I.",Non-OADS,/arxiv_data1/oa_pdf/b9/38/dmj-38-375.PMC4209352.pdf
"383GW AS for T2DM and glycemic traits  Diabetes Metab J 2014;38:375-387 http://e-dmj.orgdos MR, Fox CS, Franklin CS, Ganser M, Gieger C, Grarup N,  Green T, Griffin S, Groves CJ, Guiducci C, Hadjadj S, Hassanali  N, Herder C, Isomaa B, Jackson AU, Johnson PR, Jorgensen T,  Kao WH, Klopp N, Kong A, Kraft P , Kuusisto J, Lauritzen T, Li  M, Lieverse A, Lindgren CM, Lyssenko V , Marre M, Meitinger  T, Midthjell K, Morken MA, Narisu N, Nilsson P , Owen KR,  Payne F, Perry JR, Petersen AK, Platou C, Proenca C, Proko - penko I, Rathmann W , Rayner NW , Robertson NR, Rocheleau  G, Roden M, Sampson MJ, Saxena R, Shields BM, Shrader P ,  Sigurdsson G, Sparso T, Strassburger K, Stringham HM, Sun Q,  Swift AJ, Thorand B, Tichet J, Tuomi T, van Dam RM, van  Haeften TW , van Herpt T, van Vliet-Ostaptchouk JV , Walters  GB, Weedon MN, Wijmenga C, Witteman J, Bergman RN,  Cauchi S, Collins FS, Gloyn AL, Gyllensten U, Hansen T, Hide  W A, Hitman GA, Hofman A, Hunter DJ, Hveem K, Laakso M,  Mohlke KL, Morris AD, Palmer CN, Pramstaller PP , Rudan I,  Sijbrands E, Stein LD, Tuomilehto J, Uitterlinden A, Walker M,  Wareham NJ, Watanabe RM, Abecasis GR, Boehm BO, Camp - bell H, Daly MJ, Hattersley AT, Hu FB, Meigs JB, Pankow JS,  Pedersen O, Wichmann HE, Barroso I, Florez JC, Frayling TM,  Groop L, Sladek R, Thorsteinsdottir U, Wilson JF, Illig T,  Froguel P , van Duijn CM, Stefansson K, Altshuler D, Boehnke  M, McCarthy MI; MAGIC investigators; GIANT Consortium.",Non-OADS,/arxiv_data1/oa_pdf/b9/38/dmj-38-375.PMC4209352.pdf
"Diabetes Metab J 2014;38:375-387 http://e-dmj.orgOhnaka K, Ikegami H, Hara K, Cho YM, Cho NH, Chang TJ,  Bao Y , Hedman AK, Morris AP , McCarthy MI; DIAGRAM  Consortium; MuTHER Consortium, Takayanagi R, Park KS,  Jia W , Chuang LM, Chan JC, Maeda S, Kadowaki T, Lee JY , Wu  JY , Teo YY , Tai ES, Shu XO, Mohlke KL, Kato N, Han BG, Sei - elstad M. Meta-analysis of genome-wide association studies  identifies eight new loci for type 2 diabetes in east Asians.",Non-OADS,/arxiv_data1/oa_pdf/b9/38/dmj-38-375.PMC4209352.pdf
"385GW AS for T2DM and glycemic traits  Diabetes Metab J 2014;38:375-387 http://e-dmj.orgT, Hveem K, Hu FB, Laakso M, Stefansson K, Pedersen O,  Wareham NJ, Barroso I, Hattersley AT, Collins FS, Groop L,  McCarthy MI, Boehnke M, Altshuler D. Meta-analysis of ge - nome-wide association data and large-scale replication identi - fies additional susceptibility loci for type 2 diabetes.",OADS,/arxiv_data1/oa_pdf/b9/38/dmj-38-375.PMC4209352.pdf
"Diabetes Metab J 2014;38:375-387 http://e-dmj.orgTB, Ganesh SK, O’Donnell CJ, Hofman A, Rotter JI, Coresh J,  Benjamin EJ, Uitterlinden AG, Heiss G, Fox CS, Witteman JC,  Boerwinkle E, Wang TJ, Gudnason V , Larson MG, Chakravarti  A, Psaty BM, van Duijn CM.",Non-OADS,/arxiv_data1/oa_pdf/b9/38/dmj-38-375.PMC4209352.pdf
387GW AS for T2DM and glycemic traits  Diabetes Metab J 2014;38:375-387 http://e-dmj.org Appendix 1.,Non-OADS,/arxiv_data1/oa_pdf/b9/38/dmj-38-375.PMC4209352.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/51/dmj-38-388.PMC4209353.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:388-394 Clinical Characteristics of Diabetic Patients Transferred  to Korean Referral Hospitals Min Y oung Oh1,*, Sang Soo Kim1,*, In Joo Kim1, In Kyu Lee2, Hong Sun Baek3, Hyoung Woo Lee4, Min Y oung Chung5 1Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine, Busan,  2Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu,  3Department of Internal Medicine, Chonbuk National University Hospital, Chonnam National University Medical School, Jeonju,  4Department of Internal Medicine, Y eungnam University Medical Center, Y eungnam University College of Medicine, Daegu,  5Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea Background:  We evaluated the disease profile and clinical management, including the status of both glycemic control and com - plications, in patients with diabetes who were transferred to referral hospitals in Korea.",Non-OADS,/arxiv_data1/oa_pdf/5b/51/dmj-38-388.PMC4209353.pdf
"The increased prevalence is most likely attributable to  rapid economic development, improved living standards, an Original Article Others http://dx.doi.org/10.4093/dmj.2014.38.5.388 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/5b/51/dmj-38-388.PMC4209353.pdf
"389Diabetics transferred to referral hospitals  Diabetes Metab J 2014;38:388-394 http://e-dmj.orgaging population, and a Westernized lifestyle [2,5].",Non-OADS,/arxiv_data1/oa_pdf/5b/51/dmj-38-388.PMC4209353.pdf
"Diabetes Metab J 2014;38:388-394 http://e-dmj.orgcago, IL, USA).",Non-OADS,/arxiv_data1/oa_pdf/5b/51/dmj-38-388.PMC4209353.pdf
"391Diabetics transferred to referral hospitals  Diabetes Metab J 2014;38:388-394 http://e-dmj.orgStatus of previous diabetic management Of the total patients enrolled in the study, only 73 (11.1%) had  experience with more than one session of diabetic education,  and the rest had never experienced education or did not know.",Non-OADS,/arxiv_data1/oa_pdf/5b/51/dmj-38-388.PMC4209353.pdf
"Diabetes Metab J 2014;38:388-394 http://e-dmj.orgin 1998 to 57.4% in 2007, as universal health screening has be - come the norm and diabetes in Korea has evolved into an in - creasingly developed form [9].",Non-OADS,/arxiv_data1/oa_pdf/5b/51/dmj-38-388.PMC4209353.pdf
393Diabetics transferred to referral hospitals  Diabetes Metab J 2014;38:388-394 http://e-dmj.orgthe medical institution is required to ensure the sustainability  of the healthcare system.,Non-OADS,/arxiv_data1/oa_pdf/5b/51/dmj-38-388.PMC4209353.pdf
Diabetes Metab J 2014;38:388-394 http://e-dmj.orgDiabetes Care 2009;32:2016-20.,Non-OADS,/arxiv_data1/oa_pdf/5b/51/dmj-38-388.PMC4209353.pdf
Available from: http://www.index.go.kr (updated 2011 Sep 19).,Non-OADS,/arxiv_data1/oa_pdf/5b/51/dmj-38-388.PMC4209353.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/2f/dmj-38-395.PMC4209354.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:395-403 Background and Data Configuration Process of a  Nationwide Population-Based Study Using the Korean  National Health Insurance System Sun Ok Song1,2,*, Chang Hee Jung3,*, Y oung Duk Song1, Cheol-Y oung Park4, Hyuk-Sang Kwon5, Bong Soo Cha2,6,   Joong-Y eol Park3, Ki-Up Lee3, Kyung Soo Ko7, Byung-Wan Lee2,6 1Division of Endocrinology, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, 2Department of Medicine, Y onsei University Graduate School of Medicine, Seoul,  3Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul,  4Department of Endocrinology and Metabolism, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul,  5Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, 6Division of Endocrinology and Metabolism, Department of Internal Medicine, Severance Hospital, Y onsei University College of Medicine, Seoul,  7Department of Internal Medicine, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea Background:  The National Health Insurance Service (NHIS) recently signed an agreement to provide limited open access to the  databases within the Korean Diabetes Association for the benefit of Korean subjects with diabetes.",Non-OADS,/arxiv_data1/oa_pdf/93/2f/dmj-38-395.PMC4209354.pdf
"13, 2014; Accepted: Aug. 16, 2014Original Article Others http://dx.doi.org/10.4093/dmj.2014.38.5.395 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/93/2f/dmj-38-395.PMC4209354.pdf
"Diabetes Metab J 2014;38:395-403 http://e-dmj.orgINTRODUCTION History of the Korean Health Security system Following the ‘Medical Insurance Act’ legislation in 1963, med - ical insurance societies for companies with more than 500 em - ployees and insurance societies for public officials and private  school employees were introduced in 1977.",Non-OADS,/arxiv_data1/oa_pdf/93/2f/dmj-38-395.PMC4209354.pdf
397National Health Insurance Service data  Diabetes Metab J 2014;38:395-403 http://e-dmj.orgcies.,Non-OADS,/arxiv_data1/oa_pdf/93/2f/dmj-38-395.PMC4209354.pdf
Diabetes Metab J 2014;38:395-403 http://e-dmj.orgpractitioner or any medical care institution.,Non-OADS,/arxiv_data1/oa_pdf/93/2f/dmj-38-395.PMC4209354.pdf
399National Health Insurance Service data  Diabetes Metab J 2014;38:395-403 http://e-dmj.orgconsist of unique number table delimiter and T is referred to  “table” .,Non-OADS,/arxiv_data1/oa_pdf/93/2f/dmj-38-395.PMC4209354.pdf
Diabetes Metab J 2014;38:395-403 http://e-dmj.orggram.,Non-OADS,/arxiv_data1/oa_pdf/93/2f/dmj-38-395.PMC4209354.pdf
401National Health Insurance Service data  Diabetes Metab J 2014;38:395-403 http://e-dmj.orgNational Health Service Nonprofit National Health System National Health Insurance Etatist Social Health System Etatist Social Health Insurance Etatist Private Health System Social Health System Social Health Insurance Corporatist Private Health System Private Health SystemRegulation Financing Provision Health system type State State State Societal Private Societal  PrivateSocietal Private Private Societal Societal Societal Private Private Private Private Private Private Fig.,Non-OADS,/arxiv_data1/oa_pdf/93/2f/dmj-38-395.PMC4209354.pdf
"Diabetes Metab J 2014;38:395-403 http://e-dmj.orgas diabetes, hypertension, etc., which is life-long after onset  and produces various complications.",Non-OADS,/arxiv_data1/oa_pdf/93/2f/dmj-38-395.PMC4209354.pdf
Available from: http://www.nhis.or.kr/portal/ site/main/MENU_WBDAB0202?purl=/static/html/wbda/b/ wbdab0202.html (updated 2014 Mar 20).,Non-OADS,/arxiv_data1/oa_pdf/93/2f/dmj-38-395.PMC4209354.pdf
403National Health Insurance Service data  Diabetes Metab J 2014;38:395-403 http://e-dmj.orgment about sharing the NHIS databases .,Non-OADS,/arxiv_data1/oa_pdf/93/2f/dmj-38-395.PMC4209354.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/c4/main.PMC4209355.pdf
"Received June 13, 2014 /C15Revision received July 3, 2014 /C15Accepted July 4, 2014 /C15Available online 10 July 2014 http://dx.doi.org/10.1016/j.molmet.2014.07.002 Original article 694MOLECULAR METABOLISM 3 (2014) 694 e704/C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/7b/c4/main.PMC4209355.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/c4/main.PMC4209355.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/c4/main.PMC4209355.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/c4/main.PMC4209355.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/c4/main.PMC4209355.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/c4/main.PMC4209355.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/c4/main.PMC4209355.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/c4/main.PMC4209355.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/c4/main.PMC4209355.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/c4/main.PMC4209355.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/c4/main.PMC4209355.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/c4/main.PMC4209355.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/91/main.PMC4209356.pdf
"Received May 9, 2014 /C15Revision received July 22, 2014 /C15Accepted July 25, 2014 /C15Available online 1 August 2014 http://dx.doi.org/10.1016/j.molmet.2014.07.009 Original article MOLECULAR METABOLISM 3 (2014) 717 e730/C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/22/91/main.PMC4209356.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/91/main.PMC4209356.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/91/main.PMC4209356.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/91/main.PMC4209356.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/91/main.PMC4209356.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/91/main.PMC4209356.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/91/main.PMC4209356.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/91/main.PMC4209356.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/91/main.PMC4209356.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/91/main.PMC4209356.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/91/main.PMC4209356.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found online at http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/22/91/main.PMC4209356.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/91/main.PMC4209356.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/91/main.PMC4209356.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/91/main.PMC4209356.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by- nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/91/main.PMC4209356.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/48/57/main.PMC4209357.pdf
"Abbreviations: CB1, cannabinoid type-1; FDG, ﬂuorodeoxyglucose; FISH, ﬂuorescent in situ hybridization; PET, positron emission tomography; SF1, steroidogenic factor 1; vGlut2, vesicular transporter of glutamate 2 receptor; VMN, ventromedial nucleus Received July 2, 2014 /C15Revision received July 10, 2014 /C15Accepted July 14, 2014 /C15Available online 1 August 2014 http://dx.doi.org/10.1016/j.molmet.2014.07.004 Original article MOLECULAR METABOLISM 3 (2014) 705 e716/C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/48/57/main.PMC4209357.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.,Non-OADS,/arxiv_data1/oa_pdf/48/57/main.PMC4209357.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.,Non-OADS,/arxiv_data1/oa_pdf/48/57/main.PMC4209357.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.,Non-OADS,/arxiv_data1/oa_pdf/48/57/main.PMC4209357.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.,Non-OADS,/arxiv_data1/oa_pdf/48/57/main.PMC4209357.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.,Non-OADS,/arxiv_data1/oa_pdf/48/57/main.PMC4209357.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.,Non-OADS,/arxiv_data1/oa_pdf/48/57/main.PMC4209357.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.,Non-OADS,/arxiv_data1/oa_pdf/48/57/main.PMC4209357.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.,Non-OADS,/arxiv_data1/oa_pdf/48/57/main.PMC4209357.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.,Non-OADS,/arxiv_data1/oa_pdf/48/57/main.PMC4209357.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.,Non-OADS,/arxiv_data1/oa_pdf/48/57/main.PMC4209357.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/48/57/main.PMC4209357.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.,Non-OADS,/arxiv_data1/oa_pdf/48/57/main.PMC4209357.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.,Non-OADS,/arxiv_data1/oa_pdf/48/57/main.PMC4209357.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/5e/main.PMC4209358.pdf
"Received April 23, 2014 /C15Revision received July 11, 2014 /C15Accepted July 16, 2014 /C15Available online 28 July 2014 http://dx.doi.org/10.1016/j.molmet.2014.07.005 Original article 742MOLECULAR METABOLISM 3 (2014) 742 e753/C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/89/5e/main.PMC4209358.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/5e/main.PMC4209358.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/5e/main.PMC4209358.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/5e/main.PMC4209358.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/5e/main.PMC4209358.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/5e/main.PMC4209358.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/5e/main.PMC4209358.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/5e/main.PMC4209358.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/5e/main.PMC4209358.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/5e/main.PMC4209358.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/5e/main.PMC4209358.pdf
SUPPLEMENTARY MATERIAL Supplementary material related to this article can be found online at http://dx.doi.org/ 10.1016/j.molmet.2014.07.005 .,Non-OADS,/arxiv_data1/oa_pdf/89/5e/main.PMC4209358.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/5e/main.PMC4209358.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/5e/main.PMC4209358.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e1/f6/main.PMC4209359.pdf
"Received July 2, 2014 /C15Revision received July 10, 2014 /C15Accepted July 16, 2014 /C15Available online 11 August 2014 http://dx.doi.org/10.1016/j.molmet.2014.07.007 Original article MOLECULAR METABOLISM 3 (2014) 731 e741/C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/e1/f6/main.PMC4209359.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/e1/f6/main.PMC4209359.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/e1/f6/main.PMC4209359.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/e1/f6/main.PMC4209359.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/e1/f6/main.PMC4209359.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/e1/f6/main.PMC4209359.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/e1/f6/main.PMC4209359.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/e1/f6/main.PMC4209359.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/e1/f6/main.PMC4209359.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/e1/f6/main.PMC4209359.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/e1/f6/main.PMC4209359.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/e1/f6/main.PMC4209359.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/ae/main.PMC4209360.pdf
"Received July 7, 2014 /C15Accepted July 16, 2014 /C15Available online 29 July 2014 http://dx.doi.org/10.1016/j.molmet.2014.07.006 Brief communication 770MOLECULAR METABOLISM 3 (2014) 770 e777/C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/0e/ae/main.PMC4209360.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 3.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/ae/main.PMC4209360.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 3.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/ae/main.PMC4209360.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 3.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/ae/main.PMC4209360.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 3.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/ae/main.PMC4209360.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 3.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/ae/main.PMC4209360.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 3.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/ae/main.PMC4209360.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0e/ae/main.PMC4209360.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 3.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/ae/main.PMC4209360.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 3.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/ae/main.PMC4209360.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/31/ed/main.PMC4209361.pdf
"Received July 3, 2014 /C15Revision received July 19, 2014 /C15Accepted July 23, 2014 /C15Available online 13 August 2014 http://dx.doi.org/10.1016/j.molmet.2014.07.010 Original article 754MOLECULAR METABOLISM 3 (2014) 754 e769/C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/31/ed/main.PMC4209361.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/31/ed/main.PMC4209361.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/31/ed/main.PMC4209361.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/31/ed/main.PMC4209361.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/31/ed/main.PMC4209361.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/31/ed/main.PMC4209361.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/31/ed/main.PMC4209361.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/31/ed/main.PMC4209361.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/31/ed/main.PMC4209361.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/31/ed/main.PMC4209361.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/31/ed/main.PMC4209361.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/31/ed/main.PMC4209361.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/31/ed/main.PMC4209361.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/31/ed/main.PMC4209361.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/31/ed/main.PMC4209361.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/31/ed/main.PMC4209361.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/31/ed/main.PMC4209361.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/31/ed/main.PMC4209361.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/64/main.PMC4209380.pdf
"Received July 16, 2014 /C15Revision received July 22, 2014 /C15Accepted July 25, 2014 /C15Available online 6 August 2014 http://dx.doi.org/10.1016/j.molmet.2014.07.008 Original article MOLECULAR METABOLISM 3 (2014) 681 e693/C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/15/64/main.PMC4209380.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/64/main.PMC4209380.pdf
"Peripheral leptin treatment Leptin was obtained from Dr. Parlow (National Hormone and Peptide Program, http://www.humc.edu/hormones ).",OADS,/arxiv_data1/oa_pdf/15/64/main.PMC4209380.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/64/main.PMC4209380.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/64/main.PMC4209380.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/64/main.PMC4209380.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/64/main.PMC4209380.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/64/main.PMC4209380.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/64/main.PMC4209380.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/64/main.PMC4209380.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/64/main.PMC4209380.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/64/main.PMC4209380.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/64/main.PMC4209380.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/64/main.PMC4209380.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/64/main.PMC4209380.pdf
Available at: http://aboutworldlanguages.com/ japanese.,Non-OADS,/arxiv_data1/oa_pdf/d4/9a/srep06773.PMC4209381.pdf
available: http://mecab.sourceforge.net/ (2005).,OADS,/arxiv_data1/oa_pdf/d4/9a/srep06773.PMC4209381.pdf
Kyoto University (2013) Available at: https://code.google.com/p/mecab/ downloads/list.,Non-OADS,/arxiv_data1/oa_pdf/d4/9a/srep06773.PMC4209381.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6773 | DOI: 10.1038/srep06773 11",Non-OADS,/arxiv_data1/oa_pdf/d4/9a/srep06773.PMC4209381.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/90/32/srep06692.PMC4209402.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6692 | DOI: 10.1038/srep06692 6",Non-OADS,/arxiv_data1/oa_pdf/90/32/srep06692.PMC4209402.pdf
DEGs were applied to Parametric Analysis of Gene Set Enrichment (PAGE)56using the disease/phenotype web-PAGE (http://dpwebpage.nia.nih.gov)57to identify key biological functional gene sets derived from the Mouse Genome Informatics (MGI) database.,OADS,/arxiv_data1/oa_pdf/74/d8/srep06713.PMC4209446.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/74/d8/srep06713.PMC4209446.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6713 | DOI: 10.1038/srep06713 8",Non-OADS,/arxiv_data1/oa_pdf/74/d8/srep06713.PMC4209446.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: A.O.,Non-OADS,/arxiv_data1/oa_pdf/01/20/srep06789.PMC4209447.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6777 | DOI: 10.1038/srep06777 4",Non-OADS,/arxiv_data1/oa_pdf/25/2a/srep06777.PMC4209448.pdf
The Instrumental Intensity distribution (Figure 6a) has been performed by USGS41and is downloaded from its website (http://earthquake.usgs.gov/earthquakes/shakemap/global/shake/2008ryan/).,OADS,/arxiv_data1/oa_pdf/e2/ed/srep06770.PMC4209451.pdf
We also thank China Strong Motion Networks Center forproviding acceleration seismograms of the Wenchuan mainshock (http://www.csmnc.net/).,Non-OADS,/arxiv_data1/oa_pdf/e2/ed/srep06770.PMC4209451.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6770 | DOI: 10.1038/srep06770 8",Non-OADS,/arxiv_data1/oa_pdf/e2/ed/srep06770.PMC4209451.pdf
Methods Transcriptomic data .All data set was obtained from the Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/) database.,OADS,/arxiv_data1/oa_pdf/4f/58/srep06781.PMC4209459.pdf
"Wrote the paper: H.W., J.J., S.C. All authors read and approved the final manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.",Non-OADS,/arxiv_data1/oa_pdf/4f/58/srep06781.PMC4209459.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fc/92/srep06769.PMC4209460.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6787 | DOI: 10.1038/srep06787 7",Non-OADS,/arxiv_data1/oa_pdf/3a/05/srep06787.PMC4209461.pdf
"The JAX transgenic mouse strain B6.Cg-Tg(Thy1-YFP)16Jrs/J (http://jaxmice.jax.org/) expresses the fluorescent YFP protein in the motor and sensory neurons and in subsets of the central neurons, and is widely used to study neuronal development and regeneration5–9.",Non-OADS,/arxiv_data1/oa_pdf/60/f6/srep06776.PMC4209462.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/60/f6/srep06776.PMC4209462.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6776 | DOI: 10.1038/srep06776 7",Non-OADS,/arxiv_data1/oa_pdf/60/f6/srep06776.PMC4209462.pdf
"The secondary structures were predicted using the GOR IV server (http://npsa-pbil.ibcp.fr/cgi-bin/npsa_automat.pl?page 5npsa_gor4.html), and a-helix, b-sheet, and loop elements are represented as red rings, blue wave, and black line, respectively, above or below their amino-acid sequences.",OADS,/arxiv_data1/oa_pdf/92/b4/srep06688.PMC4209464.pdf
"Human CCT5 and P. furiosus PfCD superposed onto the crystal structure of Thermococcus strain KS-1 a.LEFT : The structure (Swiss- Model (http://swissmodel.expasy.org/) of PfCD (gold) superposed onto the crystal structure of KS1 a(momomers, displayed in marine blue, violet, and deep teal as surface, and in cyan color as ribbon).",Non-OADS,/arxiv_data1/oa_pdf/92/b4/srep06688.PMC4209464.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/92/b4/srep06688.PMC4209464.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/5a/da/srep06779.PMC4209466.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/ce/TOORTHJ-8-384.PMC4209493.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/6d/TODENTJ-8-184.PMC4209494.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/aa/TORJ-8-73.PMC4209495.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/3b/TOORTHJ-8-368.PMC4209496.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/13/TORJ-8-77.PMC4209497.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/01/TODENTJ-8-180.PMC4209498.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/bd/TORMJ-8-34.PMC4209499.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/f9/TOOPHTJ-8-75.PMC4209500.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/12/TOORTHJ-8-355.PMC4209501.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/33/TOORTHJ-8-372.PMC4209502.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/e9/TOORTHJ-8-346.PMC4209503.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/53/TOORTHJ-8-375.PMC4209504.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/86/main.PMC4209505.pdf
"Inthe acute VTE studies, the novel anticoagulants were compared with standard therapy in patients with a new VTE who were not being treated with any anticoagulation at the time of the diagnosis.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/cuthreCurrent Therapeutic Research http://dx.doi.org/10.1016/j.curtheres.2014.06.002 0011-393X/ &2014.",Non-OADS,/arxiv_data1/oa_pdf/e5/86/main.PMC4209505.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/86/main.PMC4209505.pdf
http://dx.doi.org/10.1161/CIRCULATIONAHA.,Non-OADS,/arxiv_data1/oa_pdf/e5/86/main.PMC4209505.pdf
http://dx.doi.org/10.1160/TH09-11-0758 .,Non-OADS,/arxiv_data1/oa_pdf/e5/86/main.PMC4209505.pdf
http://dx.doi.org/10.1182/ asheducation-2012.1.460 .,Non-OADS,/arxiv_data1/oa_pdf/e5/86/main.PMC4209505.pdf
http://dx.doi.org/10.1056/NEJMoa1007903 .,OADS,/arxiv_data1/oa_pdf/e5/86/main.PMC4209505.pdf
http://dx.doi.org/10.1056/NEJMoa1113572 .,OADS,/arxiv_data1/oa_pdf/e5/86/main.PMC4209505.pdf
http://dx.doi.org/10.1186/1477-9560-11-21 .,Non-OADS,/arxiv_data1/oa_pdf/e5/86/main.PMC4209505.pdf
http://dx.doi.org/10.1056/ NEJMoa1302507 .,OADS,/arxiv_data1/oa_pdf/e5/86/main.PMC4209505.pdf
"2009;361 (24):2342 –2352, http://dx.doi.org/10.1056/NEJMoa0906598 .",Non-OADS,/arxiv_data1/oa_pdf/e5/86/main.PMC4209505.pdf
http://dx.doi.org/10.1161/CIRCULATIONAHA.113.004450 .,Non-OADS,/arxiv_data1/oa_pdf/e5/86/main.PMC4209505.pdf
http://dx.doi.org/10.1056/NEJMoa1306638 .,OADS,/arxiv_data1/oa_pdf/e5/86/main.PMC4209505.pdf
"2013;368(8):699 –708, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e5/86/main.PMC4209505.pdf
http://dx.doi.org/10.1056/NEJMoa1113697 .,OADS,/arxiv_data1/oa_pdf/e5/86/main.PMC4209505.pdf
http://dx.doi.org/10.1378/chest.11-2301 .,Non-OADS,/arxiv_data1/oa_pdf/e5/86/main.PMC4209505.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e5/86/main.PMC4209505.pdf
2013;24(1):64 –70.http://dx.doi.org/10.1097/MBC.0b013e32835a72c2 .,Non-OADS,/arxiv_data1/oa_pdf/e5/86/main.PMC4209505.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/86/main.PMC4209505.pdf
http://dx.doi.org/10.1161/CIR.0b013e318214914f .,Non-OADS,/arxiv_data1/oa_pdf/e5/86/main.PMC4209505.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/86/main.PMC4209505.pdf
2012;366(1):9 –19.http://dx.doi.org/ 10.1056/NEJMoa1112277 .,Non-OADS,/arxiv_data1/oa_pdf/e5/86/main.PMC4209505.pdf
http://dx.doi.org/10.1001/ archinternmed.2011.1666 .,Non-OADS,/arxiv_data1/oa_pdf/e5/86/main.PMC4209505.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/22/main.PMC4209507.pdf
"Introduction Highly active antiretroviral therapy (HAART), a combination of at least 3 antiretroviral drugs, effectively suppresses viralContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/cuthreCurrent Therapeutic Research http://dx.doi.org/10.1016/j.curtheres.2014.05.002 0011-393X/ &2014.",Non-OADS,/arxiv_data1/oa_pdf/a4/22/main.PMC4209507.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/22/main.PMC4209507.pdf
Availableathttp://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf .2 0 1 3 .,Non-OADS,/arxiv_data1/oa_pdf/a4/22/main.PMC4209507.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/31/85/main.PMC4209508.pdf
"For example, Qin et al16suggested that the TNF- α-308 G/A polymorphism is asso- ciated with a modest decrease in the risk of developing HCC,whereas Teixeira et al 17showed that the TNF- α-308 G/A poly- morphism is signi ﬁcantly associated with higher risk of developingContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/cuthreCurrent Therapeutic Research http://dx.doi.org/10.1016/j.curtheres.2014.04.001 0011-393X/ &2014.",Non-OADS,/arxiv_data1/oa_pdf/31/85/main.PMC4209508.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/31/85/main.PMC4209508.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/cuthreCurrent Therapeutic Research http://dx.doi.org/10.1016/j.curtheres.2014.07.002 0011-393X/ &2014.,Non-OADS,/arxiv_data1/oa_pdf/68/ab/main.PMC4209509.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/ab/main.PMC4209509.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/0f/TOORTHJ-8-361.PMC4209519.pdf
http://www.news.admin.ch/NSBSubscriber/ message/attachments/16739.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8b/01/indhealth-52-225.PMC4209578.pdf
http://www.seniam.org.,Non-OADS,/arxiv_data1/oa_pdf/8b/01/indhealth-52-225.PMC4209578.pdf
http://www.aped.pt.,Non-OADS,/arxiv_data1/oa_pdf/c2/4f/indhealth-52-262.PMC4209582.pdf
European Risk Observatory report 2012. https://osha.europa.eu /en/publications/reports/esener1_osh_ management.,Non-OADS,/arxiv_data1/oa_pdf/4f/97/indhealth-52-216.PMC4209586.pdf
8) UEAPMEImplementation of the ETUC1/UNICE-UEAPME/CEEP Framework agreement on Work-related Stress Yearly Joint Table summarising ongoing social  partners activities 2006. http://www.ueapme.com/docs/ joint_position/Joint_Table_Implementation_Stress_2006.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/97/indhealth-52-216.PMC4209586.pdf
Report by European social partners adopted at the social dialogue  committee on 18 June 2008. http://www.ueapme.com/ IMG/pdf/Stress_Final_Implementation_report_231108.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/97/indhealth-52-216.PMC4209586.pdf
11) Drivers and barriers for psychosocial risk management: An analysis of the findings of the European Survey of Enterprises on New and Emerging Risks (ESENER) (2013)  https://osha.europa.eu/en/publications/reports/drivers- barriers-psychosocial-risk-management-esener.,Non-OADS,/arxiv_data1/oa_pdf/4f/97/indhealth-52-216.PMC4209586.pdf
12) Occupational Health Care Act 1383/2001 http://www.finlex.fi/fi/laki/kaannokset/2001/en20011383.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/97/indhealth-52-216.PMC4209586.pdf
13) The Social Insurance Institution of Finland http://www.kela.fi/in/internet/liite.nsf/NET/250111135142SP/$File/Ty%C3%B6nantajakirje_valmis.pdf?OpenElement.,Non-OADS,/arxiv_data1/oa_pdf/4f/97/indhealth-52-216.PMC4209586.pdf
All New BJSQ scales are available at http://www.jstress.net (only in Japanese language).,OADS,/arxiv_data1/oa_pdf/21/eb/indhealth-52-175.PMC4209588.pdf
"More detailed information about the national average scores by gender, occupation, employment type, and industry is available at http://www.jstress.net (only in Japanese lan-guage).",OADS,/arxiv_data1/oa_pdf/21/eb/indhealth-52-175.PMC4209588.pdf
Available from: http://www.nytimes.,Non-OADS,/arxiv_data1/oa_pdf/32/a1/JFMPC-3-175.PMC4209665.pdf
Available from:  http://www.unfpa.org/webdav/site/global/shared/swp2013/ EN‑SWOP2013‑final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/32/a1/JFMPC-3-175.PMC4209665.pdf
Available from:  http://unesdoc.unesco.org/images/0018/001832/183281e.,Non-OADS,/arxiv_data1/oa_pdf/32/a1/JFMPC-3-175.PMC4209665.pdf
Available from: http://www.who.int/countryfocus/ cooperation_strategy/ccsbrief_ind_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e8/00/JFMPC-3-180.PMC4209666.pdf
Available from: http://www.planningcommission.nic.in/ reports/genrep/rep_uhc0812.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e8/00/JFMPC-3-180.PMC4209666.pdf
Available from: http://www.who.int/ macrohealth/action/Report%20of%20the%20National%20 Commission.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e8/00/JFMPC-3-180.PMC4209666.pdf
Available  from: http://www.mciindia.org/tools/announcement/ MCI_booklet.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e8/00/JFMPC-3-180.PMC4209666.pdf
Available from:  http://www.u21health.org/sites/u21health.org/files/ Julio_Frenk.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e8/00/JFMPC-3-180.PMC4209666.pdf
Available from: http://www.jfmpc.com/ article.asp?issn=2249‑4863;year=2012;volume=1;issue=1; spage=3;epage=6;aulast=Velavan.,Non-OADS,/arxiv_data1/oa_pdf/d8/2e/JFMPC-3-183.PMC4209667.pdf
Available from: http://ieg.ignou.,Non-OADS,/arxiv_data1/oa_pdf/d8/2e/JFMPC-3-183.PMC4209667.pdf
Available from: http://www.ed.gov/international/usnei/ edlite‑index.html.,OADS,/arxiv_data1/oa_pdf/d8/2e/JFMPC-3-183.PMC4209667.pdf
Available from:  http://www.med.monash.edu.au/general‑practice/docs/ master‑family‑medicine.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d8/2e/JFMPC-3-183.PMC4209667.pdf
Available from:  http://web.up.ac.za/default.asp?ipkCategoryID=26111  and subid=26111 and ipklookid=8.,OADS,/arxiv_data1/oa_pdf/d8/2e/JFMPC-3-183.PMC4209667.pdf
Available from: http://www.open.ac.uk/ cetl‑workspace/cetlcontent/documents/464428ed4aa20.,Non-OADS,/arxiv_data1/oa_pdf/d8/2e/JFMPC-3-183.PMC4209667.pdf
Available from: http://www.psychology.about.com/ library/bl_psychosocial_summary.htm.,Non-OADS,/arxiv_data1/oa_pdf/b1/23/JFMPC-3-193.PMC4209670.pdf
Available from: http://www.dev.ersnet.org/uploads/ Document/e1/WEB_CHEMIN_2567_1194523664.pdf.,OADS,/arxiv_data1/oa_pdf/af/12/JFMPC-3-199.PMC4209671.pdf
Available from:  http://www.carbon‑monoxide‑survivor.com/carbon  ‑monoxide‑exposure‑poisoning‑high‑risk‑occupations.html.,Non-OADS,/arxiv_data1/oa_pdf/af/12/JFMPC-3-199.PMC4209671.pdf
Available from: http://www.idsp.nic.in/.,Non-OADS,/arxiv_data1/oa_pdf/09/75/JFMPC-3-213.PMC4209674.pdf
Available from: http://www.articles.timesofindia.,Non-OADS,/arxiv_data1/oa_pdf/09/75/JFMPC-3-213.PMC4209674.pdf
Available from: http://www.nvbdcpchd.gov.in/Health%20 Workers%20Manual.pdf.,Non-OADS,/arxiv_data1/oa_pdf/09/75/JFMPC-3-213.PMC4209674.pdf
Available from: http://www.phfi.org/research/403.,Non-OADS,/arxiv_data1/oa_pdf/09/75/JFMPC-3-213.PMC4209674.pdf
Available from:  http://www.phfi.org/.,Non-OADS,/arxiv_data1/oa_pdf/09/75/JFMPC-3-213.PMC4209674.pdf
Available from: http://www.docstoc.com/ docs/43705103/An ‑ Evaluation ‑ of ‑ Integrated ‑ Diseases  ‑ Surveillance ‑ Project ‑ Bellary ‑ Unit.,Non-OADS,/arxiv_data1/oa_pdf/09/75/JFMPC-3-213.PMC4209674.pdf
Available from: http://www.mciindia.org/ RulesandRegulations/PGMedicalEducationRegulations2000.,Non-OADS,/arxiv_data1/oa_pdf/88/0f/JFMPC-3-216.PMC4209675.pdf
Available from: http://www.commedjournal.,Non-OADS,/arxiv_data1/oa_pdf/88/0f/JFMPC-3-216.PMC4209675.pdf
Available from: http://www.isedj.org/2/30/ISEDJ.2(30).,Non-OADS,/arxiv_data1/oa_pdf/88/0f/JFMPC-3-216.PMC4209675.pdf
"Sample size was calculated using Raosoft sample size  calculator (http://www.raosoft.com/samplesize.html) assuming  a margin of  error of  5%, a total population of  patients with  chronic illness of  approximately 2000 and a response rate of   90% based on the researcher’s observation during the pilot study.",OADS,/arxiv_data1/oa_pdf/70/b2/JFMPC-3-224.PMC4209677.pdf
Available from:  http://www.wma.net/en/30publications/10policies/p13/ index.html.,Non-OADS,/arxiv_data1/oa_pdf/0d/8e/JFMPC-3-230.PMC4209678.pdf
.Available from: http://www.current‑oncology.com/index.,Non-OADS,/arxiv_data1/oa_pdf/0d/8e/JFMPC-3-230.PMC4209678.pdf
Available from:  http://www.nice.org.uk/.,Non-OADS,/arxiv_data1/oa_pdf/9e/d4/JFMPC-3-250.PMC4209682.pdf
Available from:  http://www.goldcopd.org/.,Non-OADS,/arxiv_data1/oa_pdf/9e/d4/JFMPC-3-250.PMC4209682.pdf
Available from: http://www.who.int/healthpromotion/ conferences/6gchp/hpr_050829_%20BCHP.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a6/39/JFMPC-3-255.PMC4209683.pdf
Available from: http://www.epilepsyindia.,Non-OADS,/arxiv_data1/oa_pdf/ce/7c/JFMPC-3-266.PMC4209685.pdf
Available from: http://www.merck.com/product/usa/ pi_circulars/c/cozaar/cozaar_pi.pdf.,OADS,/arxiv_data1/oa_pdf/3e/2e/JFMPC-3-272.PMC4209687.pdf
Available from:  http://www.down ‑syndrome.org.,Non-OADS,/arxiv_data1/oa_pdf/ee/d4/JFMPC-3-281.PMC4209690.pdf
Available from: http://www.down‑syndrome.org.,Non-OADS,/arxiv_data1/oa_pdf/ee/d4/JFMPC-3-281.PMC4209690.pdf
Available from: http://www.science‑frontiers.,Non-OADS,/arxiv_data1/oa_pdf/ee/d4/JFMPC-3-281.PMC4209690.pdf
"Surgical Neurology International Editor: Michel Kliot,  MD UCSF Medical Center   San Francisco, CA 94143OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neurosurgical Developments on the Horizon, a supplement to SNIS435Medical errors in neurosurgery John D. Rolston, Corinna C. Zygourakis, Seunggu J. Han, Catherine Y. Lau1, Mitchel S. Berger,  Andrew T .",Non-OADS,/arxiv_data1/oa_pdf/de/da/SNI-5-435.PMC4209704.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/11/435/142777 Copyright: © 2014 Rolston JD.,Non-OADS,/arxiv_data1/oa_pdf/de/da/SNI-5-435.PMC4209704.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Primary melanocytic tumors of the central nervous system:  Report of two cases and review of literature Victoria Trinh, Rafael Medina‑Flores1, Chirstopher L. Taylor, Howard Y onas, Muhammad O. Chohan Department of Neurosurgery, University of New Mexico, Albuquerque, New Mexico, 1Department of Neuropathology, Marshfield Clinic, Marshfield, Wisconsin,  USA  E‑mail:  Victoria Trinh ‑ victoria.t.trinh@gmail.com; Rafael Medina‑Flores ‑ rafael.medinaflores@gmail.com; Chirstopher L. Taylor ‑ ctaylor@salud.unm.edu;  Howard Yonas ‑ hyonas@salud.unm.edu; *Muhammad O. Chohan ‑ mchohan@salud.unm.edu   *Corresponding author Received: 30 March 14  Accepted: 11 August 14  Published: 13 October 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.142795  Quick Response Code: Abstract Background:  Primary melanocytic tumors of the central nervous system (CNS)  represent only 1% of all melanomas.",Non-OADS,/arxiv_data1/oa_pdf/70/ca/SNI-5-147.PMC4209706.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/147/142795 Copyright: © 2014 Trinh V.  This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/70/ca/SNI-5-147.PMC4209706.pdf
"Surgical Neurology International 2014, 5:147  http://www.surgicalneurologyint.com/content/5/1/147imaging (MRI) showed extensive leptomeningeal  enhancement with a small focus of nodular parenchymal  enhancement [Figure 1a and b], and non‑specific T2  white matter hypointensities [Figure 1c].",Non-OADS,/arxiv_data1/oa_pdf/70/ca/SNI-5-147.PMC4209706.pdf
"Surgical Neurology International 2014, 5:147  http://www.surgicalneurologyint.com/content/5/1/147intramedullary mass involving the lower thoracic spinal  cord and the conus medullaris from T11 to L1, isointense  on T1‑weighted imaging, and homogenously enhancing  following gadolinium injection [Figure 3].",Non-OADS,/arxiv_data1/oa_pdf/70/ca/SNI-5-147.PMC4209706.pdf
"Surgical Neurology International 2014, 5:147  http://www.surgicalneurologyint.com/content/5/1/147T1‑weighted imaging, hypointense on T2‑weighted  imaging,[4,16] and demonstrate intense enhancement with  gadolinium.",Non-OADS,/arxiv_data1/oa_pdf/70/ca/SNI-5-147.PMC4209706.pdf
"Surgical Neurology International 2014, 5:147  http://www.surgicalneurologyint.com/content/5/1/147CSF may not be present in a sample or can escape  recognition.",Non-OADS,/arxiv_data1/oa_pdf/70/ca/SNI-5-147.PMC4209706.pdf
"Surgical Neurology International 2014, 5:147  http://www.surgicalneurologyint.com/content/5/1/147amounts of hemorrhage.",Non-OADS,/arxiv_data1/oa_pdf/70/ca/SNI-5-147.PMC4209706.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Symptomatic de novo arteriovenous malformation in an adult:  Case report and review of the literature Jayson A. Neil, Daphne Li, Michael F .",Non-OADS,/arxiv_data1/oa_pdf/00/ee/SNI-5-148.PMC4209707.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/148/142796 Copyright: © 2014 Neil JA.,Non-OADS,/arxiv_data1/oa_pdf/00/ee/SNI-5-148.PMC4209707.pdf
"Surgical Neurology International 2014,5:148  http://www.surgicalneurologyint.com/content/5/1/148on the MRI 9 years ago.",Non-OADS,/arxiv_data1/oa_pdf/00/ee/SNI-5-148.PMC4209707.pdf
"Surgical Neurology International 2014,5:148  http://www.surgicalneurologyint.com/content/5/1/148Table 1: Previously reported cases of de novo  AVM formation Literature Patient  genderAge at time  of initial  imagingReason for  initial imagingType of imaging  performedAge at  AVM  diagnosisPresenting  symptoms at  time of AVM  diagnosisType of  imaging  performed for  AVM diagnosis No prior vascular pathology Bulsara KR, Alexander MJ,  Villavicencio AT, Graffagnino C:  De novo cerebral arteriovenous  malformation: Case report.",Non-OADS,/arxiv_data1/oa_pdf/00/ee/SNI-5-148.PMC4209707.pdf
"Surgical Neurology International 2014,5:148  http://www.surgicalneurologyint.com/content/5/1/148Genetic etiologies for cerebral AVMs are also currently  being explored.",Non-OADS,/arxiv_data1/oa_pdf/00/ee/SNI-5-148.PMC4209707.pdf
"Surgical Neurology International 2014,5:148  http://www.surgicalneurologyint.com/content/5/1/1482.",Non-OADS,/arxiv_data1/oa_pdf/00/ee/SNI-5-148.PMC4209707.pdf
"Developmental Cognitive Neuroscience 7 (2014) 13–22 Contents lists available at ScienceDirect Developmental Cognitive Neuroscience journal homepage: http://www.elsevier.com/locate/dcn Cognitive control network connectivity in adolescent women with and without a parental history of depression Peter C. Clasena,b,c,∗, Christopher G. Beeversa,b,c, Jeanette A. Mumforda,c, David M. Schnyera,b,c aDepartment of Psychology, The University of Texas at Austin, United States bInstitute for Mental Health Research, The University of Texas at Austin, United States cImaging Research Center, The University of Texas at Austin, United States article info Article history: Received 9 May 2013 Received in revised form 18 October 2013 Accepted 30 October 2013 Keywords:Depression vulnerabilityAdolescenceParental history of depression Cognitive control network Resting-state fMRIFunctional connectivityabstract Background: Adolescent women with a parental history of depression are at high risk for the onset of major depressive disorder (MDD).",Non-OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
Published by Elsevier Ltd. http://dx.doi.org/10.1016/j.dcn.2013.10.008Open access under CC BY-NC-ND license.,Non-OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Journal of Affective Disor-ders, http://dx.doi.org/10.1016/j.jad.2012.11.023.",OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Science (New York, NY) 303 (5655), 232–235,http://dx.doi.org/10.1126/science.1089504.",Non-OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Trends in Cognitive Sciences 8 (4), 170–177,http://dx.doi.org/10.1016/j.tics.2004.02.010.",Non-OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Journal of the AmericanAcademy of Child & Adolescent Psychiatry 37 (11), 1134–1141,http://dx.doi.org/10.1097/00004583-199811000-00012.",Non-OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Clinical Psychology Review 8 (1), 77–100,http://dx.doi.org/10.1016/0272-7358(88)90050-5.",Non-OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Neuroscience 167 (1), 97–103,http://dx.doi.org/10.1016/j.neuroscience.2010.01.047.",OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Am J Psychiatry168 (7), 735–741, http://dx.doi.org/10.1176/appi.ajp.2011.10091309.",Non-OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Psychiatry and Clinical Neurosciences 63 (6), 754–761,http://dx.doi.org/10.1111/j.1440-1819.2009.02030.x.",Non-OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Neuroscience Letters460 (3), 227–231, http://dx.doi.org/10.1016/j.neulet.2009.05.022.",OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Understanding vulnerability for depression from a cognitive neuroscience perspective: a reap-praisal of attentional factors and a new conceptual framework.Cognitive, Affective & Behavioral Neuroscience 10 (1), 50–70,http://dx.doi.org/10.3758/CABN.10.1.50.",Non-OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Nature Reviews.Neuroscience 12 (8), 467–477, http://dx.doi.org/10.1038/nrn3027.",Non-OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Journal of Clinical Child and Adolescent Psychol-ogy: The Ofﬁcial Journal for the Society of Clinical Child and AdolescentPsychology, American Psychological Association, Division 53 38 (3),415–426, http://dx.doi.org/10.1080/15374410902851705.",Non-OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Human Brain Mapping 32 (1), 22–31,http://dx.doi.org/10.1002/hbm.20997.",Non-OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Neuroimage 50 (3–3), 1313–1319,http://dx.doi.org/10.1016/j.neuroimage.2009.12.109.",OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Cerebral Cortex (New York, NY: 1991) 16 (12),1679–1689, http://dx.doi.org/10.1093/cercor/bhj116.",Non-OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Psychological Review 115 (2), 291–313,http://dx.doi.org/10.1037/0033-295X.115.2.291.",Non-OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Cognitive Therapy and Research 8 (5), 443–477,http://dx.doi.org/10.1007/BF01173284.",Non-OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Journal of Abnormal Psychology 116 (1), 135–143,http://dx.doi.org/10.1037/0021-843X.116.1.135.",Non-OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Journal of the AmericanAcademy of Child and Adolescent Psychiatry 36 (7), 980–988,http://dx.doi.org/10.1097/00004583-199707000-00021.",Non-OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Journal of General Internal Medicine 16 (9), 606–613,http://dx.doi.org/10.1046/j.1525-1497.2001.016009606.x.",Non-OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Journal of the AmericanAcademy of Child & Adolescent Psychiatry 38 (1), 56–63,http://dx.doi.org/10.1097/00004583-199901000-00020.",Non-OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Journal of Research on Adolescence 4 (4), 519–534,http://dx.doi.org/10.1207/s15327795jra0404 5.",Non-OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"NeuroImage 59 (3), 2142–2154,http://dx.doi.org/10.1016/j.neuroimage.2011.10.018.",OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Journal of the American Academy of Child &Adolescent Psychiatry 38 (7), 908–915, http://dx.doi.org/10.1097/ 00004583-199907000-00022.",Non-OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Neu-roImage 43 (3), 645–655, http://dx.doi.org/10.1016/j.neuroimage.",OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"NeuroImage 23 (Suppl 1), S208–S219,http://dx.doi.org/10.1016/j.neuroimage.2004.07.051.",OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Cognition & Emotion 2 (3), 247–274,http://dx.doi.org/10.1080/02699938808410927.",Non-OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Psychological Medicine 39 (6), 977–987,http://dx.doi.org/10.1017/S0033291708004443.",Non-OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Frontiers in Systems Neuroscience 4, 41,http://dx.doi.org/10.3389/fnsys.2010.00041.",Non-OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"Neuron 59 (6), 1037–1050,http://dx.doi.org/10.1016/j.neuron.2008.09.006.",OADS,/arxiv_data1/oa_pdf/0f/d9/main.PMC4209722.pdf
"I. Virtanen Institute for Molecular Sciences, University of Eastern Finland 4Laboratory Animal Center, University of Helsinki Correspondence to: Leonard Khiroug at leonard.khirug@helsinki.fi URL: http://www.jove.com/video/51869 DOI: doi:10.3791/51869 Keywords: Issue 88, awake, in vivo  two-photon microscopy, blood vessels, dendrites, dendritic spines, Ca2+ imaging, intrinsic optical imaging, patch-clamp Date Published: 6/29/2014 Citation: Kislin, M., Mugantseva, E., Molotkov, D., Kulesskaya, N., Khirug, S., Kirilkin, I., Pryazhnikov, E., Kolikova, J., Toptunov, D., Yuryev, M., Giniatullin, R., Voikar, V., Rivera, C., Rauvala, H., Khiroug, L. Flat-floored Air-lifted Platform: A New Method for Combining Behavior with Microscopy or Electrophysiology on Awake Freely Moving Rodents.",Non-OADS,/arxiv_data1/oa_pdf/86/a4/jove-88-51869.PMC4209781.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51869/ Introduction An exciting recent trend in the Neurosciences is to develop experimental approaches for molecular and cellular probing of neuronal networks in the brain of awake, behaving rodents.",Non-OADS,/arxiv_data1/oa_pdf/86/a4/jove-88-51869.PMC4209781.pdf
Availablefrom: http://stacks.cdc.gov/view/cdc/6681 26.,OADS,/arxiv_data1/oa_pdf/a4/75/trf0054-0789.PMC4209803.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJune 2014 |  88  | e51318 | Page 1 of 13Video Article The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool Richard A. Rudick1, Deborah Miller1, Francois Bethoux1, Stephen M. Rao2, Jar-Chi Lee3, Darlene Stough1, Christine Reece2, David Schindler4, Bernadett Mamone1, Jay Alberts4 1Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation 2Center for Brain Health, Cleveland Clinic Foundation 3Quantitative Health Sciences, Cleveland Clinic Foundation 4Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic Foundation Correspondence to: Richard A. Rudick at rudickr@ccf.org URL: http://www.jove.com/video/51318 DOI: doi:10.3791/51318 Keywords: Medicine, Issue 88, Multiple Sclerosis, Multiple Sclerosis Functional Composite, computer-based testing, 25-foot walk test, 9-hole peg test, Symbol Digit Modalities Test, Low Contrast Visual Acuity, Clinical Outcome Measure Date Published: 6/30/2014 Citation: Rudick, R.A., Miller, D., Bethoux, F., Rao, S.M., Lee, J.C., Stough, D., Reece, C., Schindler, D., Mamone, B., Alberts, J.",Non-OADS,/arxiv_data1/oa_pdf/5a/3b/jove-88-51318.PMC4209820.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51318/ Introduction Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS) affecting young adults, particularly women.",Non-OADS,/arxiv_data1/oa_pdf/5a/3b/jove-88-51318.PMC4209820.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/86/gft280.PMC4209875.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non -commercial re-use, distribution, and reproduction in any medium, provided th e original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/ec/gfu199.PMC4209878.pdf
SUPPLEMENTARY DATA Supplementary data are available online at http://ndt.oxford journals.org.,OADS,/arxiv_data1/oa_pdf/ac/ec/gfu199.PMC4209878.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/3.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/da/gfu201.PMC4209879.pdf
SUPPLEMENTARY DATA Supplementary data are available online at http://ndt.oxford- journals.org.,Non-OADS,/arxiv_data1/oa_pdf/09/da/gfu201.PMC4209879.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/4e/gfu292.PMC4209880.pdf
SUPPLEMENTARY DATA Supplementary data are available online at http://ndt.oxford journals.org.,OADS,/arxiv_data1/oa_pdf/75/4e/gfu292.PMC4209880.pdf
"Adding insult to injury 2009. http://www.ncepod.org.uk/ 2009aki.htm (1 September 2004, date last accessed) 22.",Non-OADS,/arxiv_data1/oa_pdf/75/4e/gfu292.PMC4209880.pdf
"http://www.ccm.pitt.edu/sapphire-investigators (1 September 2004, date last accessed) Received for publication: 2.6.2014; Accepted in revised form: 8.8.2014 ORIGINAL ARTICLE Cutoffs for [TIMP-2] [IGFBP7] 2061",Non-OADS,/arxiv_data1/oa_pdf/75/4e/gfu292.PMC4209880.pdf
"METALOR, Metalor dental(tm) Aurofluid2PF brochures,  METALOR, USA, http://www.metalor.com  17.",Non-OADS,/arxiv_data1/oa_pdf/8c/1c/10.1177_1758736014555246.PMC4209892.pdf
"Lava Technical Product Profile, 3M ESPE, USA, http://solutions.3m.com/wps/portal/3M/en_US/3M-ESPE-NA/dental-professionals/  19.",Non-OADS,/arxiv_data1/oa_pdf/8c/1c/10.1177_1758736014555246.PMC4209892.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/03/nihms-629939.PMC4209947.pdf
http://dx.doi.org/10.1007/s00018-007-7484-1  (Mar).,Non-OADS,/arxiv_data1/oa_pdf/d7/03/nihms-629939.PMC4209947.pdf
http://dx.doi.org/10.1002/jbmr.2139  (May).,OADS,/arxiv_data1/oa_pdf/d7/03/nihms-629939.PMC4209947.pdf
http://www.nccn.org/professionals/ physician_gls/f_guidelines.asp.,Non-OADS,/arxiv_data1/oa_pdf/45/14/cncr0120-2325.PMC4209960.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdCOMMENTARY Shirakawa and Terauchi http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/89/34/jdi-5-359.PMC4210059.pdf
4 July 2014 361COMMENTARY http://onlinelibrary.wiley.com/journal/jdi Loss of b-cell transcriptional factors,Non-OADS,/arxiv_data1/oa_pdf/89/34/jdi-5-359.PMC4210059.pdf
4 July 2014 473LETTER TO THE EDITOR http://onlinelibrary.wiley.com/journal/jdi Letter to the Editor,Non-OADS,/arxiv_data1/oa_pdf/42/e7/jdi-5-472.PMC4210061.pdf
4 July 2014 457ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Diaphragmatic breathing in diabetes,Non-OADS,/arxiv_data1/oa_pdf/7e/49/jdi-5-456.PMC4210062.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/7e/49/jdi-5-456.PMC4210062.pdf
4 July 2014 459ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Diaphragmatic breathing in diabetes,Non-OADS,/arxiv_data1/oa_pdf/7e/49/jdi-5-456.PMC4210062.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/7e/49/jdi-5-456.PMC4210062.pdf
4 July 2014 461ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Diaphragmatic breathing in diabetes,Non-OADS,/arxiv_data1/oa_pdf/7e/49/jdi-5-456.PMC4210062.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/7e/49/jdi-5-456.PMC4210062.pdf
4 July 2014 463ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Diaphragmatic breathing in diabetes,Non-OADS,/arxiv_data1/oa_pdf/7e/49/jdi-5-456.PMC4210062.pdf
4 July 2014 429ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Risk of CVA with irregular visits,Non-OADS,/arxiv_data1/oa_pdf/9d/bf/jdi-5-428.PMC4210063.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/9d/bf/jdi-5-428.PMC4210063.pdf
4 July 2014 431ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Risk of CVA with irregular visits,Non-OADS,/arxiv_data1/oa_pdf/9d/bf/jdi-5-428.PMC4210063.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/9d/bf/jdi-5-428.PMC4210063.pdf
"Available from: http://www.mhlw.go.jp/houdou/ 2008/12/h1225-5a.html (accessed January 9, 2013) (inJapanese).",Non-OADS,/arxiv_data1/oa_pdf/9d/bf/jdi-5-428.PMC4210063.pdf
Available from: http://www.mhlw.go.,Non-OADS,/arxiv_data1/oa_pdf/9d/bf/jdi-5-428.PMC4210063.pdf
4 July 2014 433ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Risk of CVA with irregular visits,Non-OADS,/arxiv_data1/oa_pdf/9d/bf/jdi-5-428.PMC4210063.pdf
"SPSS Inc, Chicago, IL, 2005. http://www.spsstools.net/spss_programming.htm 22.",Non-OADS,/arxiv_data1/oa_pdf/9d/bf/jdi-5-428.PMC4210063.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/9d/bf/jdi-5-428.PMC4210063.pdf
4 July 2014 401CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Combination of DPP-4 inhibitor & glinide,Non-OADS,/arxiv_data1/oa_pdf/87/62/jdi-5-400.PMC4210064.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/87/62/jdi-5-400.PMC4210064.pdf
4 July 2014 403CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Combination of DPP-4 inhibitor & glinide,Non-OADS,/arxiv_data1/oa_pdf/87/62/jdi-5-400.PMC4210064.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/87/62/jdi-5-400.PMC4210064.pdf
4 July 2014 405CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Combination of DPP-4 inhibitor & glinide,Non-OADS,/arxiv_data1/oa_pdf/87/62/jdi-5-400.PMC4210064.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/87/62/jdi-5-400.PMC4210064.pdf
4 July 2014 407CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Combination of DPP-4 inhibitor & glinide,Non-OADS,/arxiv_data1/oa_pdf/87/62/jdi-5-400.PMC4210064.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/87/62/jdi-5-400.PMC4210064.pdf
4 July 2014 409CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Combination of DPP-4 inhibitor & glinide,Non-OADS,/arxiv_data1/oa_pdf/87/62/jdi-5-400.PMC4210064.pdf
4 July 2014 363ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Attenuation of diabetic cardiomyopathy,Non-OADS,/arxiv_data1/oa_pdf/c0/30/jdi-5-362.PMC4210065.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c0/30/jdi-5-362.PMC4210065.pdf
4 July 2014 365ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Attenuation of diabetic cardiomyopathy,Non-OADS,/arxiv_data1/oa_pdf/c0/30/jdi-5-362.PMC4210065.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c0/30/jdi-5-362.PMC4210065.pdf
4 July 2014 367ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Attenuation of diabetic cardiomyopathy,Non-OADS,/arxiv_data1/oa_pdf/c0/30/jdi-5-362.PMC4210065.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c0/30/jdi-5-362.PMC4210065.pdf
4 July 2014 369ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Attenuation of diabetic cardiomyopathy,Non-OADS,/arxiv_data1/oa_pdf/c0/30/jdi-5-362.PMC4210065.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c0/30/jdi-5-362.PMC4210065.pdf
4 July 2014 371ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Attenuation of diabetic cardiomyopathy,Non-OADS,/arxiv_data1/oa_pdf/c0/30/jdi-5-362.PMC4210065.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/d2/e8/jdi-5-435.PMC4210066.pdf
4 July 2014 437ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Liraglutide and renal impairment,Non-OADS,/arxiv_data1/oa_pdf/d2/e8/jdi-5-435.PMC4210066.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/d2/e8/jdi-5-435.PMC4210066.pdf
4 July 2014 439ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Liraglutide and renal impairment,Non-OADS,/arxiv_data1/oa_pdf/d2/e8/jdi-5-435.PMC4210066.pdf
Available from: http://pi.lilly.com/us/byetta-pi.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d2/e8/jdi-5-435.PMC4210066.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/d2/e8/jdi-5-435.PMC4210066.pdf
4 July 2014 441ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Liraglutide and renal impairment,Non-OADS,/arxiv_data1/oa_pdf/d2/e8/jdi-5-435.PMC4210066.pdf
4 July 2014 419ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Physical activity and dietary intake,Non-OADS,/arxiv_data1/oa_pdf/6b/72/jdi-5-418.PMC4210067.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/6b/72/jdi-5-418.PMC4210067.pdf
4 July 2014 421ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Physical activity and dietary intake,Non-OADS,/arxiv_data1/oa_pdf/6b/72/jdi-5-418.PMC4210067.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/6b/72/jdi-5-418.PMC4210067.pdf
4 July 2014 423ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Physical activity and dietary intake,Non-OADS,/arxiv_data1/oa_pdf/6b/72/jdi-5-418.PMC4210067.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/6b/72/jdi-5-418.PMC4210067.pdf
http://www.cdc.gov/diabetes/statistics/prev/ national/figbyage.htm.,Non-OADS,/arxiv_data1/oa_pdf/6b/72/jdi-5-418.PMC4210067.pdf
4 July 2014 425ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Physical activity and dietary intake,Non-OADS,/arxiv_data1/oa_pdf/6b/72/jdi-5-418.PMC4210067.pdf
http://www.health.gov/paguidelin es/guidelines/default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/6b/72/jdi-5-418.PMC4210067.pdf
http://www.who.int/ dietphysicalactivity/pa/en/i ndex.html.,Non-OADS,/arxiv_data1/oa_pdf/6b/72/jdi-5-418.PMC4210067.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/6b/72/jdi-5-418.PMC4210067.pdf
4 July 2014 427ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Physical activity and dietary intake,Non-OADS,/arxiv_data1/oa_pdf/6b/72/jdi-5-418.PMC4210067.pdf
4 July 2014 443SHORT REPORT http://onlinelibrary.wiley.com/journal/jdi Basal insulin dose of youth with T1DM,Non-OADS,/arxiv_data1/oa_pdf/2e/d5/jdi-5-442.PMC4210068.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/2e/d5/jdi-5-442.PMC4210068.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/da/7b/jdi-5-449.PMC4210069.pdf
4 July 2014 451ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi CV risks and SVI in FDR of diabetics,Non-OADS,/arxiv_data1/oa_pdf/da/7b/jdi-5-449.PMC4210069.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/da/7b/jdi-5-449.PMC4210069.pdf
4 July 2014 453ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi CV risks and SVI in FDR of diabetics,Non-OADS,/arxiv_data1/oa_pdf/da/7b/jdi-5-449.PMC4210069.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/da/7b/jdi-5-449.PMC4210069.pdf
4 July 2014 455ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi CV risks and SVI in FDR of diabetics,Non-OADS,/arxiv_data1/oa_pdf/da/7b/jdi-5-449.PMC4210069.pdf
4 July 2014 383CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Ipragli ﬂozin in Japanese T2DM patients,Non-OADS,/arxiv_data1/oa_pdf/cd/44/jdi-5-382.PMC4210070.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/cd/44/jdi-5-382.PMC4210070.pdf
4 July 2014 385CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Ipragli ﬂozin in Japanese T2DM patients,Non-OADS,/arxiv_data1/oa_pdf/cd/44/jdi-5-382.PMC4210070.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/cd/44/jdi-5-382.PMC4210070.pdf
4 July 2014 387CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Ipragli ﬂozin in Japanese T2DM patients,Non-OADS,/arxiv_data1/oa_pdf/cd/44/jdi-5-382.PMC4210070.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/cd/44/jdi-5-382.PMC4210070.pdf
4 July 2014 389CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Ipragli ﬂozin in Japanese T2DM patients,Non-OADS,/arxiv_data1/oa_pdf/cd/44/jdi-5-382.PMC4210070.pdf
http://www.mhlw.go.jp/houdou/2008/12/h1225-5a.html (Japanese).,Non-OADS,/arxiv_data1/oa_pdf/cd/44/jdi-5-382.PMC4210070.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/cd/44/jdi-5-382.PMC4210070.pdf
4 July 2014 391CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Ipragli ﬂozin in Japanese T2DM patients,Non-OADS,/arxiv_data1/oa_pdf/cd/44/jdi-5-382.PMC4210070.pdf
4 July 2014 411ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Novel model improves glycemic control,Non-OADS,/arxiv_data1/oa_pdf/2b/ef/jdi-5-410.PMC4210071.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/2b/ef/jdi-5-410.PMC4210071.pdf
4 July 2014 413ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Novel model improves glycemic control,Non-OADS,/arxiv_data1/oa_pdf/2b/ef/jdi-5-410.PMC4210071.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/2b/ef/jdi-5-410.PMC4210071.pdf
4 July 2014 415ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Novel model improves glycemic control,Non-OADS,/arxiv_data1/oa_pdf/2b/ef/jdi-5-410.PMC4210071.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/2b/ef/jdi-5-410.PMC4210071.pdf
4 July 2014 417ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Novel model improves glycemic control,Non-OADS,/arxiv_data1/oa_pdf/2b/ef/jdi-5-410.PMC4210071.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdEDITORIAL Shigeto and Kaku http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/bb/d7/jdi-5-347.PMC4210072.pdf
"4 July 2014 465ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Albuminuria, risk factors, cardiovascular",Non-OADS,/arxiv_data1/oa_pdf/26/2f/jdi-5-464.PMC4210073.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/26/2f/jdi-5-464.PMC4210073.pdf
"4 July 2014 467ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Albuminuria, risk factors, cardiovascular",Non-OADS,/arxiv_data1/oa_pdf/26/2f/jdi-5-464.PMC4210073.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/26/2f/jdi-5-464.PMC4210073.pdf
"4 July 2014 469ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Albuminuria, risk factors, cardiovascular",Non-OADS,/arxiv_data1/oa_pdf/26/2f/jdi-5-464.PMC4210073.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/26/2f/jdi-5-464.PMC4210073.pdf
"4 July 2014 471ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Albuminuria, risk factors, cardiovascular",Non-OADS,/arxiv_data1/oa_pdf/26/2f/jdi-5-464.PMC4210073.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/2c/07/jdi-5-445.PMC4210074.pdf
4 July 2014 447SHORT REPORT http://onlinelibrary.wiley.com/journal/jdi Glycemic control and sitagliptin plus SU,Non-OADS,/arxiv_data1/oa_pdf/2c/07/jdi-5-445.PMC4210074.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/2c/07/jdi-5-445.PMC4210074.pdf
4 July 2014 373ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Shear and AGEs alter EC function,Non-OADS,/arxiv_data1/oa_pdf/a8/df/jdi-5-372.PMC4210075.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a8/df/jdi-5-372.PMC4210075.pdf
4 July 2014 375ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Shear and AGEs alter EC function,Non-OADS,/arxiv_data1/oa_pdf/a8/df/jdi-5-372.PMC4210075.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a8/df/jdi-5-372.PMC4210075.pdf
4 July 2014 377ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Shear and AGEs alter EC function,Non-OADS,/arxiv_data1/oa_pdf/a8/df/jdi-5-372.PMC4210075.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a8/df/jdi-5-372.PMC4210075.pdf
4 July 2014 379ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Shear and AGEs alter EC function,Non-OADS,/arxiv_data1/oa_pdf/a8/df/jdi-5-372.PMC4210075.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a8/df/jdi-5-372.PMC4210075.pdf
4 July 2014 381ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Shear and AGEs alter EC function,Non-OADS,/arxiv_data1/oa_pdf/a8/df/jdi-5-372.PMC4210075.pdf
4 July 2014 393CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi SBG in diabetic foot ulcers,Non-OADS,/arxiv_data1/oa_pdf/23/a3/jdi-5-392.PMC4210076.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/23/a3/jdi-5-392.PMC4210076.pdf
4 July 2014 395CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi SBG in diabetic foot ulcers,Non-OADS,/arxiv_data1/oa_pdf/23/a3/jdi-5-392.PMC4210076.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/23/a3/jdi-5-392.PMC4210076.pdf
4 July 2014 397CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi SBG in diabetic foot ulcers,Non-OADS,/arxiv_data1/oa_pdf/23/a3/jdi-5-392.PMC4210076.pdf
Available at: http://www.regranex.com/REGRANEX_DHP_Letter.pdf 2008.,Non-OADS,/arxiv_data1/oa_pdf/23/a3/jdi-5-392.PMC4210076.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/23/a3/jdi-5-392.PMC4210076.pdf
4 July 2014 399CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi SBG in diabetic foot ulcers,Non-OADS,/arxiv_data1/oa_pdf/23/a3/jdi-5-392.PMC4210076.pdf
Journal of Diabetes Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Skovsø http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a8/b9/jdi-5-349.PMC4210077.pdf
4 July 2014 351REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Modeling diabetes in HFD/STZ rats,Non-OADS,/arxiv_data1/oa_pdf/a8/b9/jdi-5-349.PMC4210077.pdf
Journal of Diabetes Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Skovsø http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a8/b9/jdi-5-349.PMC4210077.pdf
4 July 2014 353REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Modeling diabetes in HFD/STZ rats,Non-OADS,/arxiv_data1/oa_pdf/a8/b9/jdi-5-349.PMC4210077.pdf
Journal of Diabetes Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Skovsø http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a8/b9/jdi-5-349.PMC4210077.pdf
4 July 2014 355REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Modeling diabetes in HFD/STZ rats,Non-OADS,/arxiv_data1/oa_pdf/a8/b9/jdi-5-349.PMC4210077.pdf
Journal of Diabetes Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Skovsø http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a8/b9/jdi-5-349.PMC4210077.pdf
4 July 2014 357REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Modeling diabetes in HFD/STZ rats,Non-OADS,/arxiv_data1/oa_pdf/a8/b9/jdi-5-349.PMC4210077.pdf
Journal of Diabetes Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Skovsø http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a8/b9/jdi-5-349.PMC4210077.pdf
All primary data associated with this manu-script can be found at http://odr.stowers.org/websimr/datasetview/632/0/.,OADS,/arxiv_data1/oa_pdf/48/c3/embr0015-0609.PMC4210108.pdf
"Supplementary information for this article is available online: http://embor.embopress.org Acknowledgments We thank Sue Jaspersen and Jingjing Chen for assistance and helpful sugges-tions, Ivan Liachko for advice on the analysis of genome-wide replication data,A.",Non-OADS,/arxiv_data1/oa_pdf/48/c3/embr0015-0609.PMC4210108.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJuly 2014 |  89  | e51226 | Page 1 of 7Video Article Using Informational Connectivity to Measure the Synchronous Emergence of fMRI Multi-voxel Information Across Time Marc N. Coutanche1, Sharon L. Thompson-Schill1 1Department of Psychology, University of Pennsylvania Correspondence to: Marc N. Coutanche at coumarc@psych.upenn.edu URL: http://www.jove.com/video/51226 DOI: doi:10.3791/51226 Keywords: Neuroscience, Issue 89, fMRI, MVPA, connectivity, informational connectivity, functional connectivity, networks, multi-voxel pattern analysis, decoding, classification, method, multivariate Date Published: 7/1/2014 Citation: Coutanche, M.N., Thompson-Schill, S.L.",Non-OADS,/arxiv_data1/oa_pdf/e0/9c/jove-89-51226.PMC4210113.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51226/ Introduction The goal of the analysis method described here is to measure connectivity between brain regions based on fluctuations in their multi-voxel information.,Non-OADS,/arxiv_data1/oa_pdf/e0/9c/jove-89-51226.PMC4210113.pdf
http://creativecommons.org/licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/b1/d5/mpa-43-350.PMC4210173.pdf
"Available : http://www.nccn.org.Accessed April 1, 2012.",Non-OADS,/arxiv_data1/oa_pdf/b1/d5/mpa-43-350.PMC4210173.pdf
"Available:http://pancreasclub.com/wp-content /uploads/2012finalprogram.pdf#.Accessed October 1, 2012.Kobayashi et al Pancreas &Volume 43, Number 3, April 2014 360 www.pancreasjournal.com *2014 Lippincott Williams & Wilkins Copyright © 2014 Lippincott Williams & Wilkins.",Non-OADS,/arxiv_data1/oa_pdf/b1/d5/mpa-43-350.PMC4210173.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://dx.doi.org/10.11613/BM.2014.033 Biochemia Medica 2014;24(3):311-20    311Lessons in biostatistics The pits and falls of graphical presentation Sandro Sperandei Institute of Scientific and Technological Communication & Information in Health, Oswaldo Cruz Foundation (FIOCRUZ),  Rio de Janeiro, Brazil Corresponding author: ssperandei@gmail.com Received: June 18, 2014 Accepted: August 25, 2014Abstract Graphics are powerful tools to communicate research results and to gain information from data.",Non-OADS,/arxiv_data1/oa_pdf/cc/9c/biomed-24-3-311.PMC4210251.pdf
"Biochemia Medica 2014;24(3):311–20  http://dx.doi.org/10.11613/BM.2014.033  312Sperandei S. The pits and falls of graphical presentation as simple text, do it.",Non-OADS,/arxiv_data1/oa_pdf/cc/9c/biomed-24-3-311.PMC4210251.pdf
http://dx.doi.org/10.11613/BM.2014.033 Biochemia Medica 2014;24(3):311–20    313Sperandei S. The pits and falls of graphical presentation show more ideas in the shortest time with the least  ink (5) .,Non-OADS,/arxiv_data1/oa_pdf/cc/9c/biomed-24-3-311.PMC4210251.pdf
"Biochemia Medica 2014;24(3):311–20  http://dx.doi.org/10.11613/BM.2014.033  314Sperandei S. The pits and falls of graphical presentation Of course, this kind of plots can only work under  especial conditions that include the already cited small sample size and a reasonable uniform dis - persion of data.",Non-OADS,/arxiv_data1/oa_pdf/cc/9c/biomed-24-3-311.PMC4210251.pdf
http://dx.doi.org/10.11613/BM.2014.033 Biochemia Medica 2014;24(3):311–20    315Sperandei S. The pits and falls of graphical presentation Another way to represent data distribution is us - ing box plot or strip plot.,Non-OADS,/arxiv_data1/oa_pdf/cc/9c/biomed-24-3-311.PMC4210251.pdf
"Biochemia Medica 2014;24(3):311–20  http://dx.doi.org/10.11613/BM.2014.033  316Sperandei S. The pits and falls of graphical presentation cult to distinguish even the categories themselves,  especially when the use of colours are not allowed.",Non-OADS,/arxiv_data1/oa_pdf/cc/9c/biomed-24-3-311.PMC4210251.pdf
http://dx.doi.org/10.11613/BM.2014.033 Biochemia Medica 2014;24(3):311–20    317Sperandei S. The pits and falls of graphical presentation It is now clear that describing the statistics related  to the model is not enough.,Non-OADS,/arxiv_data1/oa_pdf/cc/9c/biomed-24-3-311.PMC4210251.pdf
"Biochemia Medica 2014;24(3):311–20  http://dx.doi.org/10.11613/BM.2014.033  318Sperandei S. The pits and falls of graphical presentation Although Figure 12 presents only year 2010 data,  original available data begins at 1810.",OADS,/arxiv_data1/oa_pdf/cc/9c/biomed-24-3-311.PMC4210251.pdf
http://dx.doi.org/10.11613/BM.2014.033 Biochemia Medica 2014;24(3):311–20    319Sperandei S. The pits and falls of graphical presentation bar is centered with neutral category (“no opin - ion”) equally divided between “positive” and “neg - ative” sides.,Non-OADS,/arxiv_data1/oa_pdf/cc/9c/biomed-24-3-311.PMC4210251.pdf
Biochemia Medica 2014;24(3):311–20  http://dx.doi.org/10.11613/BM.2014.033  320Sperandei S. The pits and falls of graphical presentation References  1.,Non-OADS,/arxiv_data1/oa_pdf/cc/9c/biomed-24-3-311.PMC4210251.pdf
http://dx.doi.org/10.1146/annurev.psych.52.1.305.,Non-OADS,/arxiv_data1/oa_pdf/cc/9c/biomed-24-3-311.PMC4210251.pdf
http://dx.doi.org/10.1056/NEJM199310143291613.,Non-OADS,/arxiv_data1/oa_pdf/cc/9c/biomed-24-3-311.PMC4210251.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cc/9c/biomed-24-3-311.PMC4210251.pdf
http://dx.doi.org/10.1249/ MSS.0b013e31821ece12.,Non-OADS,/arxiv_data1/oa_pdf/cc/9c/biomed-24-3-311.PMC4210251.pdf
http://dx.doi.org/10.1002/jso.23283.10.,OADS,/arxiv_data1/oa_pdf/cc/9c/biomed-24-3-311.PMC4210251.pdf
Available at: http://www.ted.,Non-OADS,/arxiv_data1/oa_pdf/cc/9c/biomed-24-3-311.PMC4210251.pdf
Available at: http://www.gapminder.org/.,Non-OADS,/arxiv_data1/oa_pdf/cc/9c/biomed-24-3-311.PMC4210251.pdf
http://dx.doi.org/10.1001/ jama.1984.03350040021015.,OADS,/arxiv_data1/oa_pdf/cc/9c/biomed-24-3-311.PMC4210251.pdf
Available at: http://www.touchgraph.com/facebook.,Non-OADS,/arxiv_data1/oa_pdf/cc/9c/biomed-24-3-311.PMC4210251.pdf
Available at: http://www2.datasus.gov.br/DATA - SUS/index.php.,OADS,/arxiv_data1/oa_pdf/cc/9c/biomed-24-3-311.PMC4210251.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://dx.doi.org/10.11613/BM.2014.034 Biochemia Medica 2014;24(3):321–8    321Abstract Peer review is widely used system for evaluating manuscripts prior to publication.",Non-OADS,/arxiv_data1/oa_pdf/42/f1/biomed-24-3-321.PMC4210252.pdf
"Biochemia Medica 2014;24(3):321–8  http://dx.doi.org/10.11613/BM.2014.034  322Šupak Smolčić V, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/42/f1/biomed-24-3-321.PMC4210252.pdf
"http://dx.doi.org/10.11613/BM.2014.034 Biochemia Medica 2014;24(3):321–8    323Šupak Smolčić V, Šimundić AM.",OADS,/arxiv_data1/oa_pdf/42/f1/biomed-24-3-321.PMC4210252.pdf
"Biochemia Medica 2014;24(3):321–8  http://dx.doi.org/10.11613/BM.2014.034  324Šupak Smolčić V, Šimundić AM.",OADS,/arxiv_data1/oa_pdf/42/f1/biomed-24-3-321.PMC4210252.pdf
Do the authors follow the recommended reporting guidelines for their type of study (available at http://www.equator-network.org/)?2.,Non-OADS,/arxiv_data1/oa_pdf/42/f1/biomed-24-3-321.PMC4210252.pdf
"http://dx.doi.org/10.11613/BM.2014.034 Biochemia Medica 2014;24(3):321–8    325Šupak Smolčić V, Šimundić AM.",OADS,/arxiv_data1/oa_pdf/42/f1/biomed-24-3-321.PMC4210252.pdf
"Biochemia Medica 2014;24(3):321–8  http://dx.doi.org/10.11613/BM.2014.034  326Šupak Smolčić V, Šimundić AM.",OADS,/arxiv_data1/oa_pdf/42/f1/biomed-24-3-321.PMC4210252.pdf
"http://dx.doi.org/10.11613/BM.2014.034 Biochemia Medica 2014;24(3):321–8    327Šupak Smolčić V, Šimundić AM.",OADS,/arxiv_data1/oa_pdf/42/f1/biomed-24-3-321.PMC4210252.pdf
JAMA 1990;263:1323-9. http://dx.doi.org/10.1001/jama.,Non-OADS,/arxiv_data1/oa_pdf/42/f1/biomed-24-3-321.PMC4210252.pdf
Croat Med J 2012;53:386-9. http://dx.doi.org/10.3325/cmj.2012.53.386.,OADS,/arxiv_data1/oa_pdf/42/f1/biomed-24-3-321.PMC4210252.pdf
Adv Physiol Educ 2007;31:145-52. http://dx.doi.org/10.1152/ advan.00104.2006.,Non-OADS,/arxiv_data1/oa_pdf/42/f1/biomed-24-3-321.PMC4210252.pdf
Science 2013; 342:60-5. http://dx.doi.org/10.1126/science.342.,Non-OADS,/arxiv_data1/oa_pdf/42/f1/biomed-24-3-321.PMC4210252.pdf
http://dx.doi.org/10.1136/ bmj.d2858.6.,Non-OADS,/arxiv_data1/oa_pdf/42/f1/biomed-24-3-321.PMC4210252.pdf
http://dx.doi.org/10.1136/ bmj.d3046.,Non-OADS,/arxiv_data1/oa_pdf/42/f1/biomed-24-3-321.PMC4210252.pdf
Available at: http://www.councils - cienceeditors.org/resource-library/editorial-policies/white-paper-on-publication-ethics/.,Non-OADS,/arxiv_data1/oa_pdf/42/f1/biomed-24-3-321.PMC4210252.pdf
"Biochemia Medica 2014;24(3):321–8  http://dx.doi.org/10.11613/BM.2014.034  328Šupak Smolčić V, Šimundić AM.",OADS,/arxiv_data1/oa_pdf/42/f1/biomed-24-3-321.PMC4210252.pdf
Available at: http://www.icmje.org/recom-mendations/.,Non-OADS,/arxiv_data1/oa_pdf/42/f1/biomed-24-3-321.PMC4210252.pdf
Oto - laryngol Head Neck Surg 2010;142:472-86. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/42/f1/biomed-24-3-321.PMC4210252.pdf
http://dx.doi.org/10.1371/ journal.pone.0035621.15.,Non-OADS,/arxiv_data1/oa_pdf/42/f1/biomed-24-3-321.PMC4210252.pdf
J Negat Results Biomed 2014;13:1-2. http://dx.doi.org/10.1186/1477-5751-13-1.,OADS,/arxiv_data1/oa_pdf/42/f1/biomed-24-3-321.PMC4210252.pdf
Biochem Med 2013;23:5-6. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/42/f1/biomed-24-3-321.PMC4210252.pdf
Biochem Med 2012;22:271. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/42/f1/biomed-24-3-321.PMC4210252.pdf
Biochem Med 2013;23:139-40. http://dx.doi.org/10.11613/BM.2013.016.,Non-OADS,/arxiv_data1/oa_pdf/42/f1/biomed-24-3-321.PMC4210252.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://dx.doi.org/10.11613/BM.2014.035 Biochemia Medica 2014;24(3):329–42    329Abstract Estrogens have long been known as important regulators of the female reproductive functions; however, our understanding of the role estrogens  play in the human body has changed significantly over the past years.",Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Biochemia Medica 2014;24(3):329–42  http://dx.doi.org/10.11613/BM.2014.035  330Vrtacnik P .,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
http://dx.doi.org/10.11613/BM.2014.035 Biochemia Medica 2014;24(3):329–42    331Vrtacnik P .,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Biochemia Medica 2014;24(3):329–42  http://dx.doi.org/10.11613/BM.2014.035  332Vrtacnik P .,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
http://dx.doi.org/10.11613/BM.2014.035 Biochemia Medica 2014;24(3):329–42    333Vrtacnik P .,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Biochemia Medica 2014;24(3):329–42  http://dx.doi.org/10.11613/BM.2014.035  334Vrtacnik P .,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
http://dx.doi.org/10.11613/BM.2014.035 Biochemia Medica 2014;24(3):329–42    335Vrtacnik P .,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Biochemia Medica 2014;24(3):329–42  http://dx.doi.org/10.11613/BM.2014.035  336Vrtacnik P .,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
http://dx.doi.org/10.11613/BM.2014.035 Biochemia Medica 2014;24(3):329–42    337Vrtacnik P .,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Biochemia Medica 2014;24(3):329–42  http://dx.doi.org/10.11613/BM.2014.035  338Vrtacnik P .,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
http://dx.doi.org/10.11613/BM.2014.035 Biochemia Medica 2014;24(3):329–42    339Vrtacnik P .,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Clin Pharmacol Ther 2011;89:44- 55. http://dx.doi.org/10.1038/clpt.2010.226.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Clin Chem Lab Med 2007;45:321-7. http://dx.doi.org/10.1515/CCLM.2007.081.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
J  Steroid Biochem Mol Biol 2003;86:225-30. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Steroids 1998;63:319-21. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
J Steroid Biochem Mol Biol 1999;69:293-7. http://dx.doi.org/10.1016/S0960-0760- (99)00048-5.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Dis Markers 2000;16:151-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
http://dx.doi.org/10.1016/0303-7207(91)90116-A.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
http://dx.doi.org/10.1371/journal.po - ne.0061758.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Endocrinology 2012;153:2953-62. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Endocrino - logy 2007;148:3236-45. http://dx.doi.org/10.1210/en.2006-1605.17.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Mol Pharmacol 2011;79:400- 10. http://dx.doi.org/10.1124/mol.110.069500.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Mol Endocrinol 2005;19:833-42. http://dx.doi.org/10.1210/me.2004-0486.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
He - redity (Edinb) 2010;105:4-13. http://dx.doi.org/10.1038/ hdy.2010.54.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Nat Biotechnol 2010;28:1057-68. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Trends Endocri- nol Metab 2012;23:223-33. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Biochemistry 2011;50:313-28. http://dx.doi.org/10.1021/bi101762x.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Int J Cancer 2003;107:353-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Clin Cancer Res 2009;15:3672-9. http://dx.doi.org/10.1158/1078-0432.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Cancer Res 2011;71:6654-64. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Car - cinogenesis 2010;31:382-7. http://dx.doi.org/10.1093/car - cin/bgp308.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Biochemia Medica 2014;24(3):329–42  http://dx.doi.org/10.11613/BM.2014.035  340Vrtacnik P .,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Cancer Res 2004;64:8184-92. http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Prostate 2008;68:210-22. http://dx.doi.org/10.1002/pros.20673.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Mol Cell Bio - chem 2012;366:111-22. http://dx.doi.org/10.1007/s11010- 012-1288-9.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Cancer Lett 2013;337:167-76. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Horm Behav 2012;62:128-35. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Mol Endocrinol 2007;21:1132-47. http://dx.doi.org/10.1210/ me.2007-0022.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
J Biol Chem 2008;283:31079-86. http://dx.doi.org/10.1074/ jbc.M806041200.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Gastroenterology 2009;136:683-93. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Oncogene 2009;28:3926-36.  http://dx.doi.org/10.1038/onc.2009.241.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Mol Cell Biol 2009;29:3783-90. http://dx.doi.org/10.1128/ MCB.01875-08.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Proc Natl Acad Sci U S A 2010;107:1553-8. http://dx.doi.org/10.1073/ pnas.0913517107.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Breast Cancer Res Treat 2011;127:69-80. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Acta Biochim Biophys Sin (Shanghai) 2011;43:640-6. http://dx.doi.org/10.1093/ abbs/gmr051.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Cancer Res  2010;70:4778-84. http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
J Natl Cancer Inst 2002;94:384-90. http://dx.doi.org/10.1093/ jnci/94.5.384.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Am J Pathol 2004;164:2003-12. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Cancer Sci 2008;99:2365-72. http://dx.doi.org/10.1111/ j.1349-7006.2008.00988.x.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Tumour Biol 2012;33:413-20. http://dx.doi.org/10.1007/s13277-011-0234-x.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
En-docrinology 2008;149:1687-96. http://dx.doi.org/10.1210/ en.2007-0969.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
http://dx.doi.org/10.11613/BM.2014.035 Biochemia Medica 2014;24(3):329–42    341Vrtacnik P .,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Bi-ogerontology 2009;10:747-55. http://dx.doi.org/10.1007/ s10522-009-9221-7.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Oncogene 2005;24:4531-9. http://dx.doi.org/10.1038/sj.onc.1208646.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Nucleic Acids Res 2009;37:2584-95. http://dx.doi.org/10.1093/nar/gkp117.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
J Biol Chem 2012;287:41514-22. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Hum Mol Genet 2014;23:355-67. http://dx.doi.org/10.1093/hmg/ddt426.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Can-cer Res 2009;69:8332-40. http://dx.doi.org/10.1158/0008- 5472.CAN-09-2206.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Carcinogenesis 2013;34:1431-41. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
J Clin Invest 2012;122:3541-51. http://dx.doi.org/10.1172/JCI64151.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
J Huazhong Univ Sci Technolog Med Sci 2010;30:69-74. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
FEBS Lett 2007;581:1441-8. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Mol Biol Rep 2009;36:2201-7. http://dx.doi.org/10.1007/s11033-008-9435-9.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Hum Reprod 2009;24:1126-32. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Mol Hum Reprod  2013;19:302-12. http://dx.doi.org/10.1093/molehr/gas062.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Histochem Cell Biol 2012;137:249-59. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Nucleic Acids Res 2013;41:8094-106. http://dx.doi.org/10.1093/nar/gkt595.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Can-cer Res 2008;68:1786-96. http://dx.doi.org/10.1158/0008- 5472.CAN-07-5547.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Cancer Res 2006;66:5624-32. http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Trends Endocri-nol Metab 2009;20:409-16. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Biochemia Medica 2014;24(3):329–42  http://dx.doi.org/10.11613/BM.2014.035  342Vrtacnik P .,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Am J Pathol 2010;176:2113-30. http://dx.doi.org/10.2353/ ajpath.2010.090837.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Horm Cancer  2012;3:65-78. http://dx.doi.org/10.1007/s12672-012-0102-1.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
http://dx.doi.org/10.1186/bcr3059.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
BMC Cancer 2012;12:29. http://dx.doi.org/10.1186/1471-2407-12-29.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Mol Cell 2009;36:340-7. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
J Natl Can-cer Inst 2010;102:706-21. http://dx.doi.org/10.1093/jnci/ djq102.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Cancer Res 2011;71:6463-74. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Horm Cancer 2013;4:78-91. http://dx.doi.org/10.1007/s12672-012-0129-3.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Carcinoge - nesis 2013;34:1889-99. http://dx.doi.org/10.1093/carcin/ bgt107.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Exp  Mol Med 2012;44:723-32. http://dx.doi.org/10.3858/ emm.2012.44.12.079.89.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Int J Cardiol 2013;169:331-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Reprod Sci 2010;17:987-94. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Blood 2008;112:4591-7. http://dx.doi.org/10.1182/blood- 2008-04-152488.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
http://dx.doi.org/10.1371/journal.pone.0090810.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Nucleic Acids Res 2009;37:4850-61. http://dx.doi.org/10.1093/nar/ gkp500.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Mol Cell Biochem 2013;379:201-11. http://dx.doi.org/10.1007/s11010-013-1642-6.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
http://dx.doi.org/10.1371/journal.po - ne.0013798.,Non-OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
Horm Can- cer 2010;1:306-19. http://dx.doi.org/10.1007/s12672-010- 0043-5.,OADS,/arxiv_data1/oa_pdf/9c/a6/biomed-24-3-329.PMC4210253.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://dx.doi.org/10.11613/BM.2014.036 Biochemia Medica 2014;24(3):343–9    343Abstract Background : Presently the necessity of fasting time for coagulation tests is not standardized.",Non-OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
Biochemia Medica 2014;24(3):343–9  http://dx.doi.org/10.11613/BM.2014.036  344Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
http://dx.doi.org/10.11613/BM.2014.036 Biochemia Medica 2014;24(3):343–9    345Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
Biochemia Medica 2014;24(3):343–9  http://dx.doi.org/10.11613/BM.2014.036  346Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
http://dx.doi.org/10.11613/BM.2014.036 Biochemia Medica 2014;24(3):343–9    347Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
Biochemia Medica 2014;24(3):343–9  http://dx.doi.org/10.11613/BM.2014.036  348Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
Clin Chem Lab Med 2006;44:358-65. http://dx.doi.org/10.1515/ CCLM.2006.073.,OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
Clin Biochem 2013;46:1175-9. http://dx.doi.org/10.1016/j.clinbiochem.2013.06.001.,OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
Biochem Med 2013;23:242-54. http://dx.doi.org/10.11613/ BM.2013.031.,OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
Clin Chem Lab Med 2007;45:2- 12. http://dx.doi.org/10.1515/CCLM.2007.006.,OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
Clin Chim Acta 2014;432:33-7. http://dx.doi.org/10.1016/j.cca.2013.11.008.,OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
http://dx.doi.org/10.11613/BM.2014.036 Biochemia Medica 2014;24(3):343–9    349Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
Ann Lab Med 2012;32:250-6. http://dx.doi.org/10.3343/ alm.2012.32.4.250.,OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
Biochem Med 2013;23:308-15. http://dx.doi.org/10.11613/BM.2013.037.,OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
Clin Chim Acta 2011;412:1482-4. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
Biochem Med 2012;22:15-23. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
2014; Available at: http://www.westgard.com/bi-odatabase1.htm.,Non-OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
Scand J Clin Lab Invest 1999;59:491-500. http://dx.doi.org/10.1080/00365519950185229.,Non-OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
Scand J Clin Lab Invest 2004;64:175-84. http://dx.doi.org/10.1080/00365510410004885.,OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
Clin Chim Acta 2013;426:33-40. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
Biochem Med 2012;22:342-51. http://dx.doi.org/10.11613/BM.2012.036.,Non-OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
Biochem Med 2013;23:218-23. http://dx.doi.org/10.11613/ BM.2013.026.,OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
Semin Thromb He - most 2012;38:565-75. http://dx.doi.org/10.1055/s-0032- 1315961.,Non-OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
Clin Chem Lab Med 2013;51:2281-5. http://dx.doi.org/10.1515/cclm- 2013-0412.,OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
Clin Chem Lab Med  2011;49:2061-3. http://dx.doi.org/10.1515/CCLM.2011.705.,OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
Biopreserv Biobank 2014;12:53-9. http://dx.doi.org/10.1089/bio.2013.0043.,Non-OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
Clin Biochem 2013;46:250-4. http://dx.doi.org/10.1016/j.clinbiochem.,OADS,/arxiv_data1/oa_pdf/40/24/biomed-24-3-343.PMC4210254.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Biochemia Medica 2014;24(3):350–8  http://dx.doi.org/10.11613/BM.2014.037  350Abstract Introduction : Capillary sampling is increasingly used to obtain blood for laboratory tests in volumes as small as necessary and as non-invasively as  possible.",Non-OADS,/arxiv_data1/oa_pdf/01/37/biomed-24-3-350.PMC4210255.pdf
http://dx.doi.org/10.11613/BM.2014.037 Biochemia Medica 2014;24(3):350–8    351Lenicek Krleza J. Croatian survey on capillary blood sampling longitudinal testing using only one sampling type.,Non-OADS,/arxiv_data1/oa_pdf/01/37/biomed-24-3-350.PMC4210255.pdf
"Biochemia Medica 2014;24(3):350–8  http://dx.doi.org/10.11613/BM.2014.037  352Lenicek Krleza J. Croatian survey on capillary blood sampling pling, as well as the existence and source of refer - ence intervals used to interpret test results.",OADS,/arxiv_data1/oa_pdf/01/37/biomed-24-3-350.PMC4210255.pdf
http://dx.doi.org/10.11613/BM.2014.037 Biochemia Medica 2014;24(3):350–8    353Lenicek Krleza J. Croatian survey on capillary blood sampling Questions and possible answers Frequency N (%)* 1 .,OADS,/arxiv_data1/oa_pdf/01/37/biomed-24-3-350.PMC4210255.pdf
"Biochemia Medica 2014;24(3):350–8  http://dx.doi.org/10.11613/BM.2014.037  354Lenicek Krleza J. Croatian survey on capillary blood sampling c) The laboratory does not know how to answer the question, because the sampling is performed by  non-laboratory personnel or is performed outside of the laboratory18 (12) d) The laboratory does not have a written protocol for sampling in multiple containers 34 (22) 8 .",Non-OADS,/arxiv_data1/oa_pdf/01/37/biomed-24-3-350.PMC4210255.pdf
"http://dx.doi.org/10.11613/BM.2014.037 Biochemia Medica 2014;24(3):350–8    355Lenicek Krleza J. Croatian survey on capillary blood sampling Group Description Frequency N (%) 1Patients on chemotherapy, regardless of age, or patients whose veins are being maintained for  long-term intravenous therapy 4 (20) 2Patient populations requiring specific tests:•	in-patients	requiring	blood	gas	analysis,	regardless	of	age•	diabetic	and	pediatric	patients	requiring	blood	glucose	testing•	pediatric	and	oncology	patients	requiring	CBC	and/or	CRP•	patients	requiring	glucose	tolerance	test	(excluding	pregnant	women)11 (55) 4Single responses mentioning the following specific populations or situations: blood donors, elderly patients, point-of care services only, newborns only, at the request of parents only5 (25) * These 20 responses were written in the “Other” field of question 5 of Table 1.CBC - complete blood count; CRP - C-reactive protein.Type of laboratoryFrequency of capillary sampling Routinely N (%)Never N (%)Occasionally  N (%) Clinical hospital center 14 (88) 3 (18) - Clinical hospital 9 (90) 1 (10) - General hospital 12 (75) 2 (13) 2 (12) National hospital 14 (54) 3 (11) 9 (35) Primary health care 37 (67) 6 (11) 12 (22) Private clinic (private  medical practice)7 (47) 3 (20) 5 (33) Private laboratory 24 (69) 1 (3) 10 (28) * Based on question 3 of Table 1.Ta b l e  2.",Non-OADS,/arxiv_data1/oa_pdf/01/37/biomed-24-3-350.PMC4210255.pdf
Biochemia Medica 2014;24(3):350–8  http://dx.doi.org/10.11613/BM.2014.037  356Lenicek Krleza J. Croatian survey on capillary blood sampling sionally as part of their routine practice.,Non-OADS,/arxiv_data1/oa_pdf/01/37/biomed-24-3-350.PMC4210255.pdf
"http://dx.doi.org/10.11613/BM.2014.037 Biochemia Medica 2014;24(3):350–8    357Lenicek Krleza J. Croatian survey on capillary blood sampling (3,8,16,17).",OADS,/arxiv_data1/oa_pdf/01/37/biomed-24-3-350.PMC4210255.pdf
Biochemia Medica 2014;24(3):350–8  http://dx.doi.org/10.11613/BM.2014.037  358Lenicek Krleza J. Croatian survey on capillary blood sampling References  1.,Non-OADS,/arxiv_data1/oa_pdf/01/37/biomed-24-3-350.PMC4210255.pdf
Available at: http://www.aacc.org/SiteCollectionDocuments/NACB/LMPG/POCTLM-PG.pdf#page=1.,Non-OADS,/arxiv_data1/oa_pdf/01/37/biomed-24-3-350.PMC4210255.pdf
Biochem Med 2010;20:200-6. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/01/37/biomed-24-3-350.PMC4210255.pdf
Avai-lable at: http://www.hkmb.hr/povjerenstva/strucna-pita- nja.html#1.,Non-OADS,/arxiv_data1/oa_pdf/01/37/biomed-24-3-350.PMC4210255.pdf
Biochem Med 2013;23:242-54. http://dx.doi.org/10.11613/ BM.2013.031.,OADS,/arxiv_data1/oa_pdf/01/37/biomed-24-3-350.PMC4210255.pdf
Available at: http://www.hkms.hr/ data/1316431477_292_mala_kompetencije_18062011_kompletno.pdf .,OADS,/arxiv_data1/oa_pdf/01/37/biomed-24-3-350.PMC4210255.pdf
Available at: http://www.hkms.hr/data/1316431523_388_mala_stand.postupci-kompletno.pdf .,OADS,/arxiv_data1/oa_pdf/01/37/biomed-24-3-350.PMC4210255.pdf
Ava-ilable at: http://www.mlo-online.com/articles/200811/ca- pillary-blood-gases-to-arterialize-or-not.php .,Non-OADS,/arxiv_data1/oa_pdf/01/37/biomed-24-3-350.PMC4210255.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/01/37/biomed-24-3-350.PMC4210255.pdf
Biochem Med 2014;24:281-92. http://dx.doi.org/10.11613/ BM.2014.031.,OADS,/arxiv_data1/oa_pdf/01/37/biomed-24-3-350.PMC4210255.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://dx.doi.org/10.11613/BM.2014.038 Biochemia Medica 2014;24(3):359–67    359Abstract Int roduction: The contamination of serum or lithium heparin blood with ethylenediaminetetraacetic acid (EDTA) salts may affect accuracy of some  critical analytes and jeopardize patient safety.",Non-OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
Biochemia Medica 2014;24(3):359–67  http://dx.doi.org/10.11613/BM.2014.038  360Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
http://dx.doi.org/10.11613/BM.2014.038 Biochemia Medica 2014;24(3):359–67    361Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
Biochemia Medica 2014;24(3):359–67  http://dx.doi.org/10.11613/BM.2014.038  362Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
http://dx.doi.org/10.11613/BM.2014.038 Biochemia Medica 2014;24(3):359–67    363Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
Biochemia Medica 2014;24(3):359–67  http://dx.doi.org/10.11613/BM.2014.038  364Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
http://dx.doi.org/10.11613/BM.2014.038 Biochemia Medica 2014;24(3):359–67    365Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
Biochemia Medica 2014;24(3):359–67  http://dx.doi.org/10.11613/BM.2014.038  366Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
Clin Chem Lab Med 2007;45:565-76. http://dx.doi.org/10.1515/CCLM.2007.110.,OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
Biochem Med 2013;23:218-23. http://dx.doi.org/10.11613/ BM.2013.026.,OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
J Clin Pa-thol 2011;64:1019-20. http://dx.doi.org/10.1136/jclinpath- 2011-200206.,Non-OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
Clin Chem Lab Med 2013;51:2281-5. http://dx.doi.org/10.1515/cclm- 2013-0412.,OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
http://dx.doi.org/10.1111/ ijlh.12230.,Non-OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
Int J Clin Pract 2009;63:1259-62. http://dx.doi.org/10.1111/j.1742- 1241.2008.01981.x.,Non-OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
Ann Clin Biochem 2002;39:273-80. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
Biochem Med 2013;23:308-15. http://dx.doi.org/10.11613/BM.2013.037.,OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
http://dx.doi.org/10.11613/BM.2014.038 Biochemia Medica 2014;24(3):359–67    367Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
Scand J Clin Lab Invest 1999;59:491-500. http://dx.doi.org/10.1080/00365519950185229.,Non-OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
Biochem Med 2012;22:342-51. http://dx.doi.org/10.11613/BM.2012.036.,Non-OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
J Chem Educ 1958;35:601-6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
Clin  Chem Lab Med 2007;45:728-36. http://dx.doi.org/10.1515/ CCLM.2007.174.,OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
Biochem Med 2013;23:242-54. http://dx.doi.org/10.11613/ BM.2013.031.,OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
Ann Clin Biochem 2011;48:87-8. http://dx.doi.org/10.1258/acb.2010.010200.,OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
http://dx.doi.org/10.1002/dta.1696.,Non-OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
ISRN Hematology 2012;2012:875357. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
Am Heart J 2012;163:7-12. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/92/biomed-24-3-359.PMC4210256.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Biochemia Medica 2014;24(3):368–75  http://dx.doi.org/10.11613/BM.2014.039  368Abstract Introduction : Preanalytical variables account for most of laboratory errors.",Non-OADS,/arxiv_data1/oa_pdf/87/d2/biomed-24-3-368.PMC4210257.pdf
http://dx.doi.org/10.11613/BM.2014.039 Biochemia Medica 2014;24(3):368–75    369Kocijancic M. et al.,OADS,/arxiv_data1/oa_pdf/87/d2/biomed-24-3-368.PMC4210257.pdf
Biochemia Medica 2014;24(3):368–75  http://dx.doi.org/10.11613/BM.2014.039  370Kocijancic M. et al.,OADS,/arxiv_data1/oa_pdf/87/d2/biomed-24-3-368.PMC4210257.pdf
http://dx.doi.org/10.11613/BM.2014.039 Biochemia Medica 2014;24(3):368–75    371Kocijancic M. et al.,OADS,/arxiv_data1/oa_pdf/87/d2/biomed-24-3-368.PMC4210257.pdf
Biochemia Medica 2014;24(3):368–75  http://dx.doi.org/10.11613/BM.2014.039  372Kocijancic M. et al.,OADS,/arxiv_data1/oa_pdf/87/d2/biomed-24-3-368.PMC4210257.pdf
http://dx.doi.org/10.11613/BM.2014.039 Biochemia Medica 2014;24(3):368–75    373Kocijancic M. et al.,OADS,/arxiv_data1/oa_pdf/87/d2/biomed-24-3-368.PMC4210257.pdf
Biochemia Medica 2014;24(3):368–75  http://dx.doi.org/10.11613/BM.2014.039  374Kocijancic M. et al.,OADS,/arxiv_data1/oa_pdf/87/d2/biomed-24-3-368.PMC4210257.pdf
http://dx.doi.org/10.11613/BM.2014.039 Biochemia Medica 2014;24(3):368–75    375Kocijancic M. et al.,OADS,/arxiv_data1/oa_pdf/87/d2/biomed-24-3-368.PMC4210257.pdf
Am J Clin Pathol  2000;113:429-52. http://dx.doi.org/10.1309/C0NM-Q7R0- LL2E-B3UY .,OADS,/arxiv_data1/oa_pdf/87/d2/biomed-24-3-368.PMC4210257.pdf
Biochem Med  2012;22:145-9. http://dx.doi.org/10.11613/BM.2012.017.,Non-OADS,/arxiv_data1/oa_pdf/87/d2/biomed-24-3-368.PMC4210257.pdf
Bi- ochem Med 2014;24:31-44. http://dx.doi.org/10.11613/ BM.2014.006.,Non-OADS,/arxiv_data1/oa_pdf/87/d2/biomed-24-3-368.PMC4210257.pdf
Biochem Med 2013;23:326-31. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/d2/biomed-24-3-368.PMC4210257.pdf
Bi- ochem Med 2012;22:180-6. http://dx.doi.org/10.11613/ BM.2012.021.,Non-OADS,/arxiv_data1/oa_pdf/87/d2/biomed-24-3-368.PMC4210257.pdf
Biochem Med 2013;23:321-5. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/d2/biomed-24-3-368.PMC4210257.pdf
BMC Clin Pathol 2013;13:20. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/d2/biomed-24-3-368.PMC4210257.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/d2/biomed-24-3-368.PMC4210257.pdf
Clin Chem Lab Med 2010;48:651-7. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/d2/biomed-24-3-368.PMC4210257.pdf
Clin Chem Lab Med  2009:47:358-61. http://dx.doi.org/10.1515/CCLM.2009.072.,OADS,/arxiv_data1/oa_pdf/87/d2/biomed-24-3-368.PMC4210257.pdf
Available at: http://www.westgard.com/bi- odatabase1.html/.,Non-OADS,/arxiv_data1/oa_pdf/87/d2/biomed-24-3-368.PMC4210257.pdf
Scand J Clin Lab Invest 1999;59:491-500. http://dx.doi.org/10.1080/00365519950185229.,Non-OADS,/arxiv_data1/oa_pdf/87/d2/biomed-24-3-368.PMC4210257.pdf
Ann Clin Biochem 2014;51:30-7. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/d2/biomed-24-3-368.PMC4210257.pdf
Biopreserv Biobank 2014;12:53-9. http://dx.doi.org/10.1089/bio.2013.0043.,Non-OADS,/arxiv_data1/oa_pdf/87/d2/biomed-24-3-368.PMC4210257.pdf
Clin Chem Lab Med 2011;49:2061-3. http://dx.doi.org/10.1515/CCLM.2011.705.,OADS,/arxiv_data1/oa_pdf/87/d2/biomed-24-3-368.PMC4210257.pdf
Clin Biochem 2013;46;285-8. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/87/d2/biomed-24-3-368.PMC4210257.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Biochemia Medica 2014;24(3):376–82  http://dx.doi.org/10.11613/BM.2014.040  376Abstract Introduction : Preanalytical errors, along the process from the beginning of test requests to the admissions of the specimens to the laboratory,  cause the rejection of samples.",Non-OADS,/arxiv_data1/oa_pdf/05/19/biomed-24-3-376.PMC4210258.pdf
http://dx.doi.org/10.11613/BM.2014.040 Biochemia Medica 2014;24(3):376–82    377Atay A. et al.,OADS,/arxiv_data1/oa_pdf/05/19/biomed-24-3-376.PMC4210258.pdf
Biochemia Medica 2014;24(3):376–82  http://dx.doi.org/10.11613/BM.2014.040  378Atay A. et al.,OADS,/arxiv_data1/oa_pdf/05/19/biomed-24-3-376.PMC4210258.pdf
http://dx.doi.org/10.11613/BM.2014.040 Biochemia Medica 2014;24(3):376–82    379Atay A. et al.,OADS,/arxiv_data1/oa_pdf/05/19/biomed-24-3-376.PMC4210258.pdf
Biochemia Medica 2014;24(3):376–82  http://dx.doi.org/10.11613/BM.2014.040  380Atay A. et al.,OADS,/arxiv_data1/oa_pdf/05/19/biomed-24-3-376.PMC4210258.pdf
http://dx.doi.org/10.11613/BM.2014.040 Biochemia Medica 2014;24(3):376–82    381Atay A. et al.,OADS,/arxiv_data1/oa_pdf/05/19/biomed-24-3-376.PMC4210258.pdf
Biochemia Medica 2014;24(3):376–82  http://dx.doi.org/10.11613/BM.2014.040  382Atay A. et al.,OADS,/arxiv_data1/oa_pdf/05/19/biomed-24-3-376.PMC4210258.pdf
Am J Clin Pathol 2009;131:418-31. http://dx.doi.org/10.1309/AJCPJF8JI4ZLDQUE .,Non-OADS,/arxiv_data1/oa_pdf/05/19/biomed-24-3-376.PMC4210258.pdf
Biochem Med 2014;24:25-30. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/19/biomed-24-3-376.PMC4210258.pdf
Clin Chem 2012;58:638-42. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/19/biomed-24-3-376.PMC4210258.pdf
Bi-ochem Med 2011;21:79-85. http://dx.doi.org/10.11613/ BM.2011.015.,Non-OADS,/arxiv_data1/oa_pdf/05/19/biomed-24-3-376.PMC4210258.pdf
Biochem Med 2014;24:57-67. http://dx.doi.org/10.11613/BM.2014.008.,OADS,/arxiv_data1/oa_pdf/05/19/biomed-24-3-376.PMC4210258.pdf
Bi- ochem Med 2014;24:31-44. http://dx.doi.org/10.11613/ BM.2014.006.,Non-OADS,/arxiv_data1/oa_pdf/05/19/biomed-24-3-376.PMC4210258.pdf
Clin Chem 2007;53:1338-42. http://dx.doi.org/10.1373/clinchem.2007.088344.12.,Non-OADS,/arxiv_data1/oa_pdf/05/19/biomed-24-3-376.PMC4210258.pdf
Clin Chem Lab Med 2004;42:578-82. http://dx.doi.org/10.1515/CCLM.2004.100.,OADS,/arxiv_data1/oa_pdf/05/19/biomed-24-3-376.PMC4210258.pdf
Clin Chem Lab Med 2008;46:849-54. http://dx.doi.org/10.1515/CCLM.2008.168.,OADS,/arxiv_data1/oa_pdf/05/19/biomed-24-3-376.PMC4210258.pdf
Am J Clin Pathol 2010;133:870-7. http://dx.doi.org/10.1309/AJCPC95YYMSLLRCX .,OADS,/arxiv_data1/oa_pdf/05/19/biomed-24-3-376.PMC4210258.pdf
Clin Chim Acta 2003;333:131-9. http://dx.doi.org/10.1016/S0009-8981(03)  00177-3.,OADS,/arxiv_data1/oa_pdf/05/19/biomed-24-3-376.PMC4210258.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://dx.doi.org/10.11613/BM.2014.041 Biochemia Medica 2014;24(3):383–9    383Abstract Introduction : Oligodendrocytes need iron in processes of energy generation and myelination.",Non-OADS,/arxiv_data1/oa_pdf/b0/f8/biomed-24-3-383.PMC4210259.pdf
Biochemia Medica 2014;24(3):383–9  http://dx.doi.org/10.11613/BM.2014.041  384Aydin O. et al.,OADS,/arxiv_data1/oa_pdf/b0/f8/biomed-24-3-383.PMC4210259.pdf
http://dx.doi.org/10.11613/BM.2014.041 Biochemia Medica 2014;24(3):383–9    385Aydin O. et al.,OADS,/arxiv_data1/oa_pdf/b0/f8/biomed-24-3-383.PMC4210259.pdf
Biochemia Medica 2014;24(3):383–9  http://dx.doi.org/10.11613/BM.2014.041  386Aydin O. et al.,OADS,/arxiv_data1/oa_pdf/b0/f8/biomed-24-3-383.PMC4210259.pdf
http://dx.doi.org/10.11613/BM.2014.041 Biochemia Medica 2014;24(3):383–9    387Aydin O. et al.,OADS,/arxiv_data1/oa_pdf/b0/f8/biomed-24-3-383.PMC4210259.pdf
Biochemia Medica 2014;24(3):383–9  http://dx.doi.org/10.11613/BM.2014.041  388Aydin O. et al.,OADS,/arxiv_data1/oa_pdf/b0/f8/biomed-24-3-383.PMC4210259.pdf
http://dx.doi.org/10.11613/BM.2014.041 Biochemia Medica 2014;24(3):383–9    389Aydin O. et al.,OADS,/arxiv_data1/oa_pdf/b0/f8/biomed-24-3-383.PMC4210259.pdf
Bra - in 2011;134:3602-15. http://dx.doi.org/10.1093/brain/awr278.,OADS,/arxiv_data1/oa_pdf/b0/f8/biomed-24-3-383.PMC4210259.pdf
Ann Neurol 2013;74:848-61. http://dx.doi.org/10.1002/ana.23974.,OADS,/arxiv_data1/oa_pdf/b0/f8/biomed-24-3-383.PMC4210259.pdf
J Neurochem 2012;120:7-25. http://dx.doi.org/10.1111/ j.1471-4159.2011.07536.x.,Non-OADS,/arxiv_data1/oa_pdf/b0/f8/biomed-24-3-383.PMC4210259.pdf
Clin Biochem 2004;37:277-85. http://dx.doi.org/10.1016/j.clinbiochem.2003.11.015.,OADS,/arxiv_data1/oa_pdf/b0/f8/biomed-24-3-383.PMC4210259.pdf
Clin Biochem 2005;38:1103-11. http://dx.doi.org/10.1016/j.clinbiochem.2005.08.008.,OADS,/arxiv_data1/oa_pdf/b0/f8/biomed-24-3-383.PMC4210259.pdf
Emerg Med J 2000;19:311-5. http://dx.doi.org/10.1016/S0736-4679(00)00255-9.,OADS,/arxiv_data1/oa_pdf/b0/f8/biomed-24-3-383.PMC4210259.pdf
Heart  2006;92:113-4. http://dx.doi.org/10.1136/hrt.2004.049643.,Non-OADS,/arxiv_data1/oa_pdf/b0/f8/biomed-24-3-383.PMC4210259.pdf
Ann Neurol 2011;69:292- 302. http://dx.doi.org/10.1002/ana.22366.,OADS,/arxiv_data1/oa_pdf/b0/f8/biomed-24-3-383.PMC4210259.pdf
Neurolo - gy 1983;33:1444-52. http://dx.doi.org/10.1212/WNL.33.11.,Non-OADS,/arxiv_data1/oa_pdf/b0/f8/biomed-24-3-383.PMC4210259.pdf
BMC Med Genomics 2009;82:2. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/f8/biomed-24-3-383.PMC4210259.pdf
Arch Med Sci 2012;8:138-53. http://dx.doi.org/10.5114/aoms.2012.,OADS,/arxiv_data1/oa_pdf/b0/f8/biomed-24-3-383.PMC4210259.pdf
J Pediatr Hematol Oncol 2009;31:583-7.  http://dx.doi.org/10.1097/MPH.0b013e3181acd93d.,Non-OADS,/arxiv_data1/oa_pdf/b0/f8/biomed-24-3-383.PMC4210259.pdf
J Clin Neurosci 2013; 20:1106-9.  http://dx.doi.org/10.1016/j.jocn.2012.09.020.,OADS,/arxiv_data1/oa_pdf/b0/f8/biomed-24-3-383.PMC4210259.pdf
Clin Biochem 2012;45:26- 30. http://dx.doi.org/10.1016/j.clinbiochem.2011.09.021.,OADS,/arxiv_data1/oa_pdf/b0/f8/biomed-24-3-383.PMC4210259.pdf
J Neurol Sci 2012;321:49-53. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/f8/biomed-24-3-383.PMC4210259.pdf
Dis Markers 2009;26:35-39. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/f8/biomed-24-3-383.PMC4210259.pdf
Neu- rochem Int 2013;62:988-97. http://dx.doi.org/10.1016/j.neuint.2013.02.025.,OADS,/arxiv_data1/oa_pdf/b0/f8/biomed-24-3-383.PMC4210259.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://dx.doi.org/10.11613/BM.2014.042 Biochemia Medica 2014;24(3):391–5    391Abstract Introduction : There are a number of pre-analytical and analytical factors, which cause false results in the complete blood count.",Non-OADS,/arxiv_data1/oa_pdf/8c/cc/biomed-24-3-391.PMC4210260.pdf
Biochemia Medica 2014;24(3):391–5  http://dx.doi.org/10.11613/BM.2014.042  392Ercan Ş. et al.,OADS,/arxiv_data1/oa_pdf/8c/cc/biomed-24-3-391.PMC4210260.pdf
http://dx.doi.org/10.11613/BM.2014.042 Biochemia Medica 2014;24(3):391–5    393Ercan Ş. et al.,OADS,/arxiv_data1/oa_pdf/8c/cc/biomed-24-3-391.PMC4210260.pdf
Biochemia Medica 2014;24(3):391–5  http://dx.doi.org/10.11613/BM.2014.042  394Ercan Ş. et al.,OADS,/arxiv_data1/oa_pdf/8c/cc/biomed-24-3-391.PMC4210260.pdf
http://dx.doi.org/10.11613/BM.2014.042 Biochemia Medica 2014;24(3):391–5    395Ercan Ş. et al.,OADS,/arxiv_data1/oa_pdf/8c/cc/biomed-24-3-391.PMC4210260.pdf
http://dx.doi.org/10.1111/j.1365- 2141.2011.08643.x.,Non-OADS,/arxiv_data1/oa_pdf/8c/cc/biomed-24-3-391.PMC4210260.pdf
Blood Rev 2012;26:107-15. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/cc/biomed-24-3-391.PMC4210260.pdf
http://dx.doi.org/10.1007/s00277-012-1515-1.,Non-OADS,/arxiv_data1/oa_pdf/8c/cc/biomed-24-3-391.PMC4210260.pdf
Lab Med 2011;5:300-8. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/cc/biomed-24-3-391.PMC4210260.pdf
N Engl J Med 1983;309:925-6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/cc/biomed-24-3-391.PMC4210260.pdf
Indian J Hematol Blood Transfus 2011;27:107-10. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/cc/biomed-24-3-391.PMC4210260.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Biochemia Medica 2014;24(3):396–402  http://dx.doi.org/10.11613/BM.2014.043  396Abstract Congenital Cytomegalovirus (CMV) infection and alpha 1-antitrypsin (A1AT) deficiency are separately well described entities, but their simultaneous  occurrence can pose a special challenge to a clinician, especially dealing with optimal diagnostic as well as therapeutic approach.",Non-OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
http://dx.doi.org/10.11613/BM.2014.043 Biochemia Medica 2014;24(3):396–402    397Potočnjak I. et al.,OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
Biochemia Medica 2014;24(3):396–402  http://dx.doi.org/10.11613/BM.2014.043  398Potočnjak I. et al.,OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
http://dx.doi.org/10.11613/BM.2014.043 Biochemia Medica 2014;24(3):396–402    399Potočnjak I. et al.,OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
Biochemia Medica 2014;24(3):396–402  http://dx.doi.org/10.11613/BM.2014.043  400Potočnjak I. et al.,OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
http://dx.doi.org/10.11613/BM.2014.043 Biochemia Medica 2014;24(3):396–402    401Potočnjak I. et al.,OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
Biochemia Medica 2014;24(3):396–402  http://dx.doi.org/10.11613/BM.2014.043  402Potočnjak I. et al.,OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
Transfus Med Hemother 2010;37:365-75. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
J Antimicrob Chemother 2009;63:862-7.  http://dx.doi.org/10.1093/jac/dkp083.,Non-OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
Pediatrics 2003;112:153-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
J Pe - diatr Gastroenterol Nutr 2007;44:99-103. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
Environ Heal- th Perspect 2003;111:1851-4. http://dx.doi.org/10.1289/ ehp.6511.,Non-OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
Thorax 2004;59:164-9. http://dx.doi.org/10.1136/ thorax.2003.006494.,Non-OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
Eur J Pediatr 2011;170:103-6. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
Thorax 2004;59:441-5. http://dx.doi.org/10.1136/thx.2003.006510.,Non-OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
Severe cholestasis in a newborn  with PiZZ alpha-1-antitrypsin genotype - a case repor t. Bi- ochem Med 2007;17:242-6. http://dx.doi.org/10.11613/ BM.2007.024.,Non-OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
Ther Adv Respir Dis 2012;6:2:79-85. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
Lancet 2005;365:2225-36. http://dx.doi.org/10.1016/S0140-6736(05)66781-5.,OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
Clin Gastroent Hepat 2012;10:6:575-80. http://dx.doi.org/10.1016/j.cgh.2011.12.028.,OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
Dig Dis Sci 2014;59:1710-3. http://dx.doi.org/10.1007/s10620-014- 3094-6.,OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
Clin Chem 2006;52:12:2236-42. http://dx.doi.org/10.1373/ clinchem.2006.072991.,OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
Eur Respir J 2010;35:960-8. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
Eur J Hum Genet 2012 Mar;20:251-7. http://dx.doi.org/10.1038/ejhg.2011.181.,OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
J Pediatr Gastroenterol Nutr 2008;47:623-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
Respiration  1999;66:373-6. http://dx.doi.org/10.1159/000029393.,Non-OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
Pediatr Res 1982;16:192-8. http://dx.doi.org/10.1203/00006450-198203000-00006.,OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
Virol J 2008;5:47. http://dx.doi.org/10.1186/1743-422X-5-47.,Non-OADS,/arxiv_data1/oa_pdf/8c/9a/biomed-24-3-396.PMC4210261.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/c8/2a/jpts-26-1515.PMC4210385.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f7/2b/jpts-26-1519.PMC4210386.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/fd/d0/jpts-26-1521.PMC4210387.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/e0/77/jpts-26-1527.PMC4210388.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/56/44/jpts-26-1531.PMC4210389.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/3f/1e/jpts-26-1537.PMC4210390.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/00/96/jpts-26-1539.PMC4210391.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/44/4e/jpts-26-1543.PMC4210392.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/5b/79/jpts-26-1547.PMC4210393.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/50/52/jpts-26-1549.PMC4210394.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/6b/1b/jpts-26-1551.PMC4210395.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/42/9f/jpts-26-1553.PMC4210396.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/32/f9/jpts-26-1557.PMC4210397.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/5d/07/jpts-26-1561.PMC4210398.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/70/51/jpts-26-1567.PMC4210399.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/c9/bd/jpts-26-1571.PMC4210400.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/89/6e/jpts-26-1575.PMC4210401.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/c0/1c/jpts-26-1579.PMC4210402.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/a9/38/jpts-26-1583.PMC4210403.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/48/cd/jpts-26-1585.PMC4210404.pdf
[Cross - Ref] 13) Korea taekwondo association: http://www.koreataekwondo.org 14) Kukkiwon: Kukki-taekwondo Manual.,Non-OADS,/arxiv_data1/oa_pdf/48/cd/jpts-26-1585.PMC4210404.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/0d/56/jpts-26-1589.PMC4210405.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/57/41/jpts-26-1593.PMC4210406.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/d3/a6/jpts-26-1597.PMC4210407.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/6c/d4/jpts-26-1601.PMC4210408.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/13/dc/jpts-26-1605.PMC4210409.pdf
REFERENCES 1) World Health Organaization: http://www.who.int/mediacentre/factsheets/ fs313/en/index.html (Accessed Mar.,Non-OADS,/arxiv_data1/oa_pdf/13/dc/jpts-26-1605.PMC4210409.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/d0/c7/jpts-26-1609.PMC4210410.pdf
"REFERENCES 1)	 STATISTICS	 KOREA:	2010	Elderly	Statistics.2010,	 http://www.nso.go.kr.",Non-OADS,/arxiv_data1/oa_pdf/d0/c7/jpts-26-1609.PMC4210410.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/52/9e/jpts-26-1613.PMC4210411.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/3d/01/jpts-26-1615.PMC4210412.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/e4/fb/jpts-26-1619.PMC4210413.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/c4/56/jpts-26-1623.PMC4210414.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f5/d8/jpts-26-1627.PMC4210415.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/61/7e/jpts-26-1631.PMC4210416.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f6/43/jpts-26-1635.PMC4210417.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/58/8e/jpts-26-1637.PMC4210418.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Review,Non-OADS,/arxiv_data1/oa_pdf/01/8b/jpts-26-1641.PMC4210419.pdf
5.1.0. http://handbook.cochrane.org (Accessed Mar.,OADS,/arxiv_data1/oa_pdf/01/8b/jpts-26-1641.PMC4210419.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Review,Non-OADS,/arxiv_data1/oa_pdf/1f/aa/jpts-26-1649.PMC4210420.pdf
REFERENCES 1) http://en.wikipedia.org/wiki/.,Non-OADS,/arxiv_data1/oa_pdf/1f/aa/jpts-26-1649.PMC4210420.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Case Study,Non-OADS,/arxiv_data1/oa_pdf/23/d0/jpts-26-1657.PMC4210421.pdf
This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/b6/6e/jpts-26-1661.PMC4210422.pdf
"REFERENCES 1) K orean Society of Nephrology: Current renal replacement therapy in Ko- rea − Insan memorial dialysis registry 2011- http://www.ksn.or.kr/jour- nal/2012/index.html (Accessed May 31, 2014).",Non-OADS,/arxiv_data1/oa_pdf/b6/6e/jpts-26-1661.PMC4210422.pdf
© 2014 Zhou and Lingle  This article is distributed under the terms of an Attribution–  Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1085/jgp.91.3.317 Armstrong, C.M.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/ 10.1085/jgp.54.5.553et al., 2002a,b).",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1085/jgp.69.4.497 Horrigan, F.T., and R.W.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/ 10.1085/jgp.114.2.305 Horrigan, F.T., and R.W.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1085/jgp.20028605 Imlach, W.L., S.C. Finch, J. Dunlop, and J.E.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1016/ j.toxicon.2011.01.013 Jiang, Y., A. Lee, J. Chen, M. Cadene, B.T.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1038/ 417515a Jiang, Y., A. Lee, J. Chen, M. Cadene, B.T.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1038/417523a Knaus, H.G., O.B.",Non-OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1038/ nature02632 Lenaeus, M.J., M. Vamvouka, P.J.",Non-OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1038/nsmb929 Liang, S. 2008.",Non-OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1586/14789450.5.5.731 Lingle, C.J.",Non-OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1126/science.1116269 MacKinnon, R., and C. Miller.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1085/jgp.91.3.335 Magidovich, E., and O. Yifrach.",Non-OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"43:13242– 13247. http://dx.doi.org/10.1021/bi048377v Meera, P., M. Wallner, and L. Toro.",Non-OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1085/jgp.59.4.388 Banerjee, A., A. Lee, E. Campbell, and R. Mackinnon.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10 .7554/eLife.00594 Brelidze, T.I., and K.L.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1085/jgp.200509286 Bruhova, I., D.B.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1124/mol.108.049759 Bush, L.P., H.H.",Non-OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1085/jgp .201110632 Chen, X., J. Yan, and R.W.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1016/0896-6273 (93)90340-W Cole, R., and R. Cox.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1126/ science.280.5360.69 Essin, K., M. Gollasch, S. Rolle, P. Weissgerber, M. Sausbier, E. Bohn,  I.B.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10 .1182/blood-2008-07-166660 Flynn, G.E., and W.N.",Non-OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1085/jgp.200308819 Fodor, A.A., K.D.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10 .1085/jgp.110.5.591 Fodor, A.A., S.E.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1085/jgp.109.1.3 Gross, A., and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.2174/138161208785777469 Hanck, D.A., E. Nikitina, M.M.",Non-OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10 .1073/pnas.100118597 Milescu, M., F. Bosmans, S. Lee, A.A. Alabi, J.I.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1038/nsmb.1679 Muroi, Y., and B. Chanda.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1085/ jgp.200810103 Narahashi, T., J.W.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1085/jgp.47.5.965 Narahashi, T., J.W.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1126/ science.156.3777.976 Neher, E., and J.H.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1126/science.285.5424.73 Raffaelli, G., C. Saviane, M.H.",Non-OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1113/jphysiol.2004.062661 Sanchez, M., and O.B.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/ 10.1016/0028-3908(96)00137-2 Shao, L.R., R. Halvorsrud, L. Borg-Graham, and J.F.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1111/j.1469- 7793.1999.00135.x Smith, C., M. Phillips, and C. Miller.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1016/S0896-6273 (00)80306-2 Swartz, K.J., and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1016/S0896- 6273(00)80307-4 Tammaro, P., A.L.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1038/sj.bjp.0705957 Tang, Q.Y., X.-H. Zeng, and C.J.",Non-OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1085/ jgp.200910251 Uysal, S., V. Vásquez, V. Tereshko, K. Esaki, F.A.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1073/ pnas.0810663106 Wang, J., V. Yarov-Yarovoy, R. Kahn, D. Gordon, M. Gurevitz, T.  Scheuer, and W.A.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1073/ pnas.1112320108 Wilkens, C.M., and R.W.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1085/jgp.200609579 Xia, X.-M., J.P. Ding, and C.J.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi .org/10.1016/S0092-8674(02)01013-9 Zhang, G., and F.T.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi .org/10.1085/jgp.200409149 Zhang, X., C.R.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi.org/10.1085/jgp.118.5.607 Zhou, M., J.H.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi .org/10.1038/35079500 Zhou, Y., Q.Y.",Non-OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
"http://dx.doi .org/10.1085/jgp.201010403 Zhou, Y., X.M.",OADS,/arxiv_data1/oa_pdf/2a/49/JGP_201411259.PMC4210426.pdf
© 2014 Maki and Popescu  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1016/j.bpj.2011.02.042 Ascher, P., and L. Nowak.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi .org/10.1523/JNEUROSCI.1471 ­05.2005clearly different: 1 and 2.5 for P and S, respectively.",Non-OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi .org/10.1073/pnas.90.24.11573 Johnson, J.W., and P. Ascher.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1038/325529a0 Karakas, E., and H. Furukawa.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1126/science.1251915 Kleckner, N.W., and R. Dingledine.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1126/science.2841759 Krupp, J.J., B. Vissel, C.G.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1016/S0028­3908(02)00031­X Kuner, T., L.P. Wollmuth, A. Karlin, P.H.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1016/S0896­6273(00)80165­8 Kussius, C.L., N. Kaur, and G.K. Popescu.",Non-OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1523/JNEUROSCI .0281­09.2009 Lee, C.­H., W. Lü, J.C. Michel, A. Goehring, J.",Non-OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi .org/10.1038/nature13548 Legendre, P., and G.L.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1074/jbc.M112 .390013 Mayer, M.L., and G.L.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1038/309261a0 Monyer, H., N. Burnashev, D.J.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1016/0896­6273(94)90210­0 Neher, E., and J.H.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1038/307462a0Banke, T.G., and S.F.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1038/ nn1000 Banke, T.G., S.M.",Non-OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.3154 ­04.2005 Benninger, C., J. Kadis, and D.A.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1016/0006 ­8993(80)90502 ­8 Borschel, W.F., S.E.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"2:498.  http://dx.doi.org/10.1038/ncomms1512 Burnashev, N., R. Schoepfer, H. Monyer, J.P. Ruppersberg, W.  Günther, P.H.",Non-OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10 .1126/science.1382314 Burnashev, N., Z. Zhou, E. Neher, and B. Sakmann.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi .org/10.1016/j.neuropharm.2007.05.018 Chen, C., and H. Okayama.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1074/ jbc.M111.258897 Christine, C.W., and D.W. Choi.",Non-OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1126/science.1359647 Colquhoun, D., and A.G. Hawkes.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1113/jphysiol.2008.158634 Erreger, K., and S.F.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1113/jphysiol.2007.143941 Erreger, K., S.M.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1113/ jphysiol.2004.080028 Hardingham, G.E., and H. Bading.",Non-OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10 .1038/nrn2911 Heinemann, U., and R. Pumain.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/ 10.1007/BF00237788 Heinemann, U., A. Konnerth, R. Pumain, and W.J.",Non-OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1677/joe.0 .1540371 Popescu, G., and A. Auerbach.",Non-OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1038/ nature02775 Premkumar, L.S., and A. Auerbach.",Non-OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1016/ S0896 ­6273(00)80107 ­5 Premkumar, L.S., F. Qin, and A. Auerbach.",Non-OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi .org/10.1085/jgp.109.2.181 Qin, F. 2004.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1016/S0006 ­3495(04)74217 ­4 Qin, F., A. Auerbach, and F. Sachs.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"264:375– 383. http://dx.doi.org/10.1098/rspb.1997.0054 Rosenmund, C., and G.L.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"10:805– 814. http://dx.doi.org/10.1016/0896 ­6273(93)90197 ­Y Rusakov, D.A., and A.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1016/ S0896 ­6273(03)00025 ­4 Rycroft, B.K., and A.J.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi .org/10.1016/j.neuropharm.2004.06.001 Rycroft, B.K., and A.J.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi .org/10.1113/jphysiol.2003.059212Schorge, S., S. Elenes, and D. Colquhoun.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1113/jphysiol.2005.095349 Sharma, G., and C.F.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1073/ pnas.93.24.14170 Silver, I.A., and M. Ereci ńska.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1085/jgp.95.5.837 Tang, C.M., M. Dichter, and M. Morad.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1038/345347a0 Vance, K.M., K.B.",Non-OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1016/j.neuropharm.2013.03.018 Watanabe, J., C. Beck, T. Kuner, L.S.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1016/0166­2236(95)93895­5 Woodhull, A.M. 1973.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi.org/10.1085/ jgp.61.6.687 Zhang, S., M.D.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
"http://dx.doi .org/10.1016/S0896­6273(00)80553­X Zhang, W., J.R. Howe, and G.K. Popescu.",OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
http://dx.doi.org/10.1038/ nn.2214,Non-OADS,/arxiv_data1/oa_pdf/0b/9f/JGP_201411244.PMC4210427.pdf
This article is distributed under the terms of an Attribution–  Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
Online supplemental mate-rial is available at http://www.jgp.org/cgi/content/full/jgp .201411185/DC1.,Non-OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1085/ jgp.201010573 Halabi, N., O. Rivoire, S. Leibler, and R. Ranganathan.",Non-OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1016/j.cell.2009.07.038 Heginbotham, L., Z. Lu, T. Abramson, and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1016/S0006-3495(94)80887-2 Horrigan, F.T., J. Cui, and R.W.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1085/jgp .114.2.277 Islas, L.D., and F.J. Sigworth.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1085/jgp.114.5.723 Kannan, N., and S. Vishveshwara.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1006/jmbi.1999.3058 Kitaguchi, T., M. Sukhareva, and K.J.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/ 10.1085/jgp.200409098 Ledwell, J.L., and R.W.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1085/ jgp.113.3.389 Lee, S.Y., A. Banerjee, and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1126/science.1116269 Long, S.B., E.B.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1126/science.1116270 Long, S.B., X. Tao, E.B.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1038/ nature06265 Lu, Z., A.M. Klem, and Y. Ramu.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1085/jgp.20028696 Mark, A.E., and W.F.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1006/jmbi.1994.1430 Muroi, Y., M. Arcisio-Miranda, S. Chowdhury, and B. Chanda.",Non-OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"17:230– 237. http://dx.doi.org/10.1038/nsmb.1749 Nepusz, T., H. Yu, and A. Paccanaro.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1038/nmeth.1938 Perozo, E., R. MacKinnon, F. Bezanilla, and E. Stefani.",Non-OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi .org/10.1016/0896-6273(93)90190-3 Ryu, S., and G. Yellen.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
http://dx.doi.org/10.1085/jgp .201210850We are thankful to the members of the Chanda laboratory for  their helpful comments and advice.,Non-OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"16:1169– 1177. http://dx.doi.org/10.1016/S0896-6273(00)80143-9 Ahern, C.A., and R. Horn.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1085/jgp.200308993 Altomare, C., A. Bucchi, E. Camatini, M. Baruscotti, C. Viscomi, A.  Moroni, and D. DiFrancesco.",Non-OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1085/jgp.117.6.519 Barghaan, J., and R. Bähring.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1085/jgp.200810073 Batulan, Z., G.A.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1074/jbc.M109.097717 Bezanilla, F. 2000.",Non-OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi .org/10.1085/jgp.200609585 Chowdhury, S., and B. Chanda.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10 .1073/pnas.1003609107 Chowdhury, S., and B. Chanda.",Non-OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1085/ jgp.201110722 Chowdhury, S., and B. Chanda.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1085/jgp.201210840 Chowdhury, S., and B. Chanda.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1085/jgp.201210860 Chowdhury, S., B.M.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1085/jgp.110.3.257 Ding, S., and R. Horn.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1085/jgp.20028611 Hackos, D.H., T.H.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
http://dx.doi.org/10.1085/jgp.20028569,OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1016/S0896- 6273(00)80142-7 Sigg, D., and F. Bezanilla.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1038/nature07620 Talukder, G., and R.W.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1016/S0006- 3495(00)76634-3Tao, X., A. Lee, W. Limapichat, D.A.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1126/science .1185954 Yarov-Yarovoy, V., P .G.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1073/ pnas.1118434109 Yellen, G. 1998.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi.org/10.1017/ S0033583598003448 Yifrach, O., and R. MacKinnon.",Non-OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
"http://dx.doi .org/10.1016/S0092-8674(02)01013-9 Zagotta, W.N., T. Hoshi, and R.W.",OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
http://dx.doi.org/10.1085/jgp.103.2.321,OADS,/arxiv_data1/oa_pdf/72/c7/JGP_201411185.PMC4210428.pdf
This article is distributed under the terms of an Attribution–Non- commercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1016/j.tins.2008.09.004 Brookes, P.S., Y. Yoon, J.L.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10 .1152/ajpcell.00139.2004 Busse, M.E., G. Hughes, C.M.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"255:1534– 1540. http://dx.doi.org/10.1007/s00415-008-0964-x Calderón, J.C., P. Bolaños, and C. Caputo.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1113/jphysiol.2009.180893 Canepari, M., M.A.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1111/j.1600-0838.2009 .00965.x Cattaneo, E., C. Zuccato, and M. Tartari.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1038/nrn1806 Caviston, J.P., and E.L. Holzbaur.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1016/j.tcb.2009.01.005 Cepeda, C., M.A.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1002/ jnr.1244 Cepeda, C., N. Wu, V.M.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1016/j.pneurobio.2006 .11.001 Chaturvedi, R.K., P. Adhihetty, S. Shukla, T. Hennessy, N. Calingasan,  L. Yang, A. Starkov, M. Kiaei, M. Cannella, J. Sassone, et al.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1093/hmg/ ddp243 Chen, X., J. Wu, S. Lvovskaya, E. Herndon, C. Supnet, and I. Bezprozvanny.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"6:81. http://dx.doi.org/ 10.1186/1750-1326-6-81 Choo, Y.S., G.V.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1038/sj.cdd.4401967 Ciammola, A., J. Sassone, M. Sciacco, N.E.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1002/mds.23258 Costa, V., M. Giacomello, R. Hudec, R. Lopreiato, G. Ermak,  D. Lim, W. Malorni, K.J.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
http://dx.doi.org/10.1002/ emmm.201000102(Fig.,Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1002/ana.410430321 Baylor, S.M., and S. Hollingworth.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10 .1113/jphysiol.2003.041608 Baylor, S.M., and S. Hollingworth.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1085/jgp.201210773 Bezprozvanny, I.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1007/978-1-4020-6191-2_11 Bezprozvanny, I.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10 .1007/s11064-010-0393-y Bezprozvanny, I., and M.R.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1016/j.bbrc.2004.08.035 Boncompagni, S., A.E.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1002/ana.20754 González, A., and E. Ríos.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1085/jgp.102.3.373 Hamilton, J.M., T. Wolfson, G.M.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1136/jnnp.2003 .017822 Harjes, P., and E.E.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1016/S0968-0004(03)00168-3 Heng, M.Y., P.J.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"29:3200– 3205. http://dx.doi.org/10.1523/JNEUROSCI.5599-08.2009 Hollingworth, S., U. Zeiger, and S.M.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"586:5063– 5075. http://dx.doi.org/10.1113/jphysiol.2008.160507 Imarisio, S., J. Carmichael, V. Korolchuk, C.W.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1152/ajpcell.00579.2003 Konishi, M., A. Olson, S. Hollingworth, and S.M.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1016/S0006-3495(88)83045-5 Kosinski, C.M., C. Schlangen, F.N.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1002/mds.21550 Krause, T., M.U.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1111/j.1365-2044.2004.03658.x Landles, C., and G.P.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10 .1038/sj.embor.7400250 Lanner, J.T., D.K.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1101/cshperspect.a003996 Lin, M.T., and M.F.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1038/nature05292 Liu, Y., S.L.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1016/S0143- 4160(96)90010-X De Stefani, D., A. Raffaello, E. Teardo, I. Szabò, and R. Rizzuto.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"588:9. http://dx.doi.org/10.1113/ jphysiol.2009.184598 Delbono, O.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.2174/1874609811104030248 Djoussé, L., B. Knowlton, L.A. Cupples, K. Marder, I. Shoulson, and  R.H. Myers.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1212/01.WNL .0000031791.10922.CF Durham, W.J., P. Aracena-Parks, C. Long, A.E.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1016/j.cell .2008.02.042 Eisner, V., G. Csordás, and G. Hajnóczky.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1242/ jcs.093609 Fan, M.M., and L.A. Raymond.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1016/j.pneurobio.2006.11.003 Favero, T.G., A.C. Zable, and J.J. Abramson.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi .org/10.1074/jbc.270.43.25557 Fernandes, H.B., K.G.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"27:13614– 13623. http://dx.doi.org/10.1523/JNEUROSCI.3455-07.2007 Friedrich, O., C. Weber, F. von Wegner, J.S.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1177/39.3.1825216 Gellerich, F.N., S. Trumbeckaite, T. Müller, M. Deschauer, Y. Chen,  Z. Gizatullina, and S. Zierz.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1023/B:MCBI.0000009885.34498.e6 Gellerich, F.N., Z. Gizatullina, H.P.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10 .1074/jbc.M709555200 Gizatullina, Z.Z., K.S.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1046/j.1471- 4159.2003.02009.x Panov, A.V., C.A.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1074/jbc.R112.420752 Perry, G.M., S. Tallaksen-Greene, A. Kumar, M.Y.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1093/hmg/ddq247 Pette, D., and R.S.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/ 10.1016/S0074-7696(08)61622-8 Prosser, B.L., E.O.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
http://dx.doi.org/10.1152/ajpcell.00180.2010 R Development Core Team.,OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"Available at: http://www.r-project.org/index.html (accessed October 3, 2014).",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1007/ s10495-007-0723-y Renganathan, M., and O. Delbono.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"434:346– 350. http://dx.doi.org/10.1016/S0014-5793(98)01009-6 Ribchester, R.R., D. Thomson, N.I.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10 .1111/j.1460-9568.2004.03783.x Robertson, S.P., J.D.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1016/S0006-3495(81)84868-0 Robin, G., and B. Allard.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1085/ jgp.201310957 Romanick, M., L.V.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1016/ j.bbadis.2013.03.011 Rosenberg, H., M. Davis, D. James, N. Pollock, and K. Stowell.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"2:21. http://dx.doi .org/10.1186/1750-1172-2-21 Ross, C.A.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1016/S0896-6273(02)00872-3 Rossi, A.E., and R.T. Dirksen.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
http://dx.doi.org/10.1002/mus.20512model of polyglutamine disease: parallel changes in muscle   and brain.,OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/ 10.1093/hmg/11.17.1911 Mangiarini, L., K. Sathasivam, M. Seller, B. Cozens, A. Harper, C.  Hetherington, M. Lawton, Y. Trottier, H. Lehrach, S.W.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10 .1016/S0092-8674(00)81369-0 Manring, H., E. Abreu, L. Brotto, N. Weisleder, and M. Brotto.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"5:37. http://dx.doi .org/10.3389/fphys.2014.00037 Marzetti, E., J.C. Hwang, H.A.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1016/j.bbagen.2009.05.007 Melzer, W. 2013.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1016/S0006-3495(87)83413-6 Milakovic, T., and G.V.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1074/jbc.M504749200 Miller, B.R., and I. Bezprozvanny.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/ 10.2217/fnl.10.41 Mochel, F., and R.G.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi .org/10.1172/JCI45691 Mochel, F., P. Charles, F. Seguin, J. Barritault, C. Coussieu, L. Perin,  Y.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1371/journal.pone.0000647 Moffitt, H., G.D. McPhail, B. Woodman, C. Hobbs, and G.P.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10 .1371/journal.pone.0008025 Moreau, V.H., R.F.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/ 10.1016/S0891-5849(98)00084-7 Murphy, R.M., N.T.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
http://dx.doi.org/10.1113/jphysiol.2012.243279,Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1093/hmg/ddi192 Strong, T.V., D.A.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1038/ng1193-259 Struk, A., G. Szücs, H. Kemmer, and W. Melzer.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1016/ S0143-4160(98)90071-9 Sun, J., C. Xin, J.P. Eu, J.S.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1016/j.bbrc.2012.10.107 Svensson, C., I. Morano, and A. Arner.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://onlinelibrary.wiley.com/doi/10.1002/%28SICI% 291097-4644%2819971101%2967:2%3C241::AID-JCB9%3E3.0.CO; 2-X/abstract Szentesi, P., C. Collet, S. Sárközi, C. Szegedi, I. Jona, V. Jacquemond,  L. Kovács, and L. Csernoch.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1085/jgp .118.4.355 Tang, T.S., H. Tu, E.Y.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1016/S0896-6273(03)00366-0 Tang, T.S., H. Tu, P.C.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"20:1779– 1787. http://dx.doi.org/10.1111/j.1460-9568.2004.03633.x Tang, T.S., E. Slow, V. Lupu, I.G.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.4411-08.2009 Teichmann, M.D., F.V.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1371/journal .pone.0003644 Timmer, J., T. Müller, and W. Melzer.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1016/ S0006-3495(98)77881-6 Toniolo, L., L. Maccatrozzo, M. Patruno, E. Pavan, F. Caliaro, R. Rossi,  C. Rinaldi, M. Canepari, C. Reggiani, and F. Mascarello.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1152/ajpcell.00601.2006Rüegg, M.A., and D.J.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1146/annurev-pharmtox- 010510-100537 Russ, D.W., J.S.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1111/j.1748-1716.2010.02191.x Saft, C., J. Zange, J. Andrich, K. Müller, K. Lindenberg, B.  Landwehrmeyer, M. Vorgerd, P.H.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1002/mds.20373 Sassone, J., C. Colciago, G. Cislaghi, V. Silani, and A. Ciammola.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10 .1016/j.expneurol.2009.05.012 Sathasivam, K., C. Hobbs, M. Turmaine, L. Mangiarini, A. Mahal,  F. Bertaux, E.E.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1093/hmg/8 .5.813 Schiaffino, S., and C. Reggiani.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10 .1152/physrev.00031.2010 Schneider, M.F., B.J.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1085/jgp .200308908 Schuhmeier, R.P., B. Dietze, D. Ursu, F. Lehmann-Horn, and W.  Melzer.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"84:1065– 1078. http://dx.doi.org/10.1016/S0006-3495(03)74923-6 Shao, J., and M.I.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1093/hmg/ddm213 Sharp, A.H., S.J.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1016/0896-6273 (95)90345-3 Shehadeh, J., H.B.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1016/j.nbd.2005 .08.001 Singh, R., G. Millman, E. Turin, L. Polisiakeiwicz, B. Lee, F. Gatti,  J. Berge, E. Smith, J. Rutter, C. Sumski, et al.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1016/j.jns.2009.06.030 Steinacker, J.M., A. Opitz-Gress, S. Baur, W. Lormes, K. Bolkart, L.  Sunder-Plassmann, F. Liewald, M. Lehmann, and Y. Liu.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1067/mva.2000.102848 Strand, A.D., A.K.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/ 10.1038/ng0595-104 Trushina, E., and C.T.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1016/j.neuroscience.2006  .10.056 Turner, C., and A.H. Schapira.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1007/s10863-010-9290-y Turner, C., J.M.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1002/mds.21540 Ursu, D., R.P.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1113/ jphysiol.2004.073882 Varshney, A., and B.E.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1016/S0896-6273(03)00425-2 Viner, R.I., T.D.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"38:12408– 12415. http://dx.doi.org/10.1021/bi9909445Wang, J.Q., Q. Chen, X. Wang, Q.C.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1074/jbc.M112.407726 Weiss, N., T. Andrianjafiniony, S. Dupré-Aucouturier, S. Pouvreau,  D. Desplanches, and V. Jacquemond.",Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10 .1007/s00424-009-0764-x White, M.M., L.Q.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1074/jbc .M110.217711 Zeron, M.M., H.B.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
"http://dx.doi.org/10.1016/j.mcn.2003.11.014 Zhou, J., J. Yi, R. Fu, E. Liu, T. Siddique, E. Ríos, and H.X.",OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
http://dx.doi.org/10.1074/jbc.M109.041319,Non-OADS,/arxiv_data1/oa_pdf/03/7b/JGP_201411255.PMC4210430.pdf
This article is distributed under the terms of an Attribution–Noncom- mercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
Online supplemental material is available at http://www.jgp .org/cgi/content/full/jgp.201411222/DC1.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1111/j.1463-1326.2011.01496.x Abraham, M.R., V.A.",Non-OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"277:24427– 24434. http://dx.doi.org/10.1074/jbc.M201777200 Aguilar-Bryan, L., C.G.",Non-OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1111/ j.1469-7793.1997.00035.x Gribble, F.M., S.J.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi .org/10.1093/emboj/16.6.1145 Gribble, F.M., S.J.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/ 10.2337/diabetes.47.9.1412 Hambrock, A., C. Löffler-Walz, and U. Quast.",Non-OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.2337/diabetes .51.9.2789 Hansen, A.M.K., J.B. Hansen, R.D.",Non-OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi .org/10.1038/nrm1684 Hopkins, W.F., S. Fatherazi, B. Peter-Riesch, B.E.",Non-OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1007/ BF00232910 Inagaki, N., T. Gonoi, J.P. Clement, C.Z.",Non-OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1016/ S0896-6273(00)80124-5 Jennings, R.B., and K.A.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi .org/10.1146/annurev.me.42.020191.001301 Koster, J.C., Q. Sha, and C.G.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1007/s00210-011-0709-8 Lawrence, C.L., P. Proks, G.C.",Non-OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
http://dx.doi.org/10.1007/ s001250100595sulfonylurea receptor: a regulator of insulin secretion.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1126/science.7716547 Alekseev, A.E., P.A.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1085/jgp .111.2.381 Ashcroft, F.M., and P. Rorsman.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1038/nrendo.2013.166 Ashcroft, F.M., D.E.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1038/ 312446a0 Ashcroft, S.J., and F.M.",Non-OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1016/0167-4889(92)90008-Y Ashfield, R., F.M.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.2165/00003088-198106030-00003 Barrett-Jolley, R., and N.W.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi .org/10.1007/s002329900178 Bienengraeber, M., T.M.",Non-OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1038/ng1329 Bokvist, K., C. Ammälä, F.M.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1007/s001250051684 de Wet, H., M.V.",Non-OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1074/jbc.273.51.33905 Drain, P., L. Li, and J. Wang.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1007/s001250051236 Gribble, F.M., and F. Reimann.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
http://dx.doi .org/10.1007/s00125-003-1143-3,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1111/j.1574-6976.1998.tb00358.x Schwanstecher, M., S. Löser, I. Rietze, and U. Panten.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"343:83– 89. http://dx.doi.org/10.1007/BF00180681 Schwanstecher, M., S. Löser, C. Brandt, K. Scheffer, F. Rosenberger,  and U. Panten.",Non-OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1111/ j.1476-5381.1992.tb09014.x Shyng, S., and C.G.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1085/jgp .110.6.643 Trapp, S., P. Proks, S.J.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1038/387179a0 Ueda, K., N. Inagaki, and S. Seino.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1074/jbc.272.37.22983 Ueda, K., J. Komine, M. Matsuo, S. Seino, and T. Amachi.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1161/01.RES.69.3.623 Vila-Carriles, W.H., G. Zhao, and J. Bryan.",Non-OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1096/fj.06-6730hyp Winkler, M., D. Stephan, S. Bieger, P. Kühner, F. Wolff, and U.  Quast.",Non-OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1124/ jpet.107.123224 Zhang, H., T.P.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1016/j.yjmcc.2009.07.002 Zingman, L.V., A.E.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1016/ S0896-6273(01)00356-7 Zünkler, B.J., S. Lenzen, K. Männer, U. Panten, and G. Trube.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1007/BF00169252Li, L., X. Geng, and P. Drain.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1085/jgp.119.1.105 Löffler-Walz, C., A. Hambrock, and U. Quast.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1124/ mol.61.2.407 Masia, R., J.C. Koster, S. Tumini, F. Chiarelli, C. Colombo, C.G.",Non-OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.2337/db06-1275 Matsuo, M., K. Tanabe, N. Kioka, T. Amachi, and K. Ueda.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1074/jbc .M004818200 Nichols, C.G., S.L.",Non-OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1126/ science.272.5269.1785 Ortiz, D., P. Voyvodic, L. Gossack, U. Quast, and J. Bryan.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1074/jbc.M112.349019 Pearson, E.R., I. Flechtner, P.R.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1056/NEJMoa061759 Proks, P., F. Reimann, N. Green, F. Gribble, and F. Ashcroft.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.2337/diabetes.51.2007.S368 Proks, P., C. Girard, S. Haider, A.L.",Non-OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1038/sj.embor.7400393 Proks, P., H. de Wet, and F.M.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.1085/jgp.201010475 Proks, P., H. de Wet, and F.M.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.2337/db13-0531 Reimann, F., M. Dabrowski, P. Jones, F.M.",Non-OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/ 10.1113/jphysiol.2002.031625 Ribalet, B., S.A. John, and J.N.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/ 10.1085/jgp.116.3.391 Ronner, P., C.M.",OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
"http://dx.doi.org/10.2337/diabetes.50.2.291 Russ, U., U. Lange, C. Löffler-Walz, A. Hambrock, and U. Quast.",Non-OADS,/arxiv_data1/oa_pdf/b3/8a/JGP_201411222.PMC4210431.pdf
This article is distributed under the terms of an Attribution–  Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
Online supplemental material is available at http://www.jgp .org/cgi/content/full/jgp.201411229/DC1.,Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1017/S0952523807070630 Cadetti, L., D. Tranchina, and W.B.",Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1113/ jphysiol.2005.096545 Cadetti, L., T .M.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1111/j.1460-9568.2008.06226.x Castillo, P.E., R. Janz, T.C.",Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1038/41574 Chen, M., M.J. Van Hook, D. Zenisek, and W.B.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1523/JNEUROSCI .3426-12.2013 Chen, Z., B. Cooper, S. Kalla, F. Varoqueaux, and S.M.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.5128-12.2013 Cho, S., G.L.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"48:1067) http://dx.doi.org/10.1016/ j.neuron.2005.09.011 Coleman, W.L., C.A.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi .org/10.1016/j.neuroscience.2007.06.011 Cooper, B., M. Hemmerlein, J. Ammermüller, C. Imig, K. Reim,  N. Lipstein, S. Kalla, H. Kawabe, N. Brose, J.H.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.4240-11.2012 Derkach, V., A. Barria, and T.R.",Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)00158-6 DeVries, S.H.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1016/S0896-6273(01)00535-9 Dittman, J.S., and W.G.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1038/nature03010 Armstrong-Gold, C.E., and F. Rieke.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1017/ S0952523801181149 Babai, N., T.M.",Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.2891-10.2010 Barrow, A.J., and S.M.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.5746-08.2009 Bartoletti, T.M., N. Babai, and W.B.",Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1152/jn.00718.2009 Bartoletti, T.M., S.L.",Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi .org/10.1152/jn.00634.2011 Benfenati, F., F. Valtorta, J.L.",Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
http://dx.doi.org/10.1038/359417a0,Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1085/jgp.200308863 Holt, M., A. Cooke, A. Neef, and L. Lagnado.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1016/j.cub.2003.12.053 Hori, T., and T. Takahashi.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1083/jcb .200505155 Jackman, S.L., S.-Y.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10 .1016/j.cell.2004.06.029 Kantardzhieva, A., M. Peppi, W.S.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1021/pr2008972 Ke, J.-B., Y.V.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1016/j.neuron.2013.10.054 Kim, A.-R., W.-H. Choi, S.-R. Lee, J.-S. Kim, C.-Y.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/ 10.1038/emm.2002.61 Kourennyi, D.E., and S. Barnes.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1016/S0896- 6273(02)00777-8 Kushmerick, C., R. Renden, and H. von Gersdorff.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)81017-X Fortune, E.S., and G.J.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/ 10.1016/S0166-2236(00)01835-X Garcia-Perez, E., and J.F.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1152/ jn.01348.2007 Geppert, M., Y. Goda, C.F.",Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1038/42954 Gomis, A., J. Burrone, and L. Lagnado.",Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1523/JNEUROSCI .1866-11.2011 Graydon, C.W., J. Zhang, N.W.",Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"34:8948– 8962. http://dx.doi.org/10.1523/JNEUROSCI.1022-14.2014 Griessmeier, K., H. Cuny, K. Rötzer, O. Griesbeck, H. Harz, M. Biel,  and C. Wahl-Schott.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1074/jbc.M109.048082 Harris, K.M., and J.K. Stevens.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10 .1016/0028-3908(95)00142-S Hayashi, Y., S.H.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1126/science .287.5461.2262 Haynes, L.W., and S.C. Stotz.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1017/ S0952523800011378 Heidelberger, R., W.B.",Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1016/j.preteyeres.2005.04.002 Hilfiker, S., V.A.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1098/rstb.1999.0378 Hilfiker, S., V.A.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1038/ nn.2945 Ohyama, A., K. Hosaka, Y. Komiya, K. Akagawa, E. Yamauchi, H.  Taniguchi, N. Sasagawa, K. Kumakura, S. Mochida, T. Yamauchi,  and M. Igarashi.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.3129-09.2010 Rabl, K., L. Cadetti, and W.B.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1016/S0896- 6273(04)00088-1 Regus-Leidig, H., C. Ott, M. Löhner, J. Atorf, M. Fuchs, T. Sedmak,  J. Kremers, A. Fejtová, E.D.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1371/journal.pone.0070373 Risinger, C., and M.K.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1046/ j.1471-4159.1999.0720614.x Rodríguez-Castañeda, F., M. Maestre-Martínez, N. Coudevylle, K.  Dimova, H. Junge, N. Lipstein, D. Lee, S. Becker, N. Brose, O. Jahn, et al.",Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi .org/10.1038/emboj.2009.373 Rubenstein, J.L., P. Greengard, and A.J.",Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1002/syn.890130207 Sakaba, T., and E. Neher.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1016/S0896-6273 (01)00543-8 Sakaba, T., R. Schneggenburger, and E. Neher.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1016/S0168-0102(02)00174-8 Schikorski, T., and C.F.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.1610-04.2004 Schlüter, O.M., J. Basu, T.C.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/ 10.1523/JNEUROSCI.3553-05.2006 Schnapf, J.L., and D.R.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1523/JNEUROSCI .3889-05.2006 Leenders, A.G., F.H.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1091/mbc.12.10.3095 Lipstein, N., S. Schaks, K. Dimova, S. Kalkhof, C. Ihling, K. Kölbel, U.  Ashery, J. Rhee, N. Brose, A. Sinz, and O. Jahn.",Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1016/j.neuron.2013.05.011 Liu, H., H. Bai, E. Hui, L. Yang, C.S.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/ 10.7554/eLife.01524 Llinás, R., T.L.",Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1016/ S0896-6273(00)80254-8 Mizoguchi, A., Y. Yano, H. Hamaguchi, H. Yanagida, C. Ide, A.  Zahraoui, H. Shirataki, T. Sasaki, and Y. Takai.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1006/bbrc.1994.2063 Nayak, A.S., C.I.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"2:144. http://dx.doi.org/10.3389/fnsyn.2010.00144 Nichols, R.A., T.S.",Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1038/343647a0 Nielander, H.B., F. Onofri, F. Valtorta, G. Schiavo, C. Montecucco,  P. Greengard, and F. Benfenati.",Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1046/ j.1471-4159.1995.65041712.x Nonet, M.L., J.E.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1016/ S0166-2236(02)02139-2 Sheng, Z., S.-Y.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1152/jn.01309.2005 Snellman, J., B. Mehta, N. Babai, T.M.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1038/ nn.2870 Stevens, C.F., and J.F.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1016/ S0896-6273(00)80550-4 Sun, J., P. Bronk, X. Liu, W. Han, and T.C.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1016/S0896-6273(04)00254-5 Tian, M., C.S.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.0265-12.2012 Uthaiah, R.C., and A.J.",Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1016/S0042-6989(97)00105-3 Van Hook, M.J., and W.B.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1523/JNEUROSCI .1764-12.2012Van Hook, M.J., and W.B.",Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.3791/50007 Verona, M., S. Zanotti, T. Schäfer, G. Racagni, and M. Popoli.",Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1046/j.1471-4159 .2000.0740209.x Von Kriegstein, K., F. Schmitz, E. Link, and T.C.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/ 10.1046/j.1460-9568.1999.00542.x Wang, L.Y., and L.K.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1038/28645 Wesseling, J.F., and D.C.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/ 10.1523/JNEUROSCI.3471-07.2007 Wu, X.-S., B.D.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"13:649) http://dx.doi.org/10.1038/nn.2355 Xu, X., and C. Karwoski.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1371/journal.pone .0016944 Zhang, J., and S.M.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"http://dx.doi.org/10.1113/jphysiol.2005.082859 Zikich, D., A. Mezer, F. Varoqueaux, A. Sheinin, H.J.",OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
http://dx.doi.org/10.1523/JNEUROSCI.5096-07.2008,Non-OADS,/arxiv_data1/oa_pdf/29/56/JGP_201411229.PMC4210432.pdf
"These studies reveal how symmetrically dividing  cells both exploit and conform to tissue organization to  orient their mitotic spindles during division and establish  new adhesive junctions during cytokinesis.Cell biology in development Cell division and the maintenance of   epithelial order Katerina Ragkousi1 and Matthew C. Gibson1,2 1Stowers Institute for Medical Research, Kansas City, MO 64110 2Department of Anatomy and Cell Biology, Kansas University Medical Center, Kansas City, KS 66160 © 2014 Ragkousi and Gibson  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"http://dx.doi.org/10.1242/   dev.04173 12013; Guillot and Lecuit, 2013a; Herszterg et al., 2013).",OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"http://dx.doi.org/10.1016/j.cub.2011.06.05 5 Goldstein, B.",OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"21:499– 505. http://dx.doi.org/10.1016/j.tcb.2011.05.00 6 Gong, Y ., C. Mo, and S.E.",OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"430:689– 693. http://dx.doi.org/10.1038/nature0279 6 Green, R.A., R. Wollman, and K.B.",OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"http://dx.doi.org/10.1091/mbc.E05-03-025 9 Guilgur, L.G., P. Prudêncio, T. Ferreira, A.R.",Non-OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"139:503– 513. http://dx.doi.org/10.1242/dev.07102 7 Guillot, C., and T. Lecuit.",Non-OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"http://dx.doi.org/10.1016/j.devcel.2013.01.01 0 Guillot, C., and T. Lecuit.",OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"http://dx.doi.org/10.1126/   science.123524 9 Halbleib, J.M., and W.J.",OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"http://dx.doi.org/10.1038/nature0884 5 Hao, Y ., Q.",OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"http://dx.doi.org/10.1016/j.cub.2010.09.03 2 Harris, T.J., and U. Tepass.",OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"http://dx.doi.org/10   .1038/nrm292 7 Herszterg, S., A. Leibfried, F. Bosveld, C. Martin, and Y .",OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"http://dx.doi.org/10.1016/j.devcel.2012.11.01 9 Herszterg, S., D. Pinheiro, and Y .",OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"http://dx.doi   .org/10.1016/j.tcb.2013.11.00 9 Hertwig, O.",OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"http://dx.doi.org/   10.1016/j.tig.2010.01.00 8 Huang, J., W. Zhou, W. Dong, A.M. Watson, and Y .",OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"http://dx.doi.org/10   .1016/j.cell.2009.07.04 1 Konno, D., G. Shioi, A. Shitamukai, A. Mori, H. Kiyonari, T. Miyata, and F.  Matsuzaki.",OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"http://dx.doi.org/10.1038/ncb167 3 Kotak, S., C. Busso, and P .",OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"http://dx.doi.org/   10.1083/jcb.20120316 6 Kunda, P., and B. Baum.",OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"http://dx.doi.org/10.1016/j.tcb   .2009.01.00 6 Lancaster, O.M., and B. Baum.",OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"http://dx.doi.org/10.1016/j.semcdb.2014.02.01 5Baena-López, L.A., A. Baonza, and A. García-Bellido.",OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"http://dx.doi.org/10.1016/j.cub.2005.07.06 2 Baker, J., and D. Garrod.",OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"http://dx.doi.org/10.1074/   jbc.273.43.2831 4 Bellaïche, Y ., A. Radovic, D.F.",Non-OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"http://dx.doi.org/10.1016/j.cub.2013.07.01 7 Bilder, D., and N. Perrimon.",OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"http://dx.doi.org/10.1126/science.289.5476.11 3 Busson, S., D. Dujardin, A. Moreau, J. Dompierre, and J.R. De Mey.",OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"http://dx.doi.org/   10.1016/S0960-9822(98)70208- 8 Campinho, P., M. Behrndt, J. Ranft, T. Risler, N. Minc, and C.P.",OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
"15:1405– 1414. http://dx.doi.org/10.1038/ncb286 9 Cavey, M., and T. Lecuit.",Non-OADS,/arxiv_data1/oa_pdf/74/cd/JCB_201408044.PMC4210436.pdf
